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Abstract 
DNA methylation, an epigenetic modification which can regulate gene transcription independently from 
alterations to the nucleotide sequence, can be manipulated by lifestyle factors such as diet and exercise, 
hypothetically reversing aberrant DNA methylation associated with disease pathogenesis. The 
underlying mechanisms by which these changes occur are currently poorly characterised, however, in 
vitro data suggest that inflammatory mediators are involved. Furthermore, regular exercise appears to 
reduce inactivity-associated systemic inflammation, possibly by alterations to the methylome, thereby 
suggesting a cyclic relationship between exercise, inflammation, and epigenetic modification.  
The aims of this research programme, therefore, were to: characterise the acute changes that occur to the 
de novo DNA methyltransferases following exercise in peripheral blood mononuclear cells (PBMCs), 
and the role of exercise-induced systemic inflammation in this process; investigate how these changes 
then translate into functional modifications to the methylome; and to determine whether a training 
programme utilising sedentary individuals manipulates DNA methylation of genes involved in chronic 
systemic inflammation associated with physical inactivity.  
Pilot investigations corroborated previous in vitro data that recombinant IL-6 is able to regulate nuclear 
concentrations of DNMT3A and DNMT3B in PBMCs. In order to isolate the influence of circulating 
proteins independently from genetic polymorphisms that may influence susceptibility to epigenetic 
change, cells were stimulated with exercise-conditioned plasma following intense endurance exercise 
which elicited significant alterations in nuclear concentrations of DNMT3A and DNMT3B. Eccentric 
exercise, which is typically not associated with elevations in circulating cytokines, did not cause any 
significant changes in nuclear or cytoplasmic DNMT concentration, or global DNA methylation; this 
supports the hypothesis that transient systemic elevations in inflammatory cytokines are important 
regulators of epigenetic modifications associated with exercise. Lack of transcriptional changes in 
DNMT3A following both exercise training and an acute maximal bout suggests that, in line with in vitro 
data, that the observed elevations in nuclear DNMT concentration are largely due to cellular 
relocalisation and not gene expression of this enzyme. It remains to be elucidated whether the training 
regime, and the subsequent response to an acute maximal bout, is able to elicit differential methylation 
of IL6, NFκB2, and ASC, however, in vitro stimulation of PBMCs with the cytokines IL-6 and IL-1β did 
cause significant changes to IL6 promoter methylation, further supporting the role of these proteins in 
epigenetic regulation. 
The data presented in this thesis support the postulation that exercise-induced changes to DNA 
methylation in PBMCs likely occur due to systemic elevations of inflammatory proteins, in particular 
IL-6, which causes manipulation of de novo DNMT nuclear concentrations due to cellular translocation 
of the enzymes themselves. While it was not possible to determine whether exercise directly modified 
gene-specific methylation, in vitro experiments suggest that inflammatory cytokines are able to regulate 
IL6 promoter methylation in human PBMCs.  
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1 General Introduction and Literature Review 
The term ‘epigenetics’, translating simply to over or above genetics, is now generally accepted to 
mean ‘the study of changes in gene function that are mitotically and/or meiotically heritable and 
that do not entail a change in the sequence of DNA’ (Wu & Morris, 2001). Within sport and 
exercise sciences, the study of epigenetics is still relatively novel, however, the underlying 
principles have been discussed and debated for some time. The term epigenetics was first coined by 
Conrad Waddington in 1942, and appeared to contradict the traditional principles of genetics where 
early 20th century data supports the Darwinian theory that genotype directly influences phenotype, 
and no interaction occurs between genes and environment. Jean-Baptiste Lamarck’s hypothesis that 
traits acquired during a lifetime can be passed on to future generations appears to be the first 
suggestion that characteristics do not simply occur from ‘nature’ or ‘nurture’ alone. In light of 
greater understanding of the genome and transcriptional regulation, Lamarck’s theory of 
heritability is being re-credited somewhat, and many scientific disciplines are now acknowledging 
and utilising epigenetic techniques within their research.  
Given that lifestyle associated morbidity and mortality has reached epidemic proportions, it seems 
worthwhile to investigate how exercise exerts salubrious effects, and the underlying epigenetic 
modifications which may regulate this process.  
The following review will provide an overview of genetic and epigenetic mechanisms, how 
aberrations in these processes can contribute to disease pathogenesis, the involvement of 
inflammation as a possible driver and/or consequence, and the role of exercise in the resolution of 
chronic inflammation and presumably health beneficial changes in DNA methylation.  
1.1 Genetics  
Deoxyribonucleic acid (DNA), located within the nucleus of a cell, acts as the template by which 
transcription and translation of a functional protein occur. The familiar double-helix structure of 
DNA consists of nucleotides; a deoxyribose molecule bound to a phosphate group on one side, and 
one of four nitrogenous bases on the opposing side. The double-ringed purine bases Adenine (A) 
and Guanine (G) pair with the single-ringed pyridimine bases Thymine (T) and Cytosine (C) (A 
with T, G with C).  
Nucleosomes, which consist of ~147 base pairs (bp) of double helix structured DNA wrapped 
around an octamer of histone proteins, are the packaging units of DNA that form chromatin fibres, 
and when condensed further, form chromosomes. 
The term ‘gene’ is most commonly used to describe a defined section of DNA that is transcribed, 
and is composed of promoter and coding regions. The coding regions, known as exons, are not 
continuous, but rather, are broken up by sections of DNA called introns that are not incorporated 
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into messenger ribonucleic acid (RNA). Upon binding of a transcription factor to a promoter 
region, typically located upstream of the gene, RNA polymerases begin to separate the two strands 
of DNA by cleaving the hydrogen bonds. RNA polymerase then adds RNA nucleotides (Uracil (U) 
replacing T) to the complementary single stranded DNA nucleotides. If the gene is protein coding, 
mRNA will exit into the cytoplasm via the nuclear pore complex, whereby ribosome-mediated 
translation into a functional protein will occur.  
 
 
 
 
Figure 1.1 – Schematic of the molecules that make up a short section of DNA. 
 
Not only did the discovery of epigenetic modifications significantly complicate this process, it also 
contradicted the long held belief that phenotypes occur as a consequence of genotype or 
environment, with no interaction between them.   
 
 
Figure 1.2 – Structure of a chromatin fibre (image provided courtesy of Abcam Inc.) 
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1.2 Epigenetics 
Environmental factors such as diet (Choi & Friso, 2010), smoking (Kanherkar, Bhatia-Dey, & 
Csoka, 2014), and physical activity (PA) (section 1.6), can exert significant influence on an 
individual’s phenotype via epigenetic manipulation of gene expression. Research into the 
underlying molecular mechanisms that regulate these processes is still relatively contemporary, 
however, there are a number of well-defined epigenetic modifications that form the basis of 
investigation thus far. 
1.2.1 Histone Modifications  
Post-translational modifications to the aforementioned histone proteins are key moderators of gene 
activity, with acetylation and methylation the best characterised, although ubiquitation, 
phosphorylation, sumoylation, ADP-ribosylation and citrullination also occur.  
 
Figure 1.3 – Histone modifications. a) Histone acetylation; open structure. b) Histone methylation 
such as H3K4me3; open structure. c) Histone methylation such as Hk9me3; closed structure. 
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Acetylation of lysine (K) residues within the N-terminal tail of the histone proteins is associated 
with gene activation by neutralising the positive charge of lysine, thus decreasing attraction 
between histones and DNA. Additionally, the attachment of an acetyl group, via histone 
acetyltransferases (HAT), can act as an attachment site for other proteins that are able to recruit 
chromatin remodelling complexes. Consequently, chromatin is less tightly bound which allows 
transcription factor binding, thus resulting in gene activation and protein translation. Histone 
acetylation can be reversed by histone deacetylases (HDAC) however, restoring the positive 
charge, and thus affinity between lysine and DNA.  
In contrast, methylation of histones, catalysed by histone methyltransferase (HMT), can correlate 
with either transcription or repression depending upon the locus of modification. For example, tri-
methylation of lysine residue 4 of histone 3 (H3K4me3) causes gene transcription, whereas tri-
methylation of lysine 9 or 27 (H3K9me3/H3K27me3) results in gene silencing. Bannister and 
Kouzarides (2011) have published a review summarising these modifications and can be referred to 
for more detail.  
1.2.2 Non-coding RNA 
Non-coding RNAs (ncRNA) are RNA molecules that are not translated into a protein and can be 
classified into many sub-groups, including, but not limited to, micro RNAs (miRNA), involved in 
post-transcriptional gene silencing; piwi-interacting RNAs, which direct DNA methylation at 
transposable elements; and long non-coding RNAs, which direct epigenetic machinery such as 
chromatin remodelling complexes. MiRNAs have gained a vast amount of research attention with 
regard to epigenetics, given the overlap with DNA methylation. For example, alterations in DNA 
methylation of dysregulated miRNA genes have been reported in a plethora of cancers, including 
hepatocellular carcinoma cell lines (He et al., 2015), in addition to breast, ovarian, pancreas, 
colorectal, renal, gastric, lung, cervical, glioblastoma, bladder, endometrial, prostate, melanoma, 
testicular, and haematological cancers (Lopez-Serra & Esteller, 2012). Furthermore, the role of 
Interleukin 6 (IL-6) in the modification of DNA methyltransferase 1 (DNMT1) expression could be 
mediated by miRNA-148a and miRNA-152 (Braconi, Huang, and Patel, 2010; Huang, Wang, Guo, 
& Sun, 2010a; Wang et al., 2012b). With regard to the de novo methyltransferases, miRNA-143 has 
been shown to target DNMT3A (Ng et al., 2009), miRNA-148 targets the DNMT3B protein coding 
region (Duursma, Kedde, Schrier, Sage, & Agami, 2008), miRNA-193a represses DNMT3A 
expression (Li et al., 2013), while miRNA-29 appears to be involved in the regulation of both 
DNMT3A and DNMT3B (Fabbri et al., 2007; Garzon et al., 2009; Takada, Berezikov, Choi, 
Yamashita, & Mano, 2009). This demonstrates a complex overlap between different epigenetic 
alterations and reinforces the fact that each one does not simply occur in isolation.  
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1.2.3 DNA Methylation 
While ‘genome’ refers to an organism’s full set of genes contained within the DNA, the term 
‘methylome’ is used to describe the methylation modifications within the genome. DNA 
methylation, characterised by the DNMT regulated addition of a methyl group to the nucleotide 
cytosine, creating 5-methylcytosine (5-mC), is the most abundantly studied of the aforementioned 
epigenetic modifications. This process occurs at CpG dinucleotides (cytosine and guanine 
separated by phosphate in the linear sequence along DNA), which contribute to less than 1% of the 
genome (Lander et al., 2001). Clusters of CpG dinucleotides are often located at transcription start 
sites of genes such as promoter regions, and although DNA methylation has also been found to 
occur at non-CpG sites (Guo et al., 2014), the process is more commonly reported at the 
former.  Unmethylated sequences with augmented CpG content are known as CpG islands, which 
were initially defined as regions of at least 200bp, with a GC content of at least 50%, and an 
observed to expected ratio of 0.6 or greater (Gardiner-Gardner & Frommer, 1987). Similar but 
slightly redefined cut offs of 500bp, 55%, and 0.65 or greater have been offered more recently by 
Takai and Jones (2002). 
These CpG islands overlap the promoter region of approximately 60 to 70% of human genes 
(Illingworth & Bird, 2009), although only 7% of genomic CpGs are actually located with CpG 
islands (Rollins et al., 2006). Furthermore, promoters with lower CpG density are generally 
reported to be hypermethylated (Weber et al., 2007). It has been suggested that these islands serve 
to assist transcription factor identification of appropriate promoter sequences (Prestridge & Burks, 
1993). Dynamic methylation patterns tend to occur more frequently in CpG shores, regions of low 
CpG content that flank CpG islands, and CpG shelves, regions that flank shores (Doi et al., 2009; 
Irizarry et al., 2009) that can also regulate gene expression (Rao et al., 2013). 
The effect of methylation at gene promoter or first exon CpG islands is transcriptional silencing of 
gene expression (Brenet et al., 2011; Rhee et al., 2013), of which the inhibition of transcription 
factor binding, and the recruitment of methyl-CpG binding proteins (MBPs) which repress the 
chromatin structure, are key mechanisms (Auclair & Weber, 2012).  
Non-promoter i.e. gene-body methylation also occurs with some evidence pointing to a correlation 
between methylation and expression within these regions (Hellman & Chess, 2007; Laurent et al., 
2010; Quierós, Beekman, & Martín-Subero, 2013; Shenker et al., 2015). The mechanisms and role 
of intragenic methylation remains poorly understood although working hypotheses suggest that 
alternative promoter usage, alternative splicing, and regulation of ncRNA are all important 
functional biological consequences (Kulis et al., 2013). 
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1.2.4 DNA Methyltransferases 
A number of DNMTs regulate the methylation process. DNMT1 methylates hemi-methylated 
DNA, and therefore, has an important role with regards to the maintenance of methylation during 
cell division. DNMT3A and DNMT3B, on the other hand, show preference toward unmethylated 
CpG dinucleotides and are both involved in de novo methylation during development, albeit at 
different stages; DNMT3B is the primary enzyme involved in the earlier embryonic stages such as 
implantation, whereas DNMT3A expression is greater in the latter stages of embryonic 
development (Okano, Bell, Haber, & Li, 1999) as well as during methylation of maturing gametes 
(Hara et al., 2014; Sakai, Suetake, Shinozaki, Yamashina, & Tajima, 2004). Both enzymes are also 
expressed in somatic cells, though at very low levels in contrast to embryonic and germ cells. 
Another DNMT variant, DNMT3L, despite a lack of methyltransferase activity, assists DNMT3A 
and DNMT3B by increasing their ability to bind to the methyl donor, S-adenosylmethionine 
(SAM) (Kareta, Botello, Ennis, Chou, & Chédin, 2006). Although the maintenance of methylation 
is primarily thought to be regulated by DNMT1, there is evidence to suggest that DNMT3A and 
DNMT3B also contribute to this process (Chen, Ueda, Dodge, Wang, & Li, 2003). All three of the 
aforementioned DNMTs are essential in mammalian development as demonstrated by the death of 
DNMT deficient mice (Lei et al., 1996; Okano et al., 1999). Mutation of the DNMT3B gene, and 
the subsequent loss of methyltransferase activity, can cause ICF (Immunodeficiency, Centromere 
instability and Facial anomalies) syndrome, an extremely rare recessive disease that affects serum 
immunoglobulin levels and leads to severe infections, often of the pulmonary or gastrointestinal 
tracts. Psychomotor and growth retardation are also common symptomologies of ICF patients 
(Ehrlich, 2003). In addition, DNMT3B has been linked to the fatty acid induced non-CpG 
methylation of the PGC1α promoter observed in Type-2 Diabetes Mellitus (T2DM) patients 
(Barrès et al., 2009). 
1.2.4.1 DNMT3A Isoforms and Transcripts 
DNMT3A has five protein coding transcripts (“1000 Genomes”, 2015), four of which are 
recognised by the National Center for Biotechnology Information (NCBI). It is not clear, however, 
whether all of these transcripts code distinct functional proteins. Chen, Ueda, Xie, and Li (2002) 
identified an isoform, DNMT3A2, initiated from a downstream intronic promoter of the DNMT3A 
gene which lacks the N-terminal 223 amino acid residue. In vitro, this isoform has been shown to 
exhibit similar methyltransferase activity to the main functional protein, however, appears to 
predominantly be expressed in embryonic, testis, ovary, thymus, and spleen cells, in contrast to the 
ubiquitously expressed main DNMT3A1 protein strongly suggesting unique functions particularly 
during development. In HEK293T cells, the two isoforms were reported to share 93% of DNA 
methylation target sites however (Choi, Heo, Byun, An, Lu, & Yang, 2011). DNMT3A1 does 
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appear to possess greater DNA binding and methylation activity due to the aforementioned 
variation in the N-terminal domain (Suetake et al., 2011). 
 
 
 
 
 
 
 
 
Figure 1.4 – DNMT-regulated transfer of a methyl group (CH3) from the methyl donor SAM, 
converting cytosine (left) into 5-methylcytosine (right), leaving S-adenosylhomocysteine (SAH). 
1.2.4.2 DNMT3B Isoforms and Transcripts  
DNMT3B has eight protein coding transcripts (“1000 Genomes”, 2015), with six of these 
recognised by the NCBI as coded proteins. DNMT3B1 and DNMT3B2 are considered to be 
enzymatically active, whereas the other isoforms which occur due to alternative splicing of exons 
10, 21 or 22, lack certain motifs and are presumed to be inactive as a consequence. Specifically, 
DNMT3B3 lacks part of motif IX (Aoki et al., 2001; Okano et al., 1999), whereas DNMT3B4 and 
DNMT3B5 encode truncated proteins lacking motifs IX and X (Robertson et al., 1999). Chen et al. 
(2002) were able to identify another variant in embryonic stem cells named DNMT3B6 which lacks 
exons 21 and 22, and similarly to DNMT3B3, lacks motif IX. Similarly to DNMT3A, particular 
isoforms appear to show tissue specificity; DNMT3B1 and DNMT3B6 were the dominant isoforms 
expressed in embryonic cells, whereas conversely, DNMT3B2 and DNMT3B3 were found to be 
expressed at a greater level in testis, ovary, spleen, thymus, and liver. Interestingly, inactive 
isoforms such as DNMT3B3 and DNMT3B4 are able to interact with active isoforms; the effects of 
binding differed drastically, as DNMT3B3 was reported to enhance de novo DNA methylation 
three to four-fold, in contrast to the three-fold reduction in methylation activity caused by 
DNMT3B4 interaction (Gordon, Hartono, & Chédin, 2013). A frequently expressed aberrant 
transcript, DNMT3B7, may also interfere with DNA methylation via disruption of binding to DNA 
methylation machinery (Ostler et al., 2007). The effect of these interactions, while considerably 
lower than the 20-fold enhancement of DNA methylation by DNMT3L, highlights a mechanistic 
role for proteins that do not necessarily cause de novo methylation alone. Unfortunately, the precise 
functional roles of the various DNMT3B isoforms is still poorly understood in both embryonic and 
somatic cells (Duymich, Charlot, Yang, Jones, & Liang, 2016).  
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1.2.5 S-adenosylmethionine Cycle 
SAM is involved in a complex pathway (figure 1.5) in order to be resynthesized following donation 
of its methyl group, as described in figure 1.4. Furthermore, it has been reported that oxidative 
stress and global DNA hypomethylation are linked due to a number of potential mechanisms; 
methionine adenosyltransferase (MAT), which catalyzes the addition of adenosine to methionine to 
yield SAM, exhibits decreased activity in an oxidised environment (Pajares, Durán, Corrales, 
Pliego, & Mato, 1992). In addition, cystathione β-synthase directs homocysteine towards 
glutathione (GSH) generation in order for glutathione peroxidase (GPx) to be formed due to its 
protective role against oxidative damage (Mosharov, Cranford, & Banerjee, 2000). Consequently, 
homocysteine is less abundantly available for methionine synthesis, and by proxy, SAM synthesis, 
thereby reducing DNA-methylating capacity (Hitchler & Domann, 2007). Niedzwiecki et al. (2013) 
showed that a more oxidised blood GSH status was associated with lower global DNA methylation 
in Bangladeshi adults, which is consistent with this hypothesis. More directly, GSH-depleting 
agents have been reported to decrease SAM, presumably due to a rebound mechanism whereby 
methionine is utilised in the transsulfuration pathway in order to replenish GSH, albeit in Syrian 
hamsters (Lertratanangkoon, Wu, Savaraj, & Thomas, 1997). Similarly, bladder cancer cells treated 
with hydrogen peroxide (H2O2) exhibited hypomethylation in the repetitive element LINE-1 (long 
interspersed nuclear element), a marker shown to correlate well with other measures of global 
methylation (Wu et al., 2011), and RUNX3 hypermethylation, furthering demonstrating that 
oxidative stress can exert a direct effect on DNA methylation at a global and gene-specific level 
(Wongpaiboonwattana, Tosukhowong, Dissayabutra, Mutirangura, & Boonla, 2013). 
1.2.6 Methyl-CpG Binding Proteins 
MBPs play an important role in transcriptional repression and heterochromatin (i.e. closed) 
structure formation. Three structural families have been identified; methyl CpG-binding domain 
(MBD), Zinc Finger, and SET and RING finger-associated domain.  
MBD1, 2 and 4, which are able to bind to methylated CpG sites, are largely considered to mediate 
the suppressive effect of DNA methylation. Conversely, MBD3, 5 and 6 do not bind with 
methylated DNA. MeCP2, another MBD, is thought to interact with a Sin3 and HDAC complex at 
methylated regions, which results in the repression of the chromatin structure via the mechanism 
discussed in 1.2.1 (Wade, 2001). There are, however, other mechanisms that can result in 
chromatin modifications, including interactions between MeCP2 and HMTs (Fuks, Hurd, Wolf, 
Nan, Bird, & Kouzarides, 2003), such as EZH2 (Mann et al., 2010).  
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Figure 1.5 – Schematic representation of how SAM is regenerated following donation of its methyl 
group during DNA methylation. 
 
Kaiso, a Zinc Finger protein, is able to differentiate between methylated and unmethylated regions, 
and acts as a transcriptional repressor. Other Zinc Finger protein family members include ZBTB4, 
ZBTB38 and ZFP57 (Clouaire & Stancheva, 2008).  
UHRF1 and UHRF2 (Ubiquitin-like, containing PHD and RING finger domains) have the ability to 
bind with methylated DNA through their SRA domains, with the former recruiting DNMT1, and 
therefore aids the maintenance of methylation. Thus far, UHRF1 is the only MBP that has been 
shown to bind 5-hydroxymethylcytosine (5-hmC), discussed in section 1.2.7, as well as 5-mC 
(Buck-Koehntop & Defossez, 2013). 
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Figure 1.6 – a) Unmethylated CpG dinucleotides at a gene promoter region - gene is active; b) 
DNMT-mediated methylation of CpG dinucleotides, followed by MBP recruitment which causes 
chromatin remodelling and blocking of transcription factors. 
 
The importance of MBPs in normal developmental regulation is highlighted by Rett’s syndrome, a 
neurodevelopmental disorder of the brain that affects 1 in 10,000 to 1 in 15,000 females, and is 
commonly mistaken for autism during the early stages of onset. Common symptoms include 
microcephaly, chorea, ataxia, apraxia and seizures (Van den Veyver & Zoghbi, 2001). Rett’s 
syndrome is caused by germline mutations in MeCP2. Given the role of MeCP2 in binding to 
methylated portions of DNA and subsequent recruitment of the aforementioned transcriptional 
repressor complex (Sin3 and HDAC), mutations, of which more than 60 have been identified, 
generally result in reduced affinity for methylated DNA. Consequently, improper gene suppression 
occurs (Dragich, Houwink-Manville, & Schanen, 2000). The interactions between the various 
enzymes and proteins discussed thus far highlights that DNA methylation does not occur in 
isolation, but rather, is part of a complex cascade of events that regulates epigenetic modification. 
1.2.7 DNA Demethylation 
An abundance of research has allowed extensive characterisation of both structure and functionality 
of the enzymes that catalyse DNA methylation. Currently however, less is known regarding the 
enzymes involved in active demethylation; the removal of a methyl group from 5-mC. If 
hypermethylation of a gene’s promoter region causes suppression of activity, reversal of this 
process should logically result in gene transcription and protein translation.  
The identification of Ten-Eleven Translocation methylcytosine dioxygenase (TET) enzymes was of 
huge importance in our understanding of the underlying mechanisms that govern the demethylation 
process. As shown in figure 1.7, TET regulates oxidation of 5-mC to 5-hmC (Tahiliani et al., 
2009), then to 5-formylcytosine (5-fC) and 5-carboxylcytosine (5-caC) which can both be 
converted back to unmodified cytosine via base excision repair or thymine-DNA glycosylase 
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(Kohli & Zhang, 2013). The TET family contains three enzymes: TET1, TET2, and TET3; TET2 is 
the most widely expressed and promotes demethylation in T cells (Ichiyama et al., 2015) and 
monocytes (Klug, Schmidhofer, Gebhard, Andreeson, & Rehli, 2013) while TET3 has also been 
found to be expressed within peripheral blood leukocytes (Lorsbach, Moore, Mathew, Raimondi, 
Mukatira, &, Downing, 2003).   
 
 
 
 
 
 
 
 
 
 
 
Figure 1.7 – Demethylation cycle. 
C = cytosine; 5-mC = 5-methylcytosine; 5-hmC = 5-hydroxymethylcytosine; 5-fC = 5-
formylcytosine; 5-caC = 5-caboxylcytosine; A = abasic; TDG = DNA glycosylase; AM-AR = 
active modification-active restoration; AM-PD = active modification-passive dilution; BER = Base 
excision repair. Enzymes in green.  
1.2.8 Role of DNA Methylation  
Not only is DNA methylation an important process in normal transcriptional regulation as 
discussed, it also plays a role in X chromosome inactivation and genomic imprinting (Jin & 
Robertson, 2011). 
X chromosome inactivation, whereby one of the two X chromosomes in the female cell are 
silenced, is a dosage compensation mechanism in order to ensure that only one set of genes are 
expressed in each cell. Sharp et al. (2011) have shown that the majority of CpG islands on the 
inactive X chromosome are hypermethylated, while conversely, genes that do not undergo X 
chromosome inactivation have lower levels of methylation within the promoter regions. The X 
Inactivation Centre, a component of the X chromosome, is composed of a number of non-coding 
RNA genes such as Xist (X-inactive specific transcript) (Penny, Kay, Sheardown, Rastan, & 
Brockdorff, 1996) and Tsix, which bind during X chromosome inactivation. An inverse relationship 
exists between Xist and Tsix expression (Ahn & Lee, 2008); Xist is only expressed in cells with at 
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least two X chromosomes, and has been found to be essential in the X inactivation process (Penny 
et al., 1996; Wutz & Jaenisch, 2000), whilst Tsix is only expressed in embryonic cells (Migeon, 
Chowdhury, Dunston, & McIntosh, 2001). 
Genomic imprinting, whereby only one working gene is inherited due to epigenetic silencing of a 
non-expressive gene, is also essential for normal development. If imprinting did not occur, the 
individual would subsequently have either two active or two inactive copies of a gene, for example 
in Prader-Willi syndrome, whereby deletion of a group of paternally inherited genes on 
chromosome 15 results in hypogonadism, infertility, behavioural and cognitive disabilities, 
hypotonia, hyperphagia, and obesity. Conversely, Angelman syndrome is caused by a maternal 
deletion on chromosome 15, and is characterised by mental retardation, seizures, ataxia and 
hyperactivity. Certain cancers such as Wilms’ tumour, an embryonic kidney cancer, are also caused 
by abnormal genomic imprinting. The paternal IGF2 and maternal H19 genes are normally 
expressed due to imprinting, however, this is lost in the cells of Wilm’s tumour patients which is 
thought to cause overexpression of IGF2 thereby promoting tumourigenesis (Lobo, 2008). 
1.3 Aberrant DNA Methylation and Disease 
While methylation is clearly an essential component of normal development and transcriptional 
regulation, aberrant patterns of methylation are associated with a number of diseases. The 
following section serves as an overview of how epigenetic dysregulation is a contributory factor in 
disease pathogenesis. 
1.3.1 Cancer 
Global DNA hypomethylation is common in cervical, prostate, stomach, lung, bladder, 
oesophageal, colorectal, breast and liver cancers in various cell and tumour types (Lu, Qiu, Hu, 
Wen, Su, & Richardson, 2006), while promoter CpG hypomethylation and subsequent augmented 
expression of EGR1 and TFF3 occurs during bladder cancer and hepatocellular carcinoma 
development, respectively (Ogishima et al., 2005; Okada et al., 2005). In addition, 
hypermethylation of tumour suppressor gene CpG islands, causing suppression and thereby 
promoting oncogenesis, is well established in a vast number of human cancers (Lu et al., 2006). 
Dysregulation of DNMTs also appears to be related to various cancers. For example, increased 
DNMT activity has been reported in colon cancer progression (Issa et al., 1993), while mutations in 
DNMT3A are common in patients suffering from myelodysplastic syndrome (Walter et al., 2011) 
and acute myeloid leukemia (Ley et al., 2010). 
 
 
  
14 
 
1.3.2 Type 2 Diabetes Mellitus 
The link between methylation and metabolic health is also beginning to be acknowledged, 
particularly within T2DM. Genome-wide analyses have shown that there are a vast number of CpG 
sites that are differentially methylated in T2D pancreatic islets compared with healthy controls 
(Dayeh et al., 2014; Volkmar et al., 2012). Similarly, vastus lateralis skeletal muscle biopsies taken 
from men with or without a family history of T2DM identified 65 genes that exhibited differential 
methylation profiles between the two groups (Nitert et al., 2012). Hypermethylation and decreased 
expression of GLP1R, responsible for glucose-dependent insulin release (Hall, Dayeh, Kirkpatrick, 
Wollheim, Nitert, & Ling, 2013), PDX1, involved in β cell maturation (Yang et al., 2012), and 
PGC1α, a regulator of mitochondrial biogenesis and function (Ling et al., 2008), have been 
reported in pancreatic islets of type-2 diabetics. Not only has hypermethylation been reported at 
CpG sites within the insulin gene promoter region, but HbA1c levels were shown to be correlated 
with methylation, thereby supporting the hypothesis that hyperglycaemia is a regulator of 
methylation, which had previously been reported in clonal rat β cells (Yang et al., 2011).  
1.3.3 Cardiovascular Disease 
Global hypomethylation of advanced human atherosclerotic lesions has been reported using High 
Performance Liquid Chromatography (Hiltunen et al., 2002). Conversely however, elevated levels 
of methylation measured in the repetitive element ALU, similar to the aforementioned LINE-1 
repetitive element method, were positively associated with risk of cardiovascular disease (Kim et 
al., 2007). This contradictory evidence is likely explained by differences in study population or the 
measurement techniques. 
Inflammatory processes are well recognised in the pathogenesis of atherosclerosis. Briefly, 
endothelium dysfunction causes adhesion of circulating monocytes, which are then directed toward 
the intima by chemokines, and thus differentiate into macrophages. Ingestion of oxidized LDL 
particles by the macrophages forms foam cells which accumulate as coronary plaque. Endothelial 
Nitric Oxide Synthase (eNOS), the enzyme responsible for nitric oxide production which inhibits 
leukocyte adhesion to the endothelium, is not only regulated by pro-inflammatory cytokines, but 
can also influence expression of NFκB and COX2 (Ying & Hofseth, 2007). Interestingly, low levels 
of methylation have been reported at the eNOS promoter in endothelial cells that express the 
protein, while conversely, high levels of methylation correlate with non-expression (Chan et al., 
2004b). Additionally, the chromatin structure of the inducible Nitric Oxide Synthase (iNOS) 
promoter can be modified when induced by cytokines (Mellott, Nick, Waters, Billiar, Geller, & 
Chesrown, 2001), while iNOS expressing cells were found to have lower levels of methylation 
within the promoter region (Chan, Fish, Mawji, Leung, Rachlis, & Marsden, 2005). iNOS is 
expressed in macrophages, endothelial cells and vascular smooth muscle cells, and contributes to 
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plaque instability due to apoptosis of smooth muscle cells (Boyle, 2005), thus, gene promoter 
hypomethylation and subsequent expression is unfavourable at this locus.  
Estrogen receptors α (ERα) and β (ERβ), the genes that code for estrogen which has 
cardioprotective effects (Mendelsohn, 2002), appear to be hypermethylated at the promoter regions 
in human atherosclerotic plaques (Post et al., 1999) which was corroborated in ascending aorta, 
carotid and femoral artery lesions (Kim et al., 2007). Similarly, promoter hypomethylation and 
subsequent elevated protein levels of plasma factor VII, a protein that causes blood coagulation, 
was found to be associated with atherosclerosis (Friso et al., 2012). 
1.3.4 Inflammatory Bowel Disease 
The role of DNA methylation in the pathogenesis of the inflammatory bowel diseases ulcerative 
colitis (UC) and Crohn’s disease was identified early on with the finding that methylation of the 
rectal mucosa was 10 times greater in chronic UC patients compared with healthy controls (Gloria 
et al., 1996). Cooke et al. (2012) reported similar findings between UC patients and controls. They 
also found that global hypermethylation had only occurred in inflamed mucosa of UC patients, and 
not in non-inflamed tissue, highlighting the importance of inflammation as a contributory factor in 
epigenetic dysregulation. Hypermethylation of the tumour suppressor DAPK promoter was shown 
to result in transcriptional inactivation, a modification related to inflammation associated tumours 
such as gastric carcinoma (Kang, Zhang, Kim, Bae, & Hyun, 2001). A direct association was also 
observed between DAPK methylation and inflammation in the mucosa of UC patients (Kuester et 
al., 2010). The direction of causality remains to be elucidated, however, it is possible that chronic 
inflammation causes hypermethylation of the DAPK promoter, which has an overall oncogenic 
effect via the downregulation of DAPK. This provides a direct mechanistic link between 
inflammatory bowel disease (IBD) and the increased risk of colitis-associated cancers.  
All of the diseases discussed thus far share a common trait in that they are all associated with 
inflammatory processes. A logical progression would be then to examine the role of aberrant 
changes in immune cells given their direct role in immune and inflammatory regulation.  
1.4 Disease-associated Genetic and Epigenetic Dysregulation in 
Leukocytes  
Peripheral blood mononuclear cells (PBMCs) are a population composed of any leukocyte located 
in the blood that has a round nucleus such as T lymphocytes, B lymphocytes, Natural Killer (NK) 
cells, monocytes, and dendritic cells, with lymphocytes comprising the vast majority. Erythrocytes 
and polymorphonuclear cells such as neutrophils and eosinophils are removed during fractionation, 
however, basophils are sometimes present in very small proportions. Peripheral blood cells share 
more than 80% of the transcriptome with nine major other tissues, including organ-specific genes 
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(Mohr & Liew, 2007), therefore it is clear that they are a useful, relatively non-invasive, and 
inexpensive biomarker for investigating genetic and epigenetic perturbations associated with 
disease. 
In addition to the aberrant epigenetic changes that contribute to the pathogenesis of a number of 
disease states in a vast number of tissues (section 1.3), a large body of evidence demonstrates that 
epigenetic dysregulation in PBMCs is central in the pathophysiology of various diseases, 
particularly those associated with inflammation. Not only this, but PBMC gene expression can be 
used as a predictive or diagnostic marker. For example, PBMC gene expression can be used in the 
prediction of chronic fatigue syndrome (Kaushik et al., 2005), pancreatic cancer (Baine et al., 
2011), and glucocorticoid sensitivity in asthma (Hakonarson et al., 2005), outcome in idiopathic 
pulmonary fibrosis (Herazo-Maya et al., 2013), and in the identification of post-traumatic stress 
disorder (Segman, Shefi, Goltser-Dubner, Friedman, Kaminski, & Shalev, 2005). In addition, 
PBMC gene expression can be used as a diagnostic marker of COPD (Bahr et al., 2013), as 16 
genes have been reported to be differentially regulated in COPD compared with controls (Wu, Sun, 
Chen, Bai, & Wang, 2014).  The expression of a number of genes, including IM2, NLRP3, ASC, 
CASP1, CASP5, and IL1β have been shown to be associated with age (Waldron & Holodniy, 
2015), while a vast number of genes are differentially expressed in peripheral arterial disease 
(Masud, Shameer, Dhar, Ding, & Kullo, 2012). Furthermore, differential expression of a number of 
genes is able to discriminate between Dengue fever and Dengue hemorrhagic fever (Ubol, 
Masrinoul, Chaijaruwanich, Kalayanarooj, Charoensirisuthikul, & Kasisith, 2008). 
Not only do aberrant alterations to the methylome occur in the variety of tissues discussed above, 
epigenetic dysregulation in PBMCs is closely linked to a number of diseases, again, with 
inflammatory components.  
1.4.1 Cancer 
On a global scale, hypomethylation of PBMC DNA appears to be an early change in carcinogenic 
processes; in a case-control study, cancer subjects, which included malignancies ranging from 
hemotalogical, bladder, gastrointestinal, prostate, breast, kidney, lung, and larynx, exhibited lower 
DNA methylation than controls, measured by Liquid Chromatography Mass Spectometry (Friso et 
al., 2013). This study highlights the use of aberrant changes to the global methylome as a useful 
biomarker of cancer risk.   
With regard to specific cancers, nasopharyngeal cancer and colorectal cancer (CRC) were both 
associated with lower LINE-1 methylation (Kitkumthorn, Tuangsintanakul, Rattanatanyong, 
Tiwawech, & Mutirangura, 2012). On a gene-specific level, methylation at FOXP3 CpGs were 
associated with transcriptional suppression of the gene in CRC patients PBMCs and tumour 
samples (Ganapathi, Beggs, Hodgson, & Kumar, 2014). Due to the role of this gene in the control 
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of regulatory T cells, suppression as a consequence of epigenetic changes likely explains the 
previously reported large number of tumour infiltrating FOXP3+ regulatory T cells, which was 
inversely correlated with outcome, in various cancers (Curiel et al., 2004; Hiraoka, Onozato, 
Kosuge, & Hirohashi, 2006; Kobayashi et al., 2007). Furthermore, over 27,000 and 15,000 
differentially methylated regions were discovered in endometrioid adenocarcinoma and uterine 
papillary serous carcinoma, respectively (Zhang et al., 2014). The majority of regions possessed 
promoter or enhancer functions of genes associated with development and disease of the uterus. 
Although not strictly a cancer, elevated LINE-1 methylation is associated with cervical 
intraepithelial neoplasia, an abnormal growth of squamous cells on the cervical lining, which can, 
however, progress to cervical cancer if untreated (Piyathilake et al., 2011). 
1.4.2 Cardiovascular Disease 
Lower LINE-1 methylation has been linked to increased risk of ischemic heart disease and stroke 
in peripheral blood (Baccarelli et al., 2010), while 83% and 75% of subjects that exhibited 
augmented ABCG1 and GALNT2 promoter methylation, respectively, also suffered from coronary 
heart disease (Peng et al., 2014). A large scale study of over 60,000 Chinese adults reported that 
global methylation, measured in the repetitive elements ALU and Satellite 2, was augmented with a 
history of cardiovascular disease in men but not women in peripheral blood leukocytes (Kim, Long, 
Arakawa, Wang, Yu, & Laird, 2010). Furthermore, global hypomethylation was reported in PBMC 
samples from Apoe-/- mice at six months but not four weeks (Lund et al., 2004). Given the role of 
apolipoprotein E in the production of lipoproteins, which in turn are involved in atherosclerosis, 
epigenetic dysregulation of this gene could be a causative event in the early stages of coronary 
artery disease.  
1.4.3 Metabolic Disorders 
Similarly to cancer, metabolic disorders are also characterised by epigenetic dysregulation in 
tissues that directly influence the progression of the disease such as tumours or pancreatic islets, 
but also in PBMCs.  
Type 1 Diabetes Mellitus (T1DM) differs from Type 2 due to the autoimmune destruction of 
pancreatic β cells, in contrast to lifestyle-induce insulin resistance that characterises Type 2. In an 
analysis of whole blood, modifications to the methylome have been shown to be associated with 
proliferative diabetic retinopathy in those with T1DM (Agardh et al., 2015). 349 differentially 
methylated CpG sites across 233 unique genes were identified, with 79% of these hypomethylated 
compared with controls. In a prospective cohort, 28 CpG sites were identified in those that then 
developed retinopathy compared with those that didn’t; many of these sites overlapped the genes 
that were previously identified in the case control analysis. Furthermore, of seven CpG sites in the 
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INS promoter region of leukocyte DNA, T1DM patients possessed differential methylation in four, 
although it must be noted that methylation did not correlate with the duration of disease or HbA1c 
(Fradin et al., 2012).  
Discordance in T1DM incidence between monozygotic twins has been reported to be 40 to 50%, 
and thus, is a useful model to investigate the epigenetic contribution to the disease. An epigenome-
wide association study identified 132 differentially methylated CpG sites in CD14+ monocytes 
isolated from discordant twin pairs which were associated with various genes involved in immune 
responses and T1DM such as NFκB1A, TNF, and GAD2 (Rakyan et al., 2011). Similarly, in B 
lymphocytes, 88 CpG sites were found to be differentially methylated between discordant twin 
pairs, with immune defence and cell signalling pathways being the associated with these 
differential methylation patterns (Stefan, Zhang, Conception, Yi, & Tomer, 2014). Once this data 
was then integrated with genome-wide association study data, six genes were shown to overlap; 
HLA-E was the only T1DM gene found to be hypomethylated at a promoter region CpG island, 
whereas two genes (HLA-DQA2 and CD226) were hypermethylated. The remaining three genes, 
HLA-DOB, INS, and IL-2RB were hypermethylated in the majority of twins, but this finding was 
independent of disease discordance. 
In a sample of T2DM patients with diabetic nephropathy, PBMC global methylation was 
significantly greater in those with albuminuria (Maghbooli, Larijani, Emamgholipour, Amini, 
Keshtkar, & Pasalar, 2014). Global methylation has also been reported to be elevated in B 
lymphocytes and natural killer (NK) cells in those with T2DM (Simar et al., 2014).  
In a large scale (n > 1,000) case-control analysis, Toperoff et al. (2012) identified a number of 
differentially methylated regions in leukocytes isolated from T2DM patients. Hypomethylation of a 
CpG site located within the first intron of the FTO gene, associated with T2DM and obesity, was 
also discovered. Importantly, this finding was significant even when factoring in the sequence 
polymorphism located in the same region. In addition to this, a prospective study in an independent 
sample showed that young individuals that later developed T2DM exhibited hypomethylation prior 
to the onset of symptoms. Similarly, although not using white blood cells but rather whole blood, 
analysis of a prospective cohort demonstrated that those that did not improve in measures of 
carbohydrate metabolism exhibited significantly lower LINE-1 methylation (Martin-Nunez et al., 
2014). Since reduced insulin sensitivity occurs early on in the progression of metabolic disorders, 
analysis of the blood or leukocytes could be a predictive biomarker of future diabetes risk.  
1.4.4 Autoimmune Disorders 
Aberrations in methylation are thought to be a contributory factor in autoimmune diseases such as 
Systemic Lupus Erythematosus (SLE). Global hypomethylation in T cells has been reported in 
patients with SLE (Richardson, Scheinbart, Strahler, Gross, Hanash, & Johnson, 1990; Zhu, Liang, 
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Li, Yang, Xiang, & Xu, 2011) due to decreased ras-MAPK (mitogen-activated protein kinase) 
pathway signalling and subsequent reduction in DNMT expression (Zhu et al., 2011) and activity 
(Deng et al., 2001). The gene that Perforin, a cytolytic protein, is transcribed from was reported to 
be hypomethylated in T cells of patients with active SLE, causing overexpression (Kaplan, Lu, Wu, 
Attwood, & Richardson, 2004).  
Global hypomethylation has been reported in CD4+ T helper cells, (Lei et al., 2009; Qin et al., 
2013), concomitantly with augmented expression of MBD2 and MeCP2, and attenuated expression 
of DNMT1 and MBD4 (Lei et al., 2009). Global methylation was also inversely correlated with 
disease severity, suggesting that epigenetic mechanisms possess a central role in the 
pathophysiology of the disease. On a gene-specific level, hypomethylation of IL-10 and IL-13 has 
been reported (Zhao et al., 2010a). Despite the role of IL-10, and to an extent IL-13, as anti-
inflammatory cytokines, aberrant expression of these genes is likely to induce faulty inflammatory 
regulation. 
In addition, active SLE is associated with hypomethylation of regions close to the ITGAL promoter, 
involved in LFA-1 (lymphocyte function-associated antigen 1) expression (Lu et al., 2002). Since 
LFA-1 overexpression is common in active SLE (Yung et al., 1996), this provides a mechanistic 
link between methylation and the development of autoimmunity.  
With a specific focus on PBMCs, Liu et al. (2011) discovered global hypomethylation and 
augmented DNMT1 and MBD2 expression. The differential expression of DNMT1 between PBMCs 
and T cells alone highlights the tissue specificity of epigenetic modulation, which is further 
demonstrated by the patterns of global methylation; the aforementioned global demethylation 
reported in T cells, CD4+ T helper cells and PBMCs contrasts the global hypermethylation that has 
been reported in whole blood (Errante, Perazzio, Rodrigues, Ferraz, & Caricati-Neto, 2014). 
Systemic sclerosis (SSc) is an autoimmune disease involving fibrosis of the skin which is preceded 
by inflammation and vasculopathy with an abundance of recent evidence suggesting that aberrant 
epigenetic mechanisms, particularly in T lymphocytes, play a key role in disease pathogenesis. It 
appears that miRNAs, long-ncRNAs, histone modifications, and DNA methylation changes are all 
involved, however, due to the scope of this literature review, only the data concerning DNA 
methylation will be discussed further. SSc is similar to SLE in that CD4+ global hypomethylation 
has been reported possibly due to the reduction in the expression of DNMT1, MBD3, and MBD4 
(Lei et al., 2009). On a gene-specific level, the CD70 promoter region was hypomethylated 
concomitantly with an increase in CD70, a member of the tumour necrosis factor (TNF) family that 
regulates T cell function (Jiang et al., 2012). 
Rheumatoid arthritis (RA) is defined as an autoimmune disease characterised by inflammation of 
synovial joints caused by release of macrophages, lymphocytes and inflammatory cytokines from 
synovial fibroblasts (SF). Hypomethylation of a number of gene promoters has been reported in 
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SFs of RA patients, namely, CXCL12 (Karouzakis et al., 2011), CHI3L1, CASP1, STAT3, 
MAP3K5, MEFV, and WISP3 (Nakano, Boyle, & Firestein, 2013). While these data were not 
discovered in cells of the immune system, similar results have been reported in PBMCs, for 
example, hypomethylation of a single CpG motif of the IL6 gene (Nile, Read, Akil, Duff, & 
Wilson, 2008), in addition to IFNGI promoter hypermethylation in CD4+CD28- T cells (Pieper et 
al., 2014). Augmented expression of DNMT1 and MBD2 has also been discovered in RA patient 
PBMC samples, with DNMT1 in particular associated with RA disease activity (Liu et al., 2011). 
Conversely, a more recent investigation by de Andres et al. (2015) revealed that DNMT1 
expression was attenuated in B cells, T cells, and monocytes, concomitantly with global 
hypomethylation in the latter two cell types. The alterations in expression of these methylation-
regulatory proteins likely contribute to the differential expression of inflammatory cytokines, such 
as IL-6, and thus the immune cell infiltration into the synovial joints. 
1.4.5 Other Diseases 
Finally, altered expression of DNMTs in PBMCs has been reported in various other conditions 
such as Schizophrenia (Auta et al., 2013), Vitiligo (Zhao, Gao, Wu, Tang, & Lu, 2010b), Alopecia 
Areata (Zhao et al., 2012), and Idiopathic Thrombocytopenic Purpura (Tao et al., 2008), in addition 
to altered global methylation in Alzheimer’s disease (Di Francesco et al., 2015) and again, 
Alopecia Areata (Zhao et al., 2012). Even body weight has been shown to inversely correlate with 
LINE-1 methylation, suggesting that unhealthy lifestyle factors can cause epigenetic change which 
may then predispose an individual to disease (Piyathilake, Badiga, Alvarez, Partridge, & 
Johanning, 2013).  
A common underlying theme with the diseases discussed so far is a chronic inflammatory state. As 
to whether inflammation as a consequence of the disease state then causes faulty epigenetic 
modifications, or whether these aberrant epigenetic processes are causative of the inflammatory 
state, thus enhancing susceptibility to a given disease, remains to be fully understood. To add 
complexity, there is also the possibility that this is a vicious cycle, with inflammation and aberrant 
epigenetic modifications exacerbating one another. Poor lifestyle habits such as physical inactivity 
(Abramson & Vaccarino, 2002; Allison, Jensky, Marshall, Bertoni, & Cushman, 2012; Gabel et al., 
2015; León-Latre et al., 2014), obesity (Greenberg & Obin, 2006; Zeyda & Stulnig 2009), and 
smoking (Kanherkar et al., 2014) are all associated with elevated systemic inflammation. 
Therefore, given the extensively reported reduced incidence, better prognosis, attenuation of 
fatigue or enhanced quality of life in many of the aforementioned diseases as a consequence of PA 
(Ayan & Martin, 2007; Colberg et al., 2010; de Jong et al., 2003; Knols, Aaronson, Uebelhart, 
Fransen, & Aufdemkampe, 2005; Lee, 2003; Loudon, Corrol, Butcher, Rawsthorne, & Bernstein, 
1999; McNeely, Campbell, Rowe, Klassen, Mackey, & Courneya, 2006; Segal et al., 2003; 
Shiroma & Lee, 2010; Singh, Newton, Galvão, Spry, & Baker, 2013; Stenstrom & Minor, 2003), it 
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seems logical that the anti-inflammatory (Geffken, Cushman, Burke, Polak, Sakkinen, & Tracy, 
2001; Gano et al., 2011; Thompson, Markovitch, Betts, Mazzatti, Turner, & Tyrell, 2010), and 
overall salubrious effects of exercise, would be at least associated with a more favourable 
epigenetic state. In addition, PBMCs are clearly an interesting population of cells that warrant 
further examination due to their wide range of immune functions which are able to impact upon 
many tissues due to their circulation throughout the body. 
1.5 In Vitro Studies: Inflammation and DNA Methylation  
Up to now, DNA methylation changes as a causal factor in the development of chronic 
inflammation and disease has been discussed. However, the question of whether inflammation in 
the absence of disease leads to epigenetic modifications should also be addressed. The following 
literature is summarised in table form in appendix A. 
1.5.1 Interleukin 6 
Data now suggests that changes in the DNMT enzymes that catalyse changes to the epigenome 
may indeed be regulated by inflammatory mechanisms. For example, inflammatory bowel disease-
associated CRC manifests with high levels of systemic IL-6 (Atreya & Neurath, 2005), while 
DNMT1 is also overexpressed in this condition (Foran et al., 2010). In vitro studies have shown 
that IL-6 stimulation of human cancer cell lines (HCT116/K562) resulted in elevated expression 
and activity of DNMT1 (Foran et al., 2010, Hodge, Xiao, Clausen, Heidecker, Szyf, & Farrar, 
2001). This augmentation of DNMT1 activity could occur through PI3K activation of protein 
kinase B (AKT), and subsequent AKT-dependent phosphorylation of the nuclear localisation signal 
of DNMT1, allowing nuclear translocation and subsequent binding of DNA (Hodge et al., 2007).  
PI3K/AKT signalling also regulates DNMT3B expression in hepatocellular carcinoma (Mei et al., 
2010).  
IL-6 has been implicated in the maintenance of promoter methylation in cholangiocarcinoma 
(Wehbe, Henson, Meng, Mize-Berge, & Patel, 2006) and multiple myeloma cells (Hodge et al., 
2005), which is likely to be due to DNMT1, given its functional role. Furthermore, upregulation of 
DNMT1, but not DNMT3A or DNMT3B, was reported to be responsible for the IL-6 induced 
hypermethylation of tumour suppressors p53 and p21 in A549 (adenocarcinomic human alveolar 
basal epithelial) cells (Liu et al., 2015a). Western blotting showed that the IL-6 mediated increase in 
DNMT1 expression was due to activation of the JAK2/STAT3 pathway, which is in support of 
previous findings that STAT3 induces DNMT1 expression, while STAT3 depletion downregulates 
DNMT1 in malignant T lymphocytes (Zhang, Wang, Woetmann, Raghunath, Odum, & Wasik, 
2006). Furthermore, IL-6 induced DNMT1 mRNA and protein expression correlated with SOCS3 
promoter methylation via STAT3 signalling in human colorectal cancer cell cultures (Li, Duering, 
Peppelenbosch, Kuipers, de Haar, & van der Woude, 2012), which was corroborated by Huang et 
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al. (2016) who reported that in pancreatic cancer cells, IL-6/STAT3 augmented DNMT activity 
thereby promoting SOCS3 promoter hypermethylation. In a novel approach, Braconi et al. (2010) 
reported similar results to Liu et al. (2015a) by transfecting cholangiocarcinoma cell lines with IL-
6, and discovered DNMT1 expression was elevated with a concomitant decrease in tumour 
suppressor expression. Together, these studies provide a mechanistic pathway between IL-6 and 
changes in DNA methylation via manipulation of DNMT expression or cellular location. 
1.5.2 Other Pro-inflammatory Cytokines 
IL-1β stimulation of fibroblast-like synoviocytes isolated from RA patients subsequently decreased 
expression of DNMT1, whereas both IL-1β and tumour necrosis factor (TNFα) decreased DNMT3A 
expression (Nakano et al., 2013). In a healthy human lung fibroblast cell line however, greater 
concentrations IL-1β (10 ng∙ml-1 compared with 2 ng∙ml-1 utilised by Nakano et al.) resulted in 
augmented expression of both DNMT1 and DNMT3A (Huang et al., 2012).  
TNFα-induced inhibition of the transmembrane protein Notch-1 has been attributed to an HMT 
(EZH2) and DNMT3B recruitment via NF-κB, resulting in hypermethylation in mouse myoblast 
cells (Acharyya et al., 2010). TNFα has also been shown to cause non-CpG methylation at the 
PGC1α promoter region in human myotubes (Barrès et al., 2009), while both TNFα and Insuline-
like Growth Factor (IGF-1) were able to increase SOCS3 expression in human coronary artery 
smooth muscle cells, via NK-κB activation and STAT3 phosphorylation, respectively (Dhar, 
Rakesh, Pankajakshan, & Agrawal, 2013). Interestingly, when these cells were stimulated with 
TNFα and IGF-1 together, DNMT1 expression was elevated, in addition to increased promoter 
methylation and decreased expression of SOCS3. These data highlight not only that genetic and 
epigenetic signatures vastly differ between different cell types, but also that within the same cell 
populations, combinations of inflammatory mediators can elicit differential effects than when the 
cytokines were present alone.  
1.5.3 Prostaglandin E2 
Prostaglandin E2  (PGE2), a lipid autocoid derived from arachidonic acid, is an important mediator 
in the acute inflammatory response, and can regulate IL6 expression in various cell types (Bagga, 
Wang, Farias-Eisner, Glaspy, & Reddy, 2003; Hinson, Williams, & Shacter, 1996; Inoue, 
Takamori, Shimoyama, Ishibashi, Yamamoto, & Koshihara, 2002; Williams & Shacter, 1997). 
Expression of Sp1 and Sp3 transcription factors, known to regulate DNMT3A (Jinawath, Miyake, 
Yanagisawa, Akiyama, & Yuasa, 2005), have been shown to be upregulated following PGE2 
stimulation, concomitant with an increase in DNMT3A expression in fibroblasts, and a decrease in 
DNMT3A and DNMT1 expression in RAW macrophages (Huang et al., 2012). Similarly, 
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pharmacological inhibition of PGE2 receptors results in attenuated expression of both DNMT3A 
and DNMT3B in endometriotic cells (Arosh, Lee, Starzinski-Powitz, & Banu, 2015). 
Furthermore, Xia, Wang, Kim, Katoh, and DuBois (2012) reported that compared with healthy 
human tissue, colorectal carcinomas exhibited a correlation between PGE2 and DNMT1 and 
DNMT3B expression. This was replicated in vitro with stimulation of various CRC cell lines with 
PGE2 leading to increased promoter methylation and decreased expression of CNR1, MGMT, 
CDKN2B, and MLH1 in the LS-174T cell line and ApcMin/+ CRC mouse model.  
1.5.4 Caffeine and Ionomycin 
Ionomycin, an ionophore that raises intracellular calcium (Ca2+) concentrations, has been used in 
order to investigate changes to DNA methylation and DNMTs; Laye and Pederson (2010) showed 
that while 0.1 µM of ionomycin was unable to alter mRNA levels of DNMT3A or DNMT3B in 
proliferating myoblasts, it was sufficient to cause a 40% downregulation of both of these enzymes 
in differentiated human myotubes. Despite utilising a much larger dose of 1 µM in L6 rat 
myotubes, Barrès et al. (2012) did not report any changes in promoter methylation of their selected 
genes, although mRNA of PGC1α, TFAM, and MEF2A was elevated. Interestingly however, 5 mM 
of caffeine, which is also able to raise intracellular Ca2+, did cause significant promoter region 
hypomethylation and mRNA upregulation of the three aforementioned genes, in addition to CS and 
PDK4. 
Lucas et al. (2012) and Barrès et al. (2012) both investigated the effects of ex vivo contractions in 
mouse soleus muscle on gene promoter methylation and subsequent transcription. Both groups 
reported significant findings; the former found promoter hypomethylation in PPARδ, PDK4, CS, 
and PGC1α at 30 minutes and 270 minutes post-contraction, with an increase in mRNA at 180 
minutes post-contraction. The latter study also reported promoter hypomethylation of PPARδ, 
PDK4, and PGC1α, in addition to MYOD1 and MEF2A at 45 minutes post-contraction, followed by 
increases in only PPARδ, PDK4, and PGC1α mRNA at 180 minutes post-contraction.  
1.5.5 Antioxidants  
All of the literature discussed thus far has addressed either regulation of de novo methyltransferases 
or DNA methylation itself. The literature concerning the use of antioxidant treatment of cells 
primarily reports the effects on the TET family of enzymes however. 100 µg∙ml-1 of ascorbic acid 
(AA) was able to increase TET activity in mouse embryonic stem cells, causing a global 
augmentation of 5-hmC which was lost after three days of AA withdrawal, demonstrating the 
dynamic nature of epigenetic modifications (Blaschke et al., 2013). Similarly, Minor, Court, 
Young, and Wang (2013) reported a dose-dependent (0 to 1000 µM) elevation of 5-hmC in mouse 
embryonic fibroblasts, although changes in TET expression could not account for this and 5-hmC 
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was still found to be elevated in TET-deficient cells. The same group also showed that as low a 
dose as 10 µM could augment 5-hmC in human HEK-293T and HeLa cell lines. Yin et al. (2013) 
also reported that TET1 expression was unaltered, suggesting that AA impacts on the catalysis of 
TET and causes TET-mediated 5-mC oxidation, leading to the dose-dependent increases in 5-hmC 
and 5-fC, intermediary molecules in the active demethylation process, with a concomitant 
attenuation of 5-mC. 
In contrast to the antioxidant AA, H2O2 is often used in order to experimentally induce cellular 
oxidative stress. Barrès et al. (2012) showed that 1 mM of H2O2 was able to cause promoter 
hypermethylation of TFAM, MEF2A, and CS in rat L6 myotubes. When combined with data from 
studies utilising AA, it initially appears that antioxidants have an effect on the demethylation cycle, 
whereas inducers of oxidative stress have the opposite effect and increase DNA methylation at 
specific loci.  
Not only is exercise known to be associated with augmented concentrations of pro-inflammatory 
cytokines, particularly following bouts of extended duration (Fischer, 2006; Walsh et al., 2011; 
Ostrowski, Rohde, Asp, Schjerling, & Pedersen, 1999; Gill et al., 2015), but it has also been shown 
to be associated with elevated concentrations of plasma PGE2 (Demers, Harrison, Halbery, & 
Santen, 1981; Venkatraman, Feng, & Pendergast, 2001), plasma Ca2+ (Ljunghall, Joborn, Benson, 
Fellström, Wide, & Åkerstrom, 1984; Salveson, Johansson, Foxdal, Wide, Piehl-Aulin, & 
Ljunghall, 1994; Vora, Kukreja, York, Bowser, Hargis, & Williams, 1983), and markers of 
systemic oxidative stress (Slattery, Bentley, & Coutts, 2015). The in vitro research discussed 
above, therefore, suggests that circulatory changes following exercise, and the subsequent health 
beneficial effects, may be regulated via epigenetic mechanisms.  
1.6 Exercise and the DNA Methylome 
The following literature is summarised in table form in appendix B. 
1.6.1 Rodent Studies  
Although not directly applicable to human physiology, rodent models of exercise are often used in 
order to gain specific mechanistic knowledge which may then inform further research in humans.  
1.6.1.1 DNA Methyltransferase Expression and Protein Concentrations  
Utilising a freely moving wheel protocol, whereby young (46 day old) mice were either given 
access to the wheel or remained sedentary for seven days, Abel and Rissman (2013) reported a 
14% and 19% attenuation of DNMT1 mRNA in the hippocampus and cerebellum, respectively. 
DNMT3A and DNMT3B expression was also significantly reduced by 17% and 19% within the 
hippocampus, with no observable change in the cerebellum. These finding were not corroborated 
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by a study that used ELISAs to measure DNMT1 and DNMT3B protein concentrations within 
hippocampal brain tissue; three month and 20 month old male Wistar rats exercised on a motorised 
treadmill at 60% of maximal oxygen uptake (?̇?O2max) for 20 minutes per day for 14 days. At 
baseline, older rats exhibited 25% lower DNMT1 protein concentrations compared with younger 
rats, with no difference in DNMT3B. Following the two week exercise period, there were no 
significant changes in DNMT1 or DNMT3B concentration in either group. These data seemingly 
contradict the results of Abel and Rissman’s study (2013), suggesting that, despite the extra four 
days of exercise, the intensity and/or duration of the sessions was not sufficient in order to elicit 
adaptations in hippocampal protein concentrations of DNMT1 or DNMT3B, regardless of whether 
transcriptional changes did indeed occur in line with Abel and Rissman’s (2013) findings. Acutely 
however, young rats exhibited a 30% and 45% reduction in DNMT3B and DNMT1 concentrations, 
one hour post-exercise, which returned to pre-exercise concentrations by 18 hours post-exercise. 
Rodrigues et al. (2015) also studied a sample of male Wistar rats that swam for 60 minutes per day, 
five days per week for four weeks, and when combined with restraint stress, a significant reduction 
was observed in DNMT1 expression in the frontal cortex compared with the controls. It is 
impossible to isolate the effects of exercise alone from this data, however, DNMT1 expression was 
found to be significantly attenuated in both the hippocampus and hypothalamus, when compared 
against stress alone (Kashimoto et al., 2016). These results could support the hypothesis that two 
weeks of exercise may be insufficient to chronically alter protein concentrations of at least DNMT1 
in the brain, but longer training periods may elicit an adaptive response. 
In line with most in vivo and in vitro investigations thus far, each tissue appears to possess a unique 
‘epigenetic profile’. The data discussed above all pertains to the brain, however, skeletal muscle is 
arguably a more relevant tissue to exercise-specific responses. Carter, Shuen, Joseph, and Hood 
(2015) utilised a contractile activity stimulus to investigate the tibialis anterior muscle of six and 
35 month old Fischer 34BN rats, and reported a 1.9-fold elevation in DNMT3B protein. Although 
an exercise stimulus was not actually used, this result still supports the notion that considerable 
tissue-specificity exists.  
1.6.1.2 Global and Gene-specific DNA Methylation  
Investigation of DNA methylation regulatory machinery such as DNMTs is essential in order to 
elucidate the precise mechanisms that underlie epigenetic modification, however, it is also 
important to clarify the downstream consequences on DNA methylation itself. Some of the studies 
discussed in the previous section also measured DNA methylation in addition to DNMT expression 
and protein concentration. Carter et al. (2015), for example, found a significantly greater proportion 
of DNA methylation in aged muscle compared to the younger rats, concomitant with 50% lower 
PGC1α transcription at rest. No further details were provided regarding the actual measurement of 
DNA methylation, and therefore these results must be interpreted with caution. Rodrigues et al. 
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(2015) reported that exercise and restraint stress did not cause any changes to global methylation in 
the hypothalamus, frontal cortex, periaquecductal gray, or hippocampus, whereas utilising the same 
ELISA-based method, Kashimoto et al. (2016) found a significant increase in global methylation in 
the hypothalamus, demonstrating that exercise alone elicits a drastically different response than 
exercise and restraint stress combined.  
On a gene-specific level, methylation has been quantified in a 230bp region downstream of a 
BDNF promoter in adult male Sprague-Dawley rat hippocampal tissue following seven days of 
running wheel access. A significant decrease in methylation 148bp upstream of the transcription 
start site was reported, in addition to 41% and 30% increases in BDNF mRNA and protein, 
respectively (Gomez-Pinillia, Zhuang, Feng, Ying, & Fan, 2011). Kanzleiter et al. (2015) also used 
a treadmill training protocol using mice, but instead of a targeted approach, built up a methylation 
and gene expression profile using whole genome sequencing and a whole genome microarray for 
transcriptional changes. 20 sessions across four weeks elicited a vast number of differentially 
methylated CpG sites distributed among 2,762 promoter regions. Although over 3,000 genes were 
differentially expressed following the training period, only 361 were actually associated with 
differential methylation; 66 hypomethylated genes were associated with augmented expression, and 
134 hypermethylated genes associated with attenuated expression. This demonstrates that while 
changes in methylation can regulate gene expression, the process is not as simple as promoter 
hypermethylation causes transcriptional downregulation and vice versa. In addition, these data 
show that many genes, at least in a murine model, may not be regulated by DNA methylation at all, 
but rather by other mechanisms, including epigenetic and non-epigenetic processes.  
The acute epigenetic response to exercise has also been investigated in rodents; following a single 
60 minute bout on a rotarod that increased from 35 to 45 rotations per minute, the quadriceps 
femoris muscle of six female mice was removed, with quantitative real-time polymerase chain 
reaction (qPCR) and TET-assisted bisulfite sequencing (TAB-seq) performed in order to 
investigate transcriptional and methylation changes in three PGC1α transcripts, namely, PGC1α-a, 
PCG1α-b, and PGC1α-c which are transcribed from two different promoters (Lochmann, Thomas, 
Bennett Jr, & Taylor, 2015). At baseline, promoter A which transcribes the PGC1α-a isoform, was 
expressed 2.4-fold higher than promoter B, concomitant with significantly lower levels of 
methylation. Following the acute bout, PGC1α-a remained unaltered, while PGC1α-b and PGC1α-
c, transcribed from promoter B, were significantly augmented. These exercise-induced 
transcriptional changes, however, were not correlated with modifications to DNA. In spite of the 
small sample size utilised within this study, the use of TAB-seq, which distinguishes between 5-
mC and 5-hmC, is a more advanced method for methylation analysis which aids interpretation. 
As alluded to within the start of this section, murine models of exercise are useful in order to 
highlight molecular processes which occur in tissues that are invasive to access such as the brain, 
or as a foundation on which to build further understanding using humans. The data is strongly 
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supportive of the posit that exercise can directly cause epigenetic modifications, both to the DNA 
methylation regulatory machinery and consequently, to DNA itself. The following sections will 
serve to review all current literature regarding the effects of PA and exercise on DNA methylation 
in humans.  
1.6.2 Human Studies 
1.6.2.1 Global DNA Methylation in the Context of Habitual Physical Activity 
A number of studies have sought to elucidate the relationship between PA history and measures of 
global or gene-specific methylation. The association between PA, measured by accelerometry over 
four days, and global methylation in LINE-1 has been investigated (Zhang et al., 2011). Those who 
performed approximately 30 minutes of PA per day, when compared to those who performed less 
than 10 minutes, had a significantly greater level of global DNA methylation in peripheral blood. 
However, following multivariate adjustment for age, gender, smoking status, ethnicity and body 
mass index (BMI), the association was no longer statistically significant. Given the methodological 
limitations of the study it is difficult to draw any firm conclusions, however, it does suggest that 
habitual PA may be linked with DNA methylation.  
More recently, White, Sandler, Bolick, Xu, Taylor, and DeRoo (2013) retrospectively assessed 
childhood, adolescent, and previous 12 months PA of over 600 non-Hispanic, white women with a 
family history of breast cancer. The women that reported being active above the median amount for 
all three periods were shown to have significantly greater peripheral blood LINE-1 methylation 
than those below the median. Similarly, in an elderly population, Luttropp, Nordfors, Ekström, & 
Lind (2013) divided 509 individuals aged 70 years and over into four discrete groups based on the 
amount of light and heavy PA they performed per week, although the timeframe was not specified. 
Leukocyte global methylation, in this case assessed using the Luminometric Methylation Assay 
(LUMA) method, was found to be significantly correlated with self-reported activity level, even 
after adjustment for gender, systolic and diastolic blood pressure (BP), LDL and HDL cholesterol, 
serum triglycerides, smoking status, and BMI. Despite the cross-sectional nature of the research, 
and the use of self-reported PA, the data demonstrates that longer term PA could be related to a 
more favourable epigenetic profile. 
1.6.2.2 Gene-specific DNA Methylation in the Context of Habitual Physical Activity  
In contrast with the above results which seem to suggest that PA is associated with 
hypermethylation of DNA across the genome, results from the Commuting Mode and 
Inflammatory Response Study did not support this association, as PA was not correlated with 
global (LINE-1) methylation in leukocytes. Interestingly, levels of IL6 promoter methylation were 
not significantly associated with any of the study variables, which also included age, gender, 
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ethnicity and BMI, in addition to PA and diet (Zhang, Santella, Wolff, Kappil, Markowitz, & 
Morabia, 2012). Specific comparisons between subgroups reiterated this, as neither LINE-1 or IL6 
promoter methylation were different between public transport users and car drivers (Morabia et al., 
2012), The substantial age range of the study population (18 to 78 years) is likely to be a significant 
confounding variable in this instance, given that aging itself is associated with differential DNA 
methylation (Agrawal, Yang, Agrawal, & Gupta, 2010; Fuke et al., 2004; Heyn et al., 2012). These 
results were corroborated with a more homogenous, albeit, aged population (Gomes et al., 2012), 
whilst also using an objective measure of PA in contrast to a block energy expenditure survey as 
utilised by Zhang et al. (2012). Similarly, in a novel longitudinal study of mixed-sex children 
(Clarke-Harris et al., 2014), measurements were taken annually from five years of age, until the 
children were 14 years old. No significant interactions between PA and DNA methylation were 
reported, however, an interesting and clinically relevant finding was that methylation of four 
PGC1α promoter CpG loci predicted adiposity, as measured by dual-energy X-ray absorptiometry, 
independently from confounding variables such as gender or PA level.  
Most recently as part of the Cardiovascular Health Study, the association between gene-specific 
methylation changes in PBMCs and PA energy expenditure (PAEE) over eight years was assessed 
in a sample of elderly men and women (Shaw, Leung, Tapp, Fitzpatrick, Saxton, & Belshaw, 
2014). Maintenance of increased PAEE of 500 kcal or more per week resulted in significant 
hypermethylation of the TNF gene, while the IL10 gene was significantly hypomethylated in those 
who increased their PAEE by 500 kcal per week, compared with those who decreased their PAEE 
by the same amount. Given the pro-inflammatory role of TNFα, and the anti-inflammatory role of 
IL-10, these PAEE-induced modifications appear to represent a favourable outcome. These two 
studies (Shaw et al., 2014; Zhang et al., 2012) differed drastically from a methodological 
standpoint; the former measured PA through the use of a questionnaire that selected 26 specific 
activities performed over the previous year, in contrast to the latter study which involved 
participants recalling any physical activities over the previous eight years. Furthermore, Shaw et 
al’s (2014) study utilised a much more defined elderly age group in comparison with the Zhang et 
al’s (2012) study that included individuals ranging from 18 to 78 years of age. Interestingly, in a 
cross-sectional comparison of experienced (defined as three or more years) and novice tai chi 
practitioners (Ren et al., 2012), six CpG sites of 60 measured across the genome showed 
differential methylation between the groups, with the more experienced group demonstrating a 
slowing of the usual age-related pattern of hypomethylation. Despite no specific rationale given for 
the selection of these specific CpG sites, this result, as well as the fact that age-related 
hypomethylation has been reported in PBMC samples (Fuke et al., 2004), clearly illustrates how 
the lack of a properly defined study population can clearly be a large confounding variable, which 
may account for the lack of significant findings in Zhang et al’s study. 
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1.6.2.3 Disease-specific DNA Methylation in the Context of Habitual Physical Activity 
In addition to general gene specific changes discussed above, several studies have attempted to 
elucidate the epigenetic effects of PA related to disease-specific genetic loci. For example, Coyle, 
Xie, Lewis, Bu, Milchgrub, and Euhus (2007) utilised a cross-sectional design in order to 
investigate the effects of self-reported PA on promoter methylation of the tumour suppressor genes 
APC and RASSF1A, an epigenetic alteration commonly associated with breast cancer risk. They 
reported that lifetime, previous five years, and previous year levels of PA were all inversely 
correlated with promoter methylation of APC but not RASSF1A, although this association did not 
reach statistical significance. Similarly, hypermethylation of APC, but again, not RASSF1A, was 
inversely associated with the requirement to have breast biopsies. These results appear to suggest 
that PA may regulate epigenetic modifications in certain tumour suppressor genes, thereby 
reducing the risk of breast tumour growth. PA has also been shown to be inversely correlated with 
methylation of CACNA2D3, another tumour-suppressor gene, in gastric carcinoma patients (Yuasa 
et al., 2009) suggesting an anti-tumorigenic effect, although no significant associations were 
reported for the remaining five tumour-related genes (CDX2, BMP2, p16, GATA5, ER) that were 
tested. The data from these two studies shows that PA may convey protective anti-oncogenic 
effects through modulation of tumour-suppressor methylation. In a large scale study whereby over 
1,000 colon cancer patients recalled activity levels for the previous year, in addition to 10 and 20 
years ago, no significant correlations were reported between PA and tumour CpG island 
methylation in MINT1, MINT2, MINT31, p16, or hMLH1 as measured by methylation-specific PCR 
(Slattery et al., 2007).  
Given the relative complexity and weaknesses of measuring PA cross-sectionally, in combination 
with various cancers which differ substantially on a pathophysiological level depending on the type 
and location, cross-sectional studies such as the aforementioned are probably insufficient evidence 
for firmer conclusions. Thus, the role of PA in the methylation status of selected cancer related 
genes is far from clear and warrants further investigation. 
There appears to be a paucity of research investigating the interaction between PA and DNA 
methylation in diseases other than cancer, although the data that does exist strongly supports the 
reported associations between PA and disease-related DNA methylation within specific CpG sites. 
Pirola et al. (2012) found that PA assessed by questionnaire was inversely correlated with MT-ND6 
methylation, but not MT-CO1 or D-loop, in liver mitochondrial DNA samples isolated from non-
alcoholic fatty liver patients. Furthermore, a similar association was reported between 
questionnaire-assessed PA and promoter methylation of COMT in peripheral blood samples 
isolated from schizophrenia patients that possessed the Val/Val genotype (Lott et al., 2013).  
From these studies discussed in section 1.6.2 thus far, no firm conclusion can be made regarding 
the effects of habitual PA on epigenetic modification, however, it is clear that methodologies must 
be appropriately selected in order to truly quantify any changes that are occurring. Apart from the 
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issues related to population selection and quantification of PA already discussed, the overall 
inconsistency in results is likely in part due to the common utilisation of global methylation as an 
outcome measure, as this does not reflect changes in DNA methylation at the gene-specific level. 
For example, a wide array of genes may be differentially methylated in response to activity, 
however, some may be hypomethylated, and others hypermethylated, resulting in little to no global 
change. Furthermore, while hypomethylation of particular genes is an undesired outcome, 
hypomethylation and thus transcription of tumour suppressor genes is highly desired in the context 
of cancer. This highlights the need to investigate gene and CpG sequence-specific changes. 
Furthermore, the plethora of methods that are currently available to quantify DNA methylation may 
have also played a role in the inconsistency of the data thus far.  
1.6.2.4 Impact of Exercise Training and Physical Activity Interventions on Epigenetic 
Modification   
Over the past six years, a number of well-controlled experimental studies have begun to 
characterise the effects of exercise and PA interventions on DNA methylation in a number of 
tissues including skeletal muscle, adipose, tumour biopsies, saliva, sperm, peripheral blood, and 
leukocytes.  
1.6.2.4.1 Skeletal Muscle and Adipose Tissue 
Within skeletal muscle, regular exercise elicits a vast number of adaptations attributable to 
cumulative increases in functional proteins due to transient genetic upregulation (Coffey & 
Hawley, 2007). Given the role of epigenetic mechanisms in the control of gene transcription, it 
appears entirely plausible that adaptation to exercise may also involve differential DNA 
methylation. In support of this, Lindholm et al. (2014) demonstrated that three months of single-leg 
knee extensions elicited a vast number of epigenetic changes within vastus lateralis biopsy samples 
taken from healthy young men and women. Specifically, the Infinium HumanMethylation 450k 
array identified 4,919 differentially methylated sites, of which 839 were altered by at least 5% in 
4,076 differentially expressed genes. Many of these areas were then validated using bisulfite 
pyrosequencing. Furthermore, the top enriched categories of molecular function were all linked to 
muscle structure, function, and bioenergetics, suggesting that epigenetic changes are at least 
associated with adaptation within the muscle.  
These data provide a much more extensive picture of methylation changes within exercising 
muscle than previous research that investigated the effects of nine days of bed rest, and the 
subsequent fourweek re-training period using a cycle ergometer on PGC1α methylation 
(Alibegovic et al., 2010). Following the rest period which induced insulin resistance, vastus 
lateralis muscle biopsies taken from the healthy young male participants exhibited significant 
hypermethylation in one of three CpG sites analysed within the promoter region, however, this did 
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not fully return to pre-bed rest levels following four weeks of retraining. A concomitant attenuation 
in PGC1α mRNA was discovered following bed rest, which again, did not return to pre-bed rest 
levels following retraining. Interestingly, these data highlight the rapidity with which physical 
inactivity can cause relatively persistent epigenetic modifications which may be related to insulin 
resistance. 
T2DM is a complex metabolic disease arising due to a combination of factors including genetic 
susceptibility and unhealthy lifestyles (Lyssenko & Laakso, 2013). A controlled study in a cohort 
of individuals with a family history of T2DM indicated that a six-month exercise intervention was 
sufficient to induce alterations in both global and gene-specific methylation, independent of family 
history of T2DM (Nitert et al., 2012). Overall, vastus lateralis skeletal muscle biopsies showed that 
hypomethylation occurred in 115 genes, and hypermethylation occurred in 19 genes. Specifically, 
hypomethylation of RUNX1 and MEF2A, key transcription factors involved in exercise training 
adaptation (Keller et al., 2011; McGee, Sparling, Olson, & Hargreaves, 2005), THADA, associated 
with T2DM (McCarthy, 2010), and NDUFC2, which encodes NADH hydrogenase, the first 
enzyme of the oxidative phosphorylation system within the mitochondrial inner membrane (Weiss, 
Friedrich, Hofhaus, & Preis, 1991), were reported following the intervention. Additionally, 
methylation of IL7, which stimulates proliferation of lymphocytes, was decreased and associated 
with an increase in mRNA expression and serum concentration post-exercise. A separate analysis 
of the same cohort (Rӧnn et al., 2013) demonstrated that the exercise intervention decreased 
abdominal adiposity and diastolic BP, and increased ?̇?O2max, HDL, and adipose tissue global DNA 
methylation. In addition to the assessment of global methylation, likely performed to enable 
comparison of results with existing literature, gene-specific analyses were also included, and thus it 
was confirmed that the intervention indeed facilitated differential CpG site methylation of 
subcutaneous adipose tissue. The majority of sites were located within gene bodies and intergenic 
regions of 18 obesity and 21 T2DM candidate genes, such as ITPR2, a locus associated with waist-
hip ratio (Heid et al., 2010), as well as KCNQ1 and TCF712, which have both been implicated in 
the pathogenesis of T2DM (McCarthy, 2010; Travers et al., 2013). An inverse relationship between 
methylation and mRNA expression was observed for TCF712, in addition to other candidate genes. 
Overall, 197 genes showed changes in both methylation level and mRNA expression, with an 
inverse relationship reported in 58% of these. The extensive analysis of both of these studies adds 
credence to the hypothesis that exercise causes epigenetic modification that epidemiological studies 
were previously unable to robustly confirm. 
The studies cited thus far have all utilised healthy individuals or those with a family history of 
disease, and have not compared different exercise modalities. Rowlands et al. (2014) compared 16 
weeks of endurance training with the same period of resistance training in a sample of Polynesian 
adults with T2DM. Analysis using the Infinium Human Methylation 450k array demonstrated that 
both training modalities elicited global hypomethylation, in addition to a vast number of gene-
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specific modifications. For example, NRF1 promoter hypomethylation occurred which 
corresponded to the large elevation in PGC1a mRNA, highlighting a mechanism by which NRF1 
controls PGC1α transcription (Scarpulla, 2002). Furthemore, FASN promoter hypermethylation 
was reported concomitantly with attenuated expression of the transcription factor SREBP1c, which 
has shown to be a regulator of FASN activity in human insulin resistant skeletal muscle, 
specifically in South Asian populations (Hall et al., 2010). It was suggested that these changes 
could have then been a causative factor in the reduced intramyocellular lipid concentrations, which 
may be reflective of changes associated with enhanced insulin sensitivity. Overall, the data 
demonstrated that endurance activity was associated with augmented mitochondrial enzyme 
activity and glucose handling due to epigenetic modifications. Resistance training elicited a number 
of changes to protein levels, albeit to a much lesser degree than endurance training. Upstream CpG 
island hypomethylation occurred in GLUT4, however, skeletal muscle GLUT4 content was not 
altered. Resistance exercise, therefore, appears to not exert significant health beneficial adaptations 
to the epigenome in a sample of Type 2 Diabetic adults. In contrast, these data clearly demonstrate 
that the protective metabolic effects of regular endurance exercise are, at least in part, due to 
differential DNA methylation in a number of genes that regulate various metabolic processes. 
1.6.2.4.2 Whole Blood 
Experimental manipulation of exercise mode and intensity has begun to enhance our understanding 
of how the epigenome of circulating cells responds to prolonged periods of exercise training; a six 
month training study consisting of high intensity interval walking exercise, utilising an aging 
sample matched to both aging and young control groups, demonstrated that methylation status of 
the p15 tumour suppressor gene was unaffected by exercise or age (Nakajima et al., 2010). 
However, methylation of the ASC gene, involved in IL-1β and IL-18 production, was significantly 
lower within the elderly population when compared with the young controls, which potentially 
explains, at least in part, the commonly described age-associated inflammatory state (Chung et al., 
2009), and thus, is an important finding within the context of this review.  ASC methylation of 
DNA extracted from peripheral blood samples was found to be higher in the older group subjected 
to the exercise protocol compared with the aging control group, which may indicate that the known 
anti-inflammatory effect of longer-term moderate exercise may be facilitated via attenuation of 
age-related hypomethylation (Agrawal et al., 2010; Fuke et al., 2004; Heyn et al., 2012). In a much 
smaller cohort, but utilising the same training stimulus, a genome-wide microarray covering 
237,000 probes (Agilent Human CpG Island 244K array) revealed that over 40 genes, including 
NFκB2, were differentially methylated following the six month training period (Zhang et al., 2015), 
which was validated using pyrosequencing. 
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These data support the posit that even very moderate intensity exercise programme, when sustained 
over an extended duration, can possibly reduce chronic low-grade systemic inflammation via 
modification of DNA methylation within inflammatory genes. 
1.6.2.4.3 Peripheral Blood Leukocytes 
Longer-term moderate exercise has also been reported to have beneficial effects on DNA 
methylation when employed as remedial or complementary therapy. For example, in primarily 
sedentary cancer patients, a six-month clinical exercise intervention consisting of 150 minutes per 
week of moderate intensity aerobic exercise on a treadmill (the control group received only usual 
clinical care) altered the methylation profile of 43 genes (Zeng et al., 2012). Most profoundly, 
hypermethylation of CXCL10, involved in chemoattraction of monocytes, T cells and NK cells, and 
EPS15, a protein involved in the EGFR pathway, was reported. In addition, hypomethylation of 
ABCB1, a protein involved in cell membrane efflux, RP11450P7.3, a gene for a kelch-like family 
protein, and KIAA0980, which encodes ninein-like protein which contributes to chromosome 
segregation and cytokinesis, was reported. Six of the 43 genes were associated with overall patient 
survival, with three of these hypomethylated following exercise, suggesting augmented gene 
expression. One gene was particularly in the context of cancer; L3MBTL1, a candidate tumour 
suppressor gene (Gurvich et al., 2010; Qin et al., 2010), was found to be inversely correlated with 
gene expression, while there was also an association between low risk of breast cancer death and 
high levels of expression.  Of interest is that this study measured changes in methylation status in 
peripheral blood leukocyte samples. It has been reported (Reinius et al., 2012) that considerable 
variation exists between PBMCs and granulocytes, and even within each cell population (T cells, 
NK cells, B cells, monocytes), a variation that is considerably more pronounced in adult blood than 
cord blood (Jacoby, Gohrbandt, Clausse, Brons, & Muller, 2012). The investigators did, however, 
expand on their initial observations by analysing tumour samples, and reported concordance 
between the two measures in terms of exercise-induced L3MBTL1 methylation, although blood 
may not be a useful surrogate for all tissues or tumour samples given the differences in gene-
specific methylation reported between muscle, colon, brain, heart, kidney and liver (Kitamura et 
al., 2007; Pai, Bell, Marioni, Pritchard, & Gilad, 2011). 
Not all studies show that exercise training programmes have an effect on DNA methylation 
although this is more than likely due to a number of methodological issues that have previously 
been discussed within this literature review, such as the reliance on global methylation as an 
isolated measure, or differences in mode, intensity, and study population. For example, 12 months 
of three supervised aerobic sessions per week in a sample of postmenopausal women was 
insufficient to elicit any significant alterations in global methylation in leukocyte DNA (Duggan, 
Xiao, Terry, & McTiernan., 2014). It was not elucidated whether any gene-specific changes 
occurred however, which, given the data presented by the studies discussed thus far, would be 
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plausible to expect. In support of this, a genome wide analysis revealed a plethora of training-
induced changes to the leukocyte methylome following only four weeks of high intensity training 
(Denham, O’Brien, Marques, & Charchar, 2015b). Over 80,000 CpG sites were hypermethylated 
and over 120,000 hypomethylated, with 19 of these sites exhibiting a 20% or greater change. As 
would normally be expected from promoter hypomethylation, UNG mRNA was then elevated 
following training. Given the role of UNG in base-excision repair in the active demethylation 
pathway, this presents a possible mechanism by which exercise is able to cause and maintain 
epigenomic changes resulting in favourable adaptations. For example, another gene that was 
hypomethylated in the promoter region, EGF, exhibited a concomitant attenuation of mRNA 
levels, which could be interpreted as beneficial to vascular health considering the role of EGF 
receptor hyperactivity in atherosclerosis (Makki, Thiel, & Miller Jr, 2013). Small changes in 
methylation also occurred at various sites in miRNA21 and miRNA210, although the changes 
observed in the former did not remain significant after the application of a false discovery rate 
correction. There were, however, significant alterations in mRNA level of both of these miRNAs. 
Maybe most importantly, the mRNA targets of miRNA-21 included pathways involved in MAPK 
and Toll-like receptor signalling, and fatty acid metabolism, whereas mRNA targets of miR-210 
were pathways related to calcium, B cell receptor, and TGF-β signalling. These data provide a 
relatively concise mechanistic pathway by which multiple epigenetic modifications work in concert 
to elicit salubrious exercise-induced adaptations.  
1.6.2.4.4 Germ Cells 
The same group also studied the transgenerational effects of regular exercise on DNA isolated from 
sperm. Anecdotal evidence of the effects of environmental exposures on transgenerational 
inheritance, such as the Dutch Hunger Famine (Heijmans et al., 2008), suggests that epigenetic 
changes occur in germ cells which are then stable enough to be passed on to the offspring. This has 
been shown in mice, whereby differentially methylated regions of sperm DNA were passed to the 
offspring, causing behaviours associated with psychiatric disorders via altered gene expression 
(Milekic et al., 2014). In humans, three months of sprint training of progressive volume, selected to 
coincide with a single human spermatogenesis cycle, was able to elicit a significant decrease in 
global methylation quantified by an ELISA-based method (Denham, O’Brien, Harvey, & Charchar, 
2015a). Further analysis using the Infinium Human Methylation 450k array highlighted a vast 
number of differentially methylated CpG islands spanning over 4,000 genes. Most importantly 
within the context of this particular investigation was that 16 paternally imprinted genes associated 
with various pathologies, including Alzheimer’s disease, T2DM, and atherosclerosis, were also 
differentially methylated following the training period, supporting the concept of environmental 
stimuli causing significant epigenetic modifications that are then able to be passed on to the next 
generation, which may then predispose to specific diseases. 
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1.6.2.4.5 Other Tissues 
The use of even more accessible tissues such as saliva to track methylation changes related to 
disease risk is an interesting and potentially useful screening tool. In the context of cancer risk, 
Bryan, Magnan, Hooper, Harlaar, and Hutchinson (2013) selected 45 CpG sites that are potentially 
associated with breast cancer, and investigated the relationship between self-reported PA in 
addition to objectively measured cardiovascular fitness using a sample of sedentary men and 
women. The intervention consisted of individually tailored self-help materials, designed to increase 
PA participation based on the participants’ motivational readiness, which, after 12 months, 
significantly increased time spent exercising, but not ?̇?O2max, when compared with the control 
group. At baseline, average methylation of the selected CpG sites was inversely correlated with ‘7 
Day Physical Activity Recall’ minutes, which remained significant after controlling for age, but not 
BMI. Following the intervention, the increase in recall score was significantly correlated with a 
decrease in methylation, even after controlling for age, BMI and baseline ?̇?O2max, highlighting that 
chronic PA may convey protective effects, even within saliva DNA, that may result in the delay or 
reversal of aberrant DNA methylation at particular sites which could promote tumorigenesis.  
The majority of studies reviewed here indeed agree that a period of four weeks to 12 months is 
sufficient to modify gene-specific methylation of a number of different genes associated with aging 
and pathologies such as cancer and T2DM. The significance of this on prognosis or long-term 
clinical outcome is an important aspect to consider for future investigation, given the potentially 
far-reaching implications for public health. 
1.6.2.5 Effects of an Acute Exercise Bout on the DNA Methylome 
The aforementioned studies show that regular exercise is able to exert significant changes to the 
epigenome, possibly as a mechanism by which exercise-induced adaptations occur. However, in 
order to fully understand how exercise is able to elicit these changes, it seems logical to investigate 
the occurrence of changes following a single bout of exercise. 
PGC1a receives a lot of research attention due to it’s role as a master regulator of mitochondrial 
biogenesis, and although not directly linked to DNA methylation as such, histone modifiers appear 
to possess a key role in expression of the gene. Healthy male subjects performed interval cycling at 
73, 100 or 133% of peak power output (PPO) and post-exercise changes in gene expression of 
PGC1α and its regulators were assessed in skeletal muscle biopsies (Edgett et al., 2013). Cycling at 
100% of PPO augmented PGC1α mRNA more than cycling at 73% PPO, but supra-maximal 
exercise seemed to blunt this response, so that a lower increase in levels of PGC1α mRNA was 
observed when compared to both 100% and 73% PPO. Increases in the mRNA of the regulators 
Sirt-1, PDK4 and RIP140 also occurred. The latter, a negative regulator of PGC1α, functions as a 
scaffold protein, linking nuclear receptors to chromatin remodelers such as HDACs (White, 
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Morganstein, Christian, Seth, Herzog, & Parker, 2008). The finding that PGC1a was augmented in 
an intensity dependent manner following cycling corroborates previous research (Egan et al., 
2010). In this study, phosphorylation of a classIIa HDAC was only elevated following a high 
intensity bout, suggesting a mediating role in PGC1α upregulation following exercise. This is of 
interest in the context of this review due to the close synergistic relationship between HDACs and 
DNMTs; not only have HDAC1 and HDAC2 been shown to bind with DNMT1 (Fuks, Burgers, 
Brehm, Hughes-Davies, & Kouzarides, 2000; Rountree, Bachman, & Baylin, 2000), HDAC 
inhibition also promotes DNMT1 degradation (Arzenani et al., 2011). In addition, in ovarian cancer 
DNMT3B was shown to correlate with HDAC1 and HDAC2 (Gu et al., 2013). These data highlight 
a potential pathway by which epigenetic modifications elicit changes to gene transcription, and 
while these results are only indirectly related to DNA methylation, a recent broad review on 
epigenetic modulation by exercise (Ntanasis-Stathopoulus, Tzanninis, Philippou, & Koutsilieris, 
2013) pointed out that this mechanism may suggest a way by which the hypermethylated status of 
PGC1α in diabetic patients (Barrès et al., 2009) could be beneficially modified.  
In a sample of sedentary young men and women following a ?̇?O2peak test on a cycle ergometer, 
global methylation of vastus lateralis skeletal muscle was reported to be attenuated. Further 
analysis demonstrated that hypomethylation occurred at promoter regions of PGC1α, PDK4 and 
PPARδ immediately post exercise (Barrès et al., 2012). Consequently, transcription was 
upregulated, and given the roles of these genes in mitochondrial and lipid metabolism, this would 
be considered to be a beneficial modification. Manipulation of TET enzymes, responsible for active 
demethylation, are even less well characterised than DNMTs following exercise, however, it 
remains to be elucidated whether significant reductions in the de novo DNMTs, transcriptional or 
actual protein activity, would result in DNA hypomethylation as in the case of this study. Bisulfite 
sequencing, a technique used for validation of DNA methylation, demonstrated that non-CpG sites 
(CpA, CpT, CpC) comprised the majority of the hypomethylated cytosines in this study. The 
authors suggested that hydroxylation of the cytosine’s methyl group could provide a possible 
mechanism as to how an acute exercise bout caused demethylation, however, due to poor 
specificity of the bisulfite technique with regard to distinguishing between methylated and 
hydroxymethylated cytosines (Huang, Pastor, Shen, Tahiliani, Liu, & Rao, 2010b) this mechanism 
has not yet been clarified. TAB-seq on the other hand, is able to quantify 5-mC and 5-hmC 
independently from one another (Yu et al., 2012), and thus, may have been a more useful method. 
Following three hours of moderate intensity cycling (60% of ?̇?O2max), DNMT3B, but not DNMT3A, 
mRNA was decreased by 50% in skeletal muscle samples (Laye & Pedersen, 2010). Despite the 
large discrepancy between the duration and intensity of the exercise bouts in the two 
aforementioned studies, if an acute reduction in DNMT availability does indeed result in passive 
demethylation, the large attenuation of DNMT3B could provide a mechanistic explanation of the 
exercise-induced hypomethylation reported by Barrès et al. (2012). 
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Contrarily, in a complex study investigating the timing of carbohydrate intake before and after 
exercise, a significant augmentation of COX4I1 promoter methylation was reported in the group 
that consumed the entirety of their carbohydrate intake before the high intensity interval evening 
session and remained fasted until the 120 minute bout of steady state cycling at 50% of PPO the 
next morning, while FABP3 promoter methylation was reported in both experimental groups four 
hours post-exercise, albeit compared with different timepoints; COX4I1 was elevated compared 
with immediately post-exercise, whereas FABP3 was elevated compared with rest. In spite of these 
modifications to the methylome, no changes in mRNA of either gene was observed at this point, 
although FABP3 mRNA was augmented immediately post-exercise which appears counterintuitive 
as it would be expected that changes in methylation would precede alterations to transcription 
(Lane et al., 2015).  The fasted group also exhibited elevated promoter methylation at PPARδ four 
hours following the 120 minute bout. The authors suggest that this alteration in promoter 
methylation may explain the lower levels of mRNA in the fasted group, however, this attenuation 
was not statistically significant. Rather, the fed group exhibited significantly augmented mRNA 
levels in comparison. This finding appears contradictory to the current viewpoint that promoter 
hypermethylation directly reduces transcription but also highlights the complexity of exercise-
induced epigenetic modifications. Indeed, the authors do carry on to hypothesise that exercising in 
a fasted state may prevent the usual PPARδ hypomethylation reported by Barrès et al. (2012) due to 
the lack of glycolytic flux which may well be necessary for such an epigenetic modification to 
occur. The data concerning the lipid metabolism genes FABP3 and PPARδ, and mitochondrial 
metabolism gene COX4I1, are difficult to interpret prior to further investigation, but do, however, 
suggest that carbohydrate availability before exercise is able to differentially regulate these genes 
involved in key metabolic processes. 
The contrasting data reported by the three investigations discussed in this section may be explained 
in part by the differences in study populations; Laye and Pedersen (2010) recruited healthy young 
men, who were presumably not specifically trained cyclists. In direct contrast, Barrès et al. (2012) 
utilised sedentary young men and women, whereas Lane et al. (2015) used trained male cyclists. 
There is likely to be a vastly different acute response between these two populations as a 
consequence of training-induced adaptations, possibly mediated by epigenetic mechanisms, in the 
latter group.  
In terms of a more general, systemic role of exercise in epigenetic modification, the effect of acute 
exercise on cells of the immune system has recently been investigated (Robson-Ansley et al., 
2014). A 120 minute treadmill run at 60% of v?̇?O2max  interspersed with sprints at 90% of v?̇?O2max  
for the last 30 seconds of every 10 minutes, followed by a 5km time trial, a protocol previously 
shown to reliably induce transient elevations in IL-6 (Walshe, Robson-Ansley, St Clair Gibson, 
Lawrence, Thompson, & Ansley, 2010), was utilised in order to quantify changes in the 
methylation of PBMCs measured using the now outdated Infinium HumanMethylation 27k 
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beadchip. Despite no significant alteration in global methylation, an interesting finding was that the 
exercise-induced increase in plasma IL-6 concentration immediately following the bout was 
significantly correlated with the methylation status of 11 genes (SLAMF1, IRAK3, LDB2, 
TMEM156, FCRL2, CDK9, SIT1, AER61, RAG2, C10orf89, CD40LG), a number of which are 
regulators of immune activities. Of particular interest was the effect on IRAK3, a key inhibitor of 
inflammation associated with the metabolic syndrome and obesity. The lack of change in global 
methylation in this study was also corroborated in NK cells following a half marathon in both 
cancer survivors and healthy controls (Zimmer et al., 2015).  
Given the relatively vast amount of in vitro research (section 1.5) demonstrating a fairly robust, 
albeit cell specific, relationship between inflammatory cytokines and epigenetic regulation, it 
seems logical to further investigate this in immune cells. While some studies have utilised whole 
blood or peripheral blood leukocytes (Denham et al., 2015b; Luttrop et al., 2013; Nakajima et al., 
2010; Shaw et al., 2014; Zhang et al., 2012), PBMCs represent a more homogenous cell 
population, and are easier to isolate than individual cell types.  
1.7 Aims 
Although research into the relationship between exercise, inflammation and epigenetic 
modification is clearly still in its infancy, and the plasticity of the effects seen remains to be 
established, the reviewed literature (sections 1.5 and 1.6) appears to support the notion that 
inflammation associated with acute exercise is likely to be a regulatory mechanism of changes in 
DNA methylation. Furthermore, regular exercise appears to reduce inactivity-associated systemic 
inflammation, at least in part, by alterations to the methylome, thereby suggesting a cyclic 
relationship between exercise and epigenetic modification. This opens up an exciting new sub-
discipline and could yield information beneficial not only to seemingly healthy individuals, but also 
to those suffering from a variety of disease states associated with chronic low-grade systemic 
inflammation.  
With the above points in mind, the aims of this research programme, therefore, were to: firstly, 
characterise the acute changes that occur to the de novo DNA methyltransferases DNMT3A and 
DNMT3B following exercise in PBMCs, and the role of exercise-induced systemic inflammation 
in this process; secondly, investigate how these changes then translate into functional modifications 
to the methylome; thirdly, elucidate the role of training status and how this then affects the acute 
response to a single exercise bout; and finally, to discover whether a longer term training 
programme in sedentary individuals will manipulate DNA methylation of genes involved in 
chronic systemic inflammation associated with physical inactivity, and the role of DNMTs in this 
process.  
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CHAPTER 2 
 
 
 
 
 
 
GENERAL METHODS 
  
  
40 
 
2 General Methods 
2.1 Ethical Approval  
All studies received ethical approval from the Northumbria University Faculty of Health and Life 
Sciences ethics committee. The study presented in chapter 5 also received appropriate ethical 
approval from Coventry University Applied Research Committee, given the collaborative nature of 
the research. All participants were provided with an approved information sheet prior to giving 
fully informed written consent (appendix C). They were reminded that they could withdraw from 
the study at any point without discrimination, and upon completion of testing they were provided 
with a debrief sheet.  
2.2 Experimental Procedures 
2.2.1 Stature and Mass 
Using the International Standards for Anthropometric Assessment (International Society for the 
Advancement of Kinanthropometry, 2011), stature was measured using a free-standing stadiometer 
to the nearest 0.1cm (SECA 217, Hamburg, Germany). Participants stood with their feet together 
and heels, buttocks, and upper part of the back touching the stadiometer. The head was then 
positioned in the Frankfort plane; the lower edge of the eye socket was positioned by hand so that it 
was level with the superior notch of the tragus. Participants were instructed to inhale while a gentle 
upward lift was applied by hand through the mastoid processes, with the top of the stadiometer 
placed firmly upon the vertex of the skull.  Body mass was measured to the nearest 0.1kg using 
digital scales (SECA 875, Hamburg, Germany) following removal of any excess clothing and 
footwear, with weight distributed evenly between both feet.  
2.2.2 Hip and Waist Circumference 
International Standards for Anthropometric Assessment (International Society for the 
Advancement of Kinanthropometry, 2011) were followed whilst measuring participant hip and 
waist circumferences. With the participant stood in a relaxed position and arms crossed across the 
thorax, a flexible anthropometric tape (Hoechstmass Roll Fix measuring tape, Germany) was used 
to measure the girth of the waist at the narrowest point between the lower costal border and iliac 
crest. Similarly, the girth of the waist was measured at the greatest posterior protuberance of the 
buttocks with both feet together. In both cases, it was ensured that the tape was parallel to the floor 
and not excessively tight as to indent the skin.   
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2.2.3 Methyl-donor Food Frequency Questionnaire 
A methyl-donor food frequency questionnaire (mdFFQ) was administered in chapters 6 and 7 
(appendix D). The questionnaire assesses intake of methionine, folate, betaine, and choline which 
are all involved in the SAM resynthesis cycle outlined in section 1.2.5. The mdFFQ has been 
reported to be a reliable tool to estimate the average intake of methyl-donors (Pauwels, Doperé, 
Huybrechts, Godderis, Koppen, & Vansant, 2015), however, the questionnaire has only been 
validated in a female population thus far.  
2.2.4 Venous Blood Sampling  
Following thorough hand decontamination, a tourniquet was applied to the arm approximately five 
finger widths above the antecubital crease. After appropriate site selection of a vein in the 
antecubital fossa region the area was disinfected with a 70% alcohol wipe. With the bevel of the 
needle (Safety-Lok, Becton-Dickinson, Oxford, UK) facing upwards, the needle was inserted into 
the vein at an approximate 30o angle, followed by lithium heparin containing Vacutainer tubes 
being pushed into the barrel. The tourniquet was released after the second Vacutainer was filled. 
After all blood was collected, pressure was applied to the puncture site with gauze while the needle 
was simultaneously withdrawn and immediately disposed of. Participants were instructed not to 
bend their arm at the elbow in order to reduce the risk of hematoma formation, and were asked to 
hold the cotton wool on the puncture site until the bleeding had stopped. 
2.3 Lab Analyses 
2.3.1 Plasma Separation 
Immediately following collection of whole blood into Vacutainer tubes they were centrifuged at 
1700*g for 10 minutes (Allegra X-22R Centrifuge, Beckman Coulter, California, USA). Plasma 
was aspirated into 1.5 ml microcentrifuge tubes and immediately stored at -80 oC. 
2.3.2 Plasma Volume Change 
Whole blood was used to determine haematocrit and haemoglobin (HemoCue Hb 201+, EKF 
Diagnostics, Germany), which was subsequently used for calculating shifts in plasma volume 
(chapters 4 and 5) using Dill and Costill’s (1974) guidelines (Alis et al., 2015): 
Change PV(%) = 100 * ((Hbpre/Hbpost) * (100 - Htcpost)/(100-Htcpre)-1) 
Hb = Haemoglobin; Hct = Haematocrit. 
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2.3.3 Peripheral Blood Mononuclear Cells - Rationale  
As discussed in chapter 1, not only are the genetic and epigenetic profiles of PBMCs linked to 
various pathologies, peripheral blood cells share 80% of the transcriptome with nine other major 
tissues (Mohr  & Liew, 2007). Furthermore, the muscle biopsy procedure may actually contribute 
to elevated local inflammation (Malm, 2001), thus it has been postulated that studying the 
responses of PBMCs to exercise may be a useful alternative (Jiménez-Jiménez et al., 2008). It has 
also been hypothesised that mononuclear cells, given that they circulate throughout the body and 
represent systemic changes (Denham et al., 2015b), may prove to be an important cell population to 
investigate in order to link exercise and health (Connolly et al., 2004). 
2.3.4 Isolation of Peripheral Blood Mononuclear Cells  
15 ml of Lymphoprep (Stemcell Technologies, Vancouver, Canada) was added to LeucoSep 
centrifuge tubes (Greiner Bio-One, Frickenhausen, Germany), followed by centrifugation for 20 
seconds at 400*g. Under a laminar flow hood, whole blood was poured from the Vacutainer tubes 
into the Leucosep tubes (approximately 20 ml of blood per Leucosep tube). Leucosep tubes were 
then centrifuged for 12 minutes at 850*g with the brake set to 0. Using sterile pastettes, the top 
layer of plasma was removed without disturbing the layer of PBMCs which were then poured into a 
new 50 ml centrifuge tube, which was topped up to 50 ml with R0 medium (RPMI 1640 medium 
plus Penicillin/Streptomycin/Glutamine, Sigma Aldrich, Missouri, USA). These tubes were 
centrifuged for 10 minutes at 400*g. The supernatant was poured off and the cell pellet 
resuspended by tapping the tube. A freezing medium was prepared of nine-parts fetal calf serum 
(FCS) to one-part Dimethyl sulfoxide (DMSO), added to the cells, transferred into microtubes and 
placed into a Mr Frosty freezing container (Sigma Aldrich, Missouri, USA) to be stored at -80 oC. 
2.3.5 Exercise-conditioned Plasma Stimulation of Peripheral Blood Mononuclear 
Cells 
Exercise is well known to elicit a vast number of changes to the proteins and molecules located in 
the plasma, including, but not limited to, changes in pro- and anti-inflammatory cytokines. In order 
to elucidate the role of circulating proteins on DNA methylation and DNMTs, it was necessary to 
control for exercise-induced changes to the fractional cellular composition of PBMC samples 
(Connolly et al., 2004) by utilising an identical cell sample isolated from a single, resting 
participant in all experimental conditions in each study. Furthermore, the existence of single 
nucleotide polymorphisms of genes involved in the DNA methylation cycle has led to the assertion 
that some individuals may exhibit a genetic susceptibility to epigenetic modification (Terruzzi et 
al., 2011) and therefore a standardised set of cells was essential to be able to isolate the specific 
effects of exercise-conditioned plasma. It has been demonstrated that exposure to blood from 
young mice can aid in muscle and skin healing in older mice due to proteins and RNA located in 
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the plasma, and red or white blood cells (Conboy, Conboy, Wagers, Girma, Weissman, & Rando, 
2005), suggesting that plasma alone can exert a significant impact on various cellular signals. This 
supports the use of our experimental protocol to clarify the role of circulating proteins on 
epigenetic modification in PBMCs.  
In all chapters, the following procedure was used prior to further analysis. PBMC samples were 
thawed quickly in a waterbath at 37oC, transferred to a 15 ml tube containing 10 ml of R0 medium 
and centrifuged at 400*g for five minutes. Supernatants were discarded and cells were counted 
using a Casey TT cell counter and analyser system (Roche, Basel, Switzerland). Cells were then 
diluted accordingly with R0 medium in order to yield 4*106 cells∙ml-1. In order to extract nuclear 
proteins (section 2.3.6), on a 24 well cell culture plate (Cellstar, Greiner Bio One, Gloucestershire, 
UK) 250 µl of PBMCs (1*106 cells) were stimulated with 100 µl of plasma separated from whole 
blood of the exercising participants, 150 µl of R0 medium, followed by incubation at 37 oC for four 
hours. The utilisation of an incubation period of this duration was to mimic the post-exercise state 
in which transient elevations of circulating IL-6 may be maintained for up to four hours; following 
a marathon, Toft et al. (2000) and Ostrowski et al. (1999) both reported that plasma IL-6 remained 
elevated for three and four hours respectively. Various other studies have shown post-exercise 
elevations immediately following cessation of exercise (Bernecker, Scherr, Schinner, Braun, 
Scherbaum, & Halle, 2013; Nieman et al., 2001), but did not take further measurements until 24 
hours (Howatson et al., 2010; Scherr et al., 2011). Therefore, given the duration and relative 
intensity of the exercise bouts utilised within the forthcoming chapters, it was decided that four 
hours was a sensible and informed choice of incubation period.  
In chapters 3 to 6, PBMCs isolated from a single resting participant were used in all experimental 
conditions, however, chapter 7 investigates both acute and chronic changes, therefore it was 
deemed necessary to use cells that had been isolated from the blood of sedentary individuals prior 
to the training programme, but also cells isolated after exercise-induced adaptations had occurred.  
2.3.6 Nuclear Extraction 
Cells were transferred into a 15 ml conical tube and centrifuged for five minutes at 400*g. The 
supernatant was discarded and the cells washing with 500 µL of 1x phosphate buffered saline 
(PBS) by centrifugation for five minutes at 300*g. The supernatant was again discarded, and cells 
resuspended by tapping of the tube. A 10x pre-extraction buffer was diluted with distilled water at 
a 1:10 ratio, followed by the addition of Diothiothreitol (DTT) solution and Protease Inhibitor 
Cocktail (PIC) to the 1x pre-extraction buffer at a 1:1000 ratio. 100 µL of the complete 1x pre-
extraction buffer was added per 106 cells, and transferred to a microcentrifuge vial. Vials were then 
incubated on ice for 10 minutes, vortexed vigorously for 10 seconds, followed by centrifugation for 
1 minute at 12,000 rotations per minute in a microcentrifuge. The cytoplasmic extract was carefully 
removed from the nuclear pellet using a pipette and sterile tips, and stored at -80oC for later 
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analysis (chapter 6 only). DTT and PIC were then added to the extraction buffer at a 1:1000 ratio, 
and 20 µL per 106 cells was added. The extract was then incubated on ice for 15 minutes with 
vortexing for five seconds every three minutes. The suspension was then centrifuged for 10 
minutes at rotations per minute in a microcentrifuge, and the supernatant transferred to new clean 
microcentrifuge vials. 
2.3.7 Bradford Assay  
A Bradford assay was used in order to quantify the amount of protein per µl of nuclear extract 
(Quick Start Bradford Protein Assay, Bio Rad, California, USA). 5 µl of each of the seven Bovine 
Gamma-Globulin standards (2, 1.5, 1, 0.75, 0.5, 0.25, 0.125 mg∙ml-1), and 5 µl of each of the 
nuclear extracts, were added to duplicate wells. Each well then received 250 µl of 1x dye reagent 
(containing methanol and phosphoric acid). The microplate was placed on a microplate mixer at 
120 rotations per minute for 10 minutes at room temperature, then read using a microplate reader 
(Synergy HT, Bio Tek, Vermont, USA) at an absorbance of 595 nm. The average blank value was 
subtracted from the sample absorbance, and a standard curve was generated in order to quantify 
protein amount for each nuclear extract. 
2.3.8 DNA Methyltransferase ELISA 
Quantification of nuclear DNMT3A and DNMT3B concentrations were performed as per 
manufacturer guidelines (Epiquik DNMT3A/B Assay Kit, Epigentek, New York, USA).  Briefly, 
nuclear extracts were loaded into well in duplicate and incubated with the capture reagent and 
assay buffer. After washing the wells, an affinity antibody was added, and following further 
washing, a detection antibody added. Microplates were scanned at 450 nm with a reference 
wavelength of 655 nm to measure absorbance following the addition of a colour developing 
solution (Synergy HT, BioTek, Winooski, USA). A standard curve was generated from diluted 
DNMT3A/DNMT3B standards ranging from 1 ng·μl-1 to 20 ng·μl-1. The following equation was 
then used to quantify enzyme concentration: 
Concentration (ng∙mg of protein-1) = (sample OD – blank OD)/(slope*protein amount)*1000 
OD is optical density/absorbance; Slope generated from the standard curve; Protein amount (µg) as 
quantified by Bradford assay. 
2.3.9 Interleukin-6 ELISA 
A QuantiGlo Human IL-6 ELISA (R&D Systems, Minneapolis, USA) was used in order to 
quantify pre- and post-exercise plasma concentrations of IL-6 as per standard manufacturer 
guidelines. Samples were assayed in duplicate, including positive controls and various dilutions 
(1500, 300, 60, 12, 2.4, 0.48 pg∙ml-1) of the IL-6 standard which were used to plot a standard curve. 
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The mean minimum detectable dose was 0.16 pg∙ml-1. Assay sensitivity was 0.35 pg∙ml-1, and the 
assay detection range was between 0.480 and 1,500 pg∙ml-1.  
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CHAPTER 3 
 
 
 
 
 
 
PILOT INVESTIGATIONS 
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3 Pilot Investigations 
3.1 Introduction 
As outlined in chapter 2, stimulation of PBMCs with exercise-conditioned plasma is a new 
technique designed to mimic the effects of circulatory changes following exercise in a controlled 
manner, therefore, it was important to ensure that this process did not result in a significant 
reduction in cell viability prior to further analysis.  
Furthermore, a large body of evidence (section 1.5) demonstrates that pro-inflammatory cytokines 
can elicit significant changes to the transcription and cellular localisation of DNA methylation-
regulatory enzymes in vitro. Given Robson-Ansley et al’s finding that post-exercise elevations in 
plasma IL-6 were associated with methylation at a number of CpG loci in PBMCs, combined with 
this in vitro data, a logical assertion would be that IL-6 may be an important regulator of DNMTs 
following exercise, resulting in exercise-induced epigenetic modifications. Thus far however, no 
such experimental data has been reported concerning the direct effects of inflammatory cytokines 
on DNMT transcription or localisation in PBMCs, nor has IL-6 been shown to exert significant 
influence over the de novo DNA methyltransferases DNMT3A and DNMT3B.  
The aim of this initial investigation, therefore, was to initially examine whether exercise-
conditioned plasma significantly affected PBMC viability following the incubation period, and to 
quantify whether recombinant IL-6 (rIL-6) was able to significantly alter nuclear concentrations of 
DNMT3A and DNMT3B in vitro. Furthermore, since this is a very contemporary area of research, 
particularly within exercise physiology, these initial investigations also serve to provide some data 
on which sample size and statistical power calculations can be based. Based upon the literature 
discussed in section 1.5.1, it was hypothesized that rIL-6 would cause an augmentation of 
DNMT3A and DNMT3B nuclear concentrations.   
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3.2 Methods 
3.2.1 Peripheral Blood Mononuclear Cell Viability  
Preliminarily, PBMC viability following incubation with exercise-conditioned plasma was 
calculated. Whole blood was collected from a rested recreationally active male into six 10 ml 
lithium heparin vacutainer tubes (Becton Dickinson, Oxford, UK). ‘Recreationally active’ in this 
instance was defined as currently engaging in exercise for at least the minimum government 
guidelines of 150 minutes of moderate intensity exercise per week, but not currently involved in 
intense sport-specific training. PBMCs were isolated using centrifugation of a LeucoSep centrifuge 
tube (Greiner Bio-One, Frickenhausen, Germany) containing Lymphoprep (Stemcell Technologies, 
Vancouver, Canada) as outlined in chapter 2. Following counting of the cells, they were diluted 
accordingly in order to yield 4*106 cells∙ml-1. 250 µl of PBMCs (1*106 cells) were treated with 100 
µl of either pre-exercise plasma, post-exercise plasma (exercise protocol outlined in section 4.2), or 
fetal calf serum (FCS), in addition to 150 µl of RPMI-1640 medium and 
Penicillin/Streptomycin/Glutamine solution (Sigma Aldrich, Missouri, USA),followed by 
incubation at 37 oC for four hours. Each condition was performed in triplicate. Before and after 
incubation, the cells were mixed with Trypan Blue solution (Sigma Aldrich, Missouri, USA) in a 
1:1 ratio, followed by 10 µl of the resultant solution being pipetted into the upper chamber of an 
Improved Neubauer cell counting chamber (Hawksley, Sussex, United Kingdom). The number of 
live and dead cells was then counted using a Nikon TMS-F inverted microscope (Nikon, Tokyo, 
Japan).  
3.2.2 Recombinant IL-6 Stimulation  
In order to trial nuclear extraction and DNMT ELISA protocols, a preliminary experiment was 
performed whereby 250 µl of PBMCs (1*106 cells) were treated with 150 µl of R0 medium 
containing 10 and 100 ng∙ml-1 of rIL-6 and 100 µl of FCS followed by incubation at 37 oC for four 
hours. 100 ng∙ml-1 has previously been shown (Foran et al., 2010; Hodge et al., 2005) to increase 
DNMT1 expression in a multiple myeloma cell line, while 10 ng∙ml-1 was utilised by Liu et al. 
(2015a), who reported an increase in DNMT1 expression in a lung cancer cell line. Nuclear protein 
extraction was then performed as per the manufacturer guidelines and nuclear DNMT3A and 
DNMT3B protein concentrations quantified, as outlined in sections 2.3.6 and 2.3.7. 
Although the concentrations of rIL-6 that were utilised mimicked previous research, albeit using 
different cell lines, these would be considered to be supra-physiological and not representative of 
pre- or post-exercise plasma concentrations. Therefore, in a separate experiment, 250 µl of PBMCs 
(1*106 cells) were treated with 150 µl of R0 medium (section 2.3.5) containing various 
concentrations of rIL-6: 0, 0.01, 0.1, 1, 10, and 100 ng∙ml-1 followed by incubation at 37 oC for four 
hours. The lowest concentration would be considered to be within the expected physiological range 
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following prolonged endurance exercise (i.e. 10 pg∙ml-1). In both rIL-6 experiments, each condition 
was performed in duplicate. Intra-assay coefficient of variations was calculated as 9.8% and 10.8% 
for DNMT3A and DNMT3B, respectively.  
3.2.3 Statistical Analysis 
Data was analysed using IBM SPSS Statistics version 22. Normality of data was ensured using the 
Shapiro-Wilk test of normality. Non-normally distributed data was subsequently log10 transformed. 
Paired Samples T Tests were used to test for significant differences between pre- and post-
incubation cell viability, and nuclear concentrations following the first rIL-6 experiment. As the 
subsequent experiment involved a larger range of rIL-6 concentrations, Mauchly’s test of sphericity 
and a one-way repeated measures analysis of variance (ANOVA) was utilised. Levene’s Test for 
Equality of Variances and Independent Samples T Tests were used to analyse differences between 
enzymes at each concentration of rIL-6. Statistical significance was defined as p ≤ 0.05.  
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3.3 Results 
3.3.1 Peripheral Blood Mononuclear Cell Viability 
Table 3.1 shows that in each condition, there was no statistically significant difference in cell 
viability before and after incubation for four hours at 37 oC. 
Table 3.1 - Mean (± SD) percentage of viable peripheral blood mononuclear cells before and after 
incubation period. 
Condition Mean (± SD) Pre-incubation (%)  Mean (± SD) Post-incubation (%)  
Pre-exercise plasma 99.2 (± 0.7) 98.1 (± 0.1) 
Post-exercise plasma 98.7 (± 0.1) 96.9 (± 2.7) 
Fetal calf serum 95.6 (± 1.5) 97.7 (± 2.0) 
 
3.3.2 Recombinant IL-6 Stimulation  
Table 3.2 shows that as the dose of rIL-6 increases, nuclear concentrations of both DNMT3A and 
DNMT3B also significantly increase. 
Table 3.2 - Mean (± SD) peripheral blood mononuclear cell nuclear concentration of DNMT3A 
and DNMT3B following stimulation with recombinant interleukin 6 (10 and 100 ng·ml-1). 
rIL-6 Concentration 
(ng∙ml-1) 
Mean (± SD) Nuclear DNMT3A 
Concentration (ng∙mg protein-1) 
Mean (± SD) Nuclear DNMT3B 
Concentration (ng∙mg protein-1) 
10 2.0 (± 1.3) 365.6 (± 11.4) 
100 8.8 (± 3.4)a 490.5 (± 90.2)a 
asignificantly greater than ‘10 ng∙ml-1’ (p < 0.05). 
 
Table 3.3 represents a larger range of rIL-6 concentrations, ranging from normal physiological 
ranges up to supra-physiological concentrations. Every concentration of rIL-6 significantly 
augments nuclear DNMT3A concentrations compared with the blank control. 1 ng·ml-1 of rIL-6 
also caused a significant increase compared with 0.01 ng·ml-1, however, no other significant effects 
were observed.  
With regard to DNMT3B, 0.01 ng·ml-1 and 1 ng·ml-1 of rIL-6 did not exert a statistically significant 
effect. 0.1 ng·ml-1 was found to be significantly augmented compared with the blank control, while 
the two supra-physiological concentrations that had previously been utilised, significantly elevated 
nuclear DNMT3B concentrations compared with every other rIL-6 condition.  
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Furthermore, nuclear DNMT3B concentrations were significantly greater than nuclear DNMT3A 
concentrations in the following conditions: 0 (p = 0.001), 0.1 (p = 0.018), 10 (p = 0.019), and 100 
ng∙ml-1 (p = 0.028). 
Table 3.3 - Mean (± SD) peripheral blood mononuclear cell nuclear concentration of DNMT3A 
and DNMT3B following stimulation with various concentrations of recombinant interleukin 6 (rIL-
6) (0, 0.01, 0.1, 1, 10, 100 ng·ml-1). 
rIL-6 Concentration 
(ng∙ml-1) 
Mean (± SD) Nuclear DNMT3A 
Concentration (ng∙mg protein-1) 
Mean (± SD) Nuclear DNMT3B 
Concentration (ng∙mg protein-1) 
0 3.3 (± 0.9) 32.8 (± 0.8) 
0.01 28.9 (± 3.2)a 46.1 (± 16.7) 
0.1 44.2 (± 1.1) a 88.8 (± 3.2) a 
1 53.0 (± 4.5) ab 90.9 (± 11.3) 
10 60.3 (± 1.6) a 205.1 (± 7.7) abcd 
100 80.2 (± 5.7)a 458.7 (± 28.7) abcde 
asignificantly greater than ‘0 ng∙ml-1’ (p < 0.05); bsignificantly greater than ‘0.01 ng∙ml-1’ (p < 
0.05); csignificantly greater than ‘0.1 ng∙ml-1’ (p < 0.05); dsignificantly greater than ‘1 ng∙ml-1’ (p 
< 0.05); esignificantly greater than ’10 ng∙ml-1’ (p < 0.05). 
 
 
 
  
  
52 
 
3.4 Discussion  
The results of the initial pilot investigation presented within this chapter demonstrate that 
incubating PBMCs in the presence of exercise-conditioned plasma does not alter cell viability, even 
compared with the commonly utilised addition of FCS during cell culture. This procedure, 
therefore, is suitable for future investigation.  
This is also the first known study using human PBMCs to mimic previous in vitro data that has 
consistently demonstrated that when cells are cultured in the presence of rIL-6, expression of 
DNMTs can be significantly altered (section 1.5.1). A novel aspect of this present study is that 
nuclear protein concentrations of the de novo DNMTs were measured, theoretically representing 
methylating capacity due to nuclear protein abundance. Furthermore, as most studies have focussed 
on disease-specific cell lines, supra-physiological concentrations of rIL-6 are often utilised. Since 
the focus of the research presented in this thesis is exercise-induced modifications in healthy males, 
it seemed a logical progression to also test normal physiological ranges of rIL-6; 0.01 and 0.1 
ng∙ml-1 convert to 10 and 100 pg∙ml-1 – typical post-exercise plasma IL-6 concentrations, dependent 
upon duration and intensity (Fischer, 2006). 
Although the pathways by which IL-6 augments DNMT activity have not been fully elucidated, 
some results suggest PI3K-dependent activation of AKT and subsequent phosphorylation of the 
DNMT nuclear localisation signal may cause cellular translocation from the cytoplasm into the 
nucleus (Hodge et al., 2007). Since IL-6 has been shown to target PI3K in a variety of cell types 
(Hideshima, Nakamura, Chauhan, Anderson, 2001; Smith, Kiba, Zong, & Witte, 2013; Wegiel, 
Bjartell, Culig, & Persson, 2008; Xie et al., 2004; Yang et al., 2003), this appears to be a likely 
signalling pathway by which IL-6 is able to alter nuclear concentrations of DNMTs.  
Due to limited resources and the fact that these experiments were pilot investigations on which 
further studies would potentially be based, a small number of datapoints were used for statistical 
testing, potentially resulting in type 2 errors. Visually however, the data appears to suggest a linear 
dose-response relationship between rIL-6 and nuclear DNMT3A, and an almost exponential 
elevation in DNMT3B with increasing rIL-6 concentrations.  
3.4.1 Conclusion  
In conclusion, the data strongly supports the hypothesis that IL-6 is able to significantly alter 
nuclear concentrations of the de novo DNA methyltransferases DNMT3A and DNMT3B, and 
warrants further investigation into whether post-exercise plasma IL-6 may be a significant regulator 
of exercise-induced epigenetic modifications via manipulation of DNMT nuclear concentration.  
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CHAPTER 4 
 
 
 
 
 
 
THE EFFECTS OF EXERCISE-CONDITIONED PLASMA 
ON NUCLEAR CONCENTRATIONS OF DNMT3A AND 
DNMT3B FOLLOWING AN ACUTE BOUT OF INTENSE 
AEROBIC EXERCISE 
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4 The Effects of Exercise-Conditioned Plasma on Nuclear 
Concentrations of DNMT3A and DNMT3B Following an Acute 
Bout of Intense Aerobic Exercise 
4.1 Introduction 
In the previous chapter, pilot data corroborated in vitro studies that have demonstrated that IL-6 is 
able to significantly affect nuclear localisation of DNMTs and supports the rationale that exercise-
induced changes in DNA methylation may be regulated through IL-6 dependent pathways.  
A number of studies have shown that long term exercise, in the form of habitual PA or exercise 
intervention, is able to elicit changes to the global and gene-specific methylome. Much less is 
known regarding the acute effects, which may aid in the understanding of the underlying processes 
by which longer term adaptations occur. Barrès et al. (2012) reported that a single ?̇?O2peak test 
conducted on a cycle ergometer was able to cause global hypomethylation of vastus lateralis 
skeletal muscle in a cohort of sedentary young men and women. Hypomethylation occurred at the 
PGC-1α, PDK4, PPARδ, TFAM, and CS gene promoter regions concomitantly with transcriptional 
upregulation. The methylation status of muscle specific genes MEF2A and MYOD1 remained 
unaltered. This suggests that the exercise-induced upregulation (mRNA and protein level) of genes 
involved in mitochondrial biogenesis and substrate metabolism (Coffey & Hawley, 2007) is due to 
epigenetic modification. However, there is very little data to explain the underlying molecular 
mechanisms by which these changes occur. Furthermore, Robson-Ansley et al. (2014) reported that 
plasma IL-6 may be linked with DNA methylation in human PBMCs. The researchers investigated 
the effect of a 120 minute treadmill run at 60% of v?̇?O2max interspersed with sprints at 90% of 
v?̇?O2max for the last 30 seconds of every 10 minutes (previously shown to induce elevations in 
plasma IL-6 – (Walshe et al., 2010)), followed by a 5 km time trial, on subsequent changes in DNA 
methylation as measured by the Infinium HumanMethylation 27k beadchip. Despite no significant 
change in global DNA methylation, the exercise-induced elevation in plasma IL-6 concentration 
was significantly correlated with the methylation status of 11 genes (SLAMF1, IRAK3, LDB2, 
TMEM156, FCRL2, CDK9, SIT1, AER61, RAG2, C10orf89, CD40LG), a number of which are 
regulators of activities involving B and T cells, while IRAK3 is a key inhibitor of inflammation 
associated with the metabolic syndrome and obesity. Given the in vitro data discussed in section 
1.5 and our pilot investigation data, it seems likely that IL-6 plays a key role in modifying DNA 
methylation via manipulation of DNMT expression and/or cellular translocation, and therefore, 
warrants further investigation.   
The aim of the present study was to characterise potential changes in PBMC nuclear concentrations 
of the de novo DNA methyltransferases DNMT3A and DNMT3B caused by circulatory factors 
located in the plasma following a protocol shown to elicit an acute, transient increase in plasma IL-
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6. It was hypothesized that nuclear concentrations of DNMT3A and DNMT3B would be 
significantly attenuated following stimulation with post-exercise plasma, in line with results 
reported by Laye and Pedersen (2010), who demonstrated that DNMT3B transcription was reduced 
post-exercise, albeit in skeletal muscle samples. 
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4.2 Methods 
4.2.1 Participants 
10 recreationally active males were recruited from Northumbria University to take part in the 
exercise trial. ‘Recreationally active’ was defined as regularly meeting the government’s exercise 
guidelines of 150 minutes of moderate intensity activity per week, but not currently undertaking 
vigorous resistance or plyometric training more than once per week. Mean (± SD) characteristics 
are reported in table 4.1. Participants gave written informed consent, and all methods were 
approved by the Northumbria University Ethics Committee. All PBMCs were isolated from a 
resting, recreationally active participant who was recruited under the same criteria as other 
participants. Furthermore, his characteristics fit within the standard deviation of the exercising 
participants’ age, height, weight and BMI. 
4.2.1.1 Sample Size Estimation  
At the time of planning of this study, there had not been any data published that reported changes 
in nuclear concentrations in DNA methyltransferase enzymes, and therefore, power calculations 
were based upon initial findings presented in chapter 3 that recombinant human IL-6 was able to 
significantly augment nuclear concentrations of these enzymes (appendix E). Sample size was 
calculated using a spreadsheet accessed from the Boston University and Boston Medical Centre 
Research Compliance website (“Sample-Size Calculations”, 2014). 
4.2.2  Experimental Protocol 
The following protocol has previously been reported elsewhere (Walshe et al., 2010) and has been 
shown to elicit a significant transient increase in plasma IL-6. The protocol is described in full in 
section 4.2.2.3. 
4.2.2.1 Familiarisation 
Participants first attended the lab in order to be familiarised with the study protocol. This involved 
completing the full experimental protocol, as described below, without blood samples being taken. 
4.2.2.2 ?̇?O2max Assessment 
Seven days after the initial familiarisation, ?̇?O2max was quantified using a motorised treadmill 
(Pulsar, h/p/cosmos, Germany). Treadmill speed was set to 12 km∙hour-1 on a 1% gradient, and 
increased by 1 km∙hour-1 every three minutes until the participant reached volitional exhaustion. An 
online breath by breath analyser (Metalyzer 3B, Cortex, Germany) measured inspired and expired 
gases, which was used to calculate running velocity at ?̇?O2max (v?̇?O2max). Heart rate (HR) was 
  
57 
 
recorded via short range telemetry (Polar RS400, Finland) during the last 30 seconds of each stage. 
The test was considered maximal if two of the following criteria were met; a HR greater than 90% 
of the age predicted maximum (220 beats∙min-1 – age), a change in ?̇?O2 of less than 2 ml∙kg-1∙min-1 
in the final two stages, or a respiratory exchange ratio of 1.15 or greater.  
4.2.2.3 Main Trial 
The main experimental trial was conducted following a rest period of seven days. Participants were 
instructed to abstain from exercise, alcohol and caffeine for the 24 hour period prior to testing. 
Participants arrived at 09:00 following an overnight 12 hour fast, during which they were allowed 
to consume water ad libitum. Stature and mass were measured using standard procedures (section 
2.2.1), and 22.5 ml of blood was then collected into Lithium Heparin containing vacutainers 
(Becton Dickinson, Oxford, UK) from a vein in the antecubital fossa of the forearm (section 2.2.4). 
The main protocol required participants to run at 60% of v?̇?O2max for 120 minutes, interspersed 
with sprints at 90% of v?̇?O2max for the last 30 seconds of every 10 minutes. Immediately upon 
completion of the run, a further blood sample was taken using the same procedure as previously 
described. Pre- and post-run blood samples were centrifuged at 1700*g for 10 minutes at 4 oC in 
order for plasma to be separated. Samples were immediately stored at -80 oC for later analysis. 
Plasma volume shift was determined as described in section 2.3.2. 
4.2.3 Lab Analyses 
As described in full in sections 2.3.4 and 2.3.5, a standardised sample of PBMCs were incubated 
with exercise-conditioned plasma isolated before and after exercise. Nuclear proteins were then 
extracted and quantified by Bradford assay prior to analysis of DNMT quantification.  
4.2.3.1 DNMT Quantification 
Quantification of nuclear DNMT3A and DNMT3B enzyme concentrations were performed as per 
manufacturer guidelines described in section 2.3.8 (Epiquik DNMT3A/B Assay Kit, Epigentek, 
New York, USA). All samples were assayed in duplicate. Intra-assay coefficient of variation for 
DNMT3A and DNMT3B was calculated as 3.95% and 9.92%, respectively.  
4.2.3.2 Plasma Interleukin-6 Assay 
As outlined in section 2.3.9, a QuantiGlo Human IL-6 ELISA (R&D Systems, Minneapolis, USA) 
was used in order to quantify pre- and post-exercise plasma concentrations of IL-6 as per standard 
manufacturer guidelines. Intra-assay coefficient of variation was calculated as 4.3%. 
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4.2.4 Statistical Analysis 
Data was analysed using IBM SPSS Statistics version 22. Prior to performing parametric testing of 
the data, the Shapiro-Wilk test of normality was utilised. Non-normally distributed data was 
subsequently log10 transformed. Paired Samples T Tests were used to test for significance of 
repeated measures data. For independent group analysis, Levene’s test was utilised in order to 
ensure equality of variances, followed by Independent Samples T Test. Levene’s Test for Equality 
of Variances and an Independent Samples T Test were used to analyse differences between 
enzymes at baseline. Statistical significance was set as p ≤ 0.05. 
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4.3 Results 
4.3.1 Participant Characteristics 
Mean characteristics of the participants are provided in Table 4.1. Mean BMI shows that 
participants were within the normal healthy range of less than 25 kg∙m2. Participants were defined 
as recreationally active and showed a relatively high level of aerobic fitness, reflected by a mean 
maximal oxygen consumption of approximately 51.9 ml·kg-1·min-1. 
Table 4.1 - Mean (± SD) participant characteristics at baseline (n = 10). 
Variable Mean (± SD) 
Age (years) 24 (± 3) 
Stature (cm) 178.5 (± 5.6) 
Mass (kg) 77.5 (± 8.8) 
Body Mass Index (kg∙m2) 24.3 (± 2.6) 
?̇?O2max (ml∙kg-1∙min-1) 51.9 (± 6.7) 
4.3.2 DNMT Concentrations 
The effects of cell stimulation with plasma isolated following 120 minutes of treadmill running on 
subsequent changes in nuclear concentrations of the de novo DNA methyltransferases DNMT3A 
and DNMT3B are illustrated visually in figures 4.1 and 4.2. No change was observed in nuclear 
concentration of DNMT3A following the exercise stimulus, with mean (± SD) ‘pre’ and ‘post’ 
concentrations measured at 43.1 (± 8.7) and 41.5 (± 17.4) ng·mg protein-1 respectively.  
Conversely however, mean (± SD) nuclear concentrations of DNMT3B significantly decreased 
from 365.9 (± 363.6) to 87.2 (± 73.3) ng·mg protein-1 (p = 0.042); an approximate 76% reduction 
immediately following the exercise bout. 
Baseline concentrations of DNMT3B were significantly higher than DNMT3A (p = 0.02), showing 
that DNMT3B is more immediately abundant within PBMC nuclei, corroborating data presented in 
chapter 3.  
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Figure 4.1 - Mean (± SD) nuclear DNMT3A concentrations following stimulation with exercise-
conditioned plasma. 
 
 
Figure 4.2 - Mean (± SD) nuclear DNMT3B concentrations following stimulation with exercise-
conditioned plasma. *significantly lower than ‘pre’ (p < 0.05). 
 
4.3.3 Plasma IL-6 Concentration 
Plasma concentrations of IL-6 were also quantified. Figure 4.3 shows that mean (± SD) systemic 
concentrations significantly increased from 0.4 (± 0.3) to 14.9 (± 7.4) pg·ml-1; a 35-fold increase 
‘pre’ to ‘post’ exercise (p = 0.005). 
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Figure 4.3 - Mean (± SD) pre- and post-exercise plasma concentrations of IL-6. *significantly 
greater than ‘pre’ (p < 0.05). 
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4.4 Discussion  
This is the first study to investigate changes in the concentrations of the de novo DNA 
methyltransferases DNMT3A and DNMT3B following stimulation of PBMCs with plasma isolated 
before and after an acute bout of intense treadmill exercise. While DNMT3A concentrations 
remained unaltered, a significant reduction in the nuclear concentration of DNMT3B was observed 
which could be considered to be consistent with previous findings showing decreased DNMT3B 
mRNA in vastus lateralis skeletal muscle samples following exercise (Laye & Pedersen, 2010). 
These data suggest that the two de novo methyltransferases have distinct roles in response to 
exercise, and highlights a possible mechanism by which exercise may be able to acutely alter levels 
of DNA methylation.  
The significant elevation in plasma IL-6 immediately following the exercise bout suggests that 
nuclear transport or transcription of DNMT3A is unlikely to be solely regulated by IL-6 mediated 
signalling pathways immediately upon cessation of exercise, in contrast to the response of 
DNMT3B. The posit that DNMT3A and DNMT3B possess diverse functions following an acute 
exercise stimulus may be supported by findings that show that the enzymes are differentially 
expressed during development; DNMT3B is the primary active enzyme during earlier embryonic 
stages such as implantation, whereas DNMT3A expression is greater in the later stages of 
embryonic development (Okano et al., 1999) and during methylation of maturing gametes (Hara et 
al., 2014). It is also of interest that these data corroborate the findings reported in chapter 3 that 
DNMT3A is less abundant within the nuclei of PBMCs, possibly suggesting that DNMT3B may be 
a more important regulator of DNA methylation in somatic cells.  
The observed decrease in nuclear concentration of DNMT3B could be due to two mechanisms; 
downregulation of gene transcription and/or enhanced nuclear export. Laye and Pedersen (2010) 
reported a 50% decrease in skeletal muscle DNMT3B mRNA following three hours of cycling at 
60% of v ?̇? O2max. Furthermore, ionomycin stimulation of differentiated myotubes, but not 
proliferating myoblasts, caused attenuation of both DNMT3A and DNMT3B mRNA by 
approximately 40%. The 75% decrease in nuclear concentration of DNMT3B within the present 
study suggests nuclear export of the enzymes may also be occurring concurrently with 
transcriptional downregulation; 60 minutes of cycling has previously been shown to significantly 
decrease nuclear concentrations of the class IIa histone deacetylases HDAC4 and HDAC5 in 
skeletal muscle, possibly due to enhanced nuclear export (McGee et al., 2009) via 
Ca2+/calmodium-dependent protein kinase (CaMK) signalling (McKinsey et al., 2000). Since 
skeletal muscle CaMKII activity can be augmented by muscular contraction in an intensity 
dependent manner (Rose et al., 2006), when combined with reported contraction-induced DNA 
hypomethylation of mouse skeletal muscle (Barrès et al., 2012; Lucas et al., 2012), this suggests a 
mechanistic link between exercise, specifically muscular contraction, and nuclear export of 
epigenetic enzymes. Furthermore, HDACs have been shown to bind DNMT1 (Fuks, Burgers, 
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Brehm, Hughes-Davies, & Kouzarides, 2000; Rountree et al., 2000), while DNMT3B was shown 
to correlate with HDAC1 and HDAC2 in ovarian cancer (Gu et al., 2013), therefore it is plausible 
that DNMTs are exported as part of a complex with HDACs. Whether signalling within peripheral 
blood cells is the same as within muscle in response to exercise remains to be elucidated. 
If the observed decrease in nuclear concentration of DNMT3B did indeed translate into DNA 
hypomethylation, this would be in contrast to the results reported by Robson-Ansley et al. (2014), 
who found no differences in global or gene-specific DNA methylation following an identical 
protocol. However, the participants used by Robson-Ansley et al. (2014) were trained, as opposed 
to the participants and cell donor utilised within the present study who were not specifically 
endurance trained males, despite a good level of aerobic fitness. It is possible, therefore, that 
endurance training-associated increases in CaMKII (Rose et al., 2007) may attenuate the acute 
epigenetic response to a further single exercise bout. Furthermore, the Infinium 
HumanMethylation27 beadchip was utilised in this study which only covers 27, 578 CpG sites 
across 14, 495 genes, which may explain the lack of detectable changes.  
The conflicting outcomes between the exercise and rIL-6 stimulation (chapter 3) data suggests that 
molecules found in the plasma other than IL-6 could have profound influences on nuclear 
concentrations of DNMTs. PGE2, a lipid autocoid derived from arachidonic acid, is an important 
mediator in the acute inflammatory response, and can regulate IL6 expression in various cell types 
(Bagga et al., 2003; Hinson et al., 1996; Inoue et al., 2002; Williams & Shacter, 1997). Elevated 
plasma PGE2 has previously been reported following a marathon (Demers et al., 1981) and run to 
exhaustion at 80% of ?̇?O2max (Venkatraman et al., 2001), thus, given the intensity of the exercise 
bout in the present study, it is possible that plasma PGE2 was indeed elevated, contributing to the 
augmentation of circulating IL-6. Furthermore, expression of Sp1 and Sp3 transcription factors, 
known to regulate DNMT3A (Jinawath et al., 2005), have been shown to be upregulated following 
PGE2 stimulation, concomitant with an increase in DNMT3A expression in fibroblasts, and a 
decrease in DNMT3A and DNMT1 expression in RAW macrophages (Huang et al., 2012). 
Unfortunately, no data appears to support the supposition that DNMT3B may be altered by PGE2, 
however, the available data demonstrates that PGE2 is able to modify the expression of other 
epigenetic regulatory enzymes. 
Circulating miRNAs are another candidate group of plasma molecules that could influence the 
expression or transport of DNMTs. Changes in plasma concentrations of a multitude of miRNAs 
have been reported following acute aerobic (Nielsen et al., 2014), resistance (Sawada, Kon, Wada, 
Ushida, Suzuki, & Akimoto, 2013), and eccentric (Banzet et al., 2013) exercise. The role of IL-6 in 
the modification of DNMT1 expression, which has been discussed elsewhere within this paper, 
could be mediated by miRNA-148a and miRNA-152 (Braconi et al., 2010; Huang et al., 2010a). 
Furthermore, miRNA-143 has been shown to target DNMT3A (Ng et al., 2009), miRNA-148 
targets the DNMT3B protein coding region (Duursma et al., 2008), while miRNA-29 appears to be 
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involved in the regulation of both DNMT3A and DNMT3B (Fabbri et al., 2007; Garzon et al., 
2009; Takada et al., 2009).When combining these data, it appears entirely possible that exercise-
induced changes to plasma miRNAs could have a profound influence on nuclear DNMT transport 
and/or gene expression.  
A limitation of the present study was the lack of a direct measure of genomic or gene-specific 
methylation, and thus, it is not known whether the attenuation of DNMT3B resulted directly in the 
modification of DNA methylation. Hypomethylation is known to occur passively via 
downregulation of DNMT1, or actively via upregulation of TET activity (Kohli & Zhang, 2013), 
however, the functional effects of a reduction in DNMT3B are unknown. 
It must also be noted that due to the utilisation of a standardised cell sample from a single 
participant in all experimental conditions, results may lack generalisability. For example, the cell 
donor in the present study could be a low or non-responder due to their particular genotype 
(Terruzzi et al., 2011) possibly accounting for the lack of change in DNMT3A concentration 
following stimulation with exercise-conditioned plasma. 
4.4.1 Conclusion 
The data presented thus far demonstrates that IL-6, recombinant or located in the plasma, exerts 
significant effects on de novo DNA methyltransferases in human PBMCs. An investigation into the 
distinct functions of DNMT3A and DNMT3B is necessary in order to elucidate how the enzymes 
are differentially regulated; whether DNMT3A exhibits a delayed response to exercise, similar to 
the expression of the enzyme later in embryonic development, or if it is simply unreceptive to 
stimulation with plasma proteins. Further studies should also look to sample at multiple timepoints 
following exercise bouts of varying modes and durations in order to clarifying how differential 
systemic changes affect nuclear localisation of these enzymes.  
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CHAPTER 5 
 
 
 
 
 
 
THE EFFECTS OF EXERCISE-CONDITIONED PLASMA 
ON NUCLEAR CONCENTRATIONS OF DNMT3A, 
DNMT3B, AND TET FOLLOWING ULTRA-ENDURANCE 
EXERCISE 
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5 The Effects of Exercise-Conditioned Plasma on Nuclear 
Concentrations of DNMT3A, DNMT3B, and TET Following Ultra-
Endurance Exercise 
5.1 Introduction  
Results presented in chapters 3 and 4 thus far strongly support the plethora of in vitro data that 
inflammation, particularly IL-6, plays a key role in the manipulation of DNMTs, and therefore, 
epigenetic modification. Specifically, in chapter 4, it was demonstrated that when PBMCs of a 
recreationally active individual were incubated in the presence of exercise-conditioned plasma, 
there was a significant attenuation of DNMT3B nuclear concentrations, despite no change in the 
lesser abundant DNMT3A. These data highlight that, similar to expression during fetal 
development, the two de novo DNA methyltransferases possess distinct roles, and also raises the 
possibility that DNMT3A transcription and/or cellular transport is either not significantly altered by 
changes in circulating proteins and molecules following exercise, or simply that these exercise-
induced systemic changes were not large enough to elicit a response. In order to investigate this, 
therefore, it appeared logical to utilise an exercise bout that would elicit a much more extreme 
inflammatory response. Furthermore, as to whether the attenuation in DNMT3B would result in 
previously reported exercise-induced hypomethylation via passive mechanisms, or whether this 
would be due to TET-dependent active demethylation, remains to be clarified.  
Marathon races, officially defined as a distance of 26.2 miles or 42.2 km, place an extraordinary 
physiological demand on the body, resulting in pronounced changes to systemic inflammatory 
markers. Scherr et al. (2011) reported that plasma high sensitivity C-reactive protein (hsCRP), IL-
6, IL-10 and TNFα were all elevated following the Munich marathon, although no change was 
observed in IL6 and TNFα mRNA in PBMCs (Bernecker et al., 2013). Similarly, Howatson et al. 
(2010) reported elevations in plasma IL-6 and hsCRP concentrations, immediately following, and 
up to 48 hours following the London marathon, respectively. Nieman et al. (2001) also found that 
circulating IL-10, IL-1ra, IL-6 and IL-8 concentrations were elevated post-marathon, in addition to 
small, yet significant, increases in IL-1β and TNFα. Interestingly, while previous research has 
identified numerous miRNAs that are transiently upregulated in plasma following exercise (Nielsen 
et al., 2014; Sawada et al., 2013; Banzet et al., 2013), de Gonzalo-Calvo et al. (2015) were the first 
to show that endurance exercise is able to elicit significant alterations to circulatory inflammatory 
miRNAs profiles, with a marathon causing significant augmentation of 12 of these, in contrast to a 
10 km run, which only resulted in a single inflammatory miRNA to be elevated.  
It is well established that ultra-endurance races, which are generally considered to consist of any 
distance greater than 42km covered in a standard marathon, are also able to cause considerable 
transient increases in plasma concentrations of a number of inflammatory markers such as hsCRP 
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and IL-6. Following a 50km race, plasma IL-6 was significantly elevated upon completion 
(Mastaloudis, Morrow, Hopkins, Devaraj, & Traber, 2004), while a 200km run, with a duration that 
ranged from 24 to 35 hours, caused significant augmentation of both plasma IL-6 and hsCRP, but 
TNFα remained unchanged (Kim et al., 2007). During races of even greater duration, such as a 48 
hour ultra-marathon, IL-6 was significantly augmented by the 6 hour mark and remained elevated 
at 48 hours, returning to baseline another 48 hours following completion of the race (Klapcinska, 
Waśkiewicz, Chrapusta, Sadowska-Krępa, Czuba, & Langfort et al., 2013), while CRP was found 
to be elevated at 12 hours, with a further increase at 24 hours. Similar results were reported 
following a 308km race with a time limit of 64 hours; IL-6, IL-8, CRP, and IL-10 were all elevated 
by the 100km mark, and remained at a similar level for the duration of the race (Shin and Lee, 
2013). More specifically to the present investigation, IL-6 was shown to be elevated immediately 
following a 24 hour race (Waśkiewicz et al., 2012), while more frequent measurements 
demonstrated that a significant increase occurred at 6 hours, with a further increase at 12 hours, 
which remained elevated at 24 hours (Wallberg, Mattson, Enqvist, & Ekblom, 2011). Neither study 
showed significant increases in TNFα or CRP immediately following the ultra-marathon, although 
CRP was elevated at 12 and 24 during recovery (Waśkiewicz et al., 2012). 
Given the potential of singular bouts of ultra-endurance activity to cause large elevations in 
circulating levels of inflammatory markers such as IL-6, combined with the convincing evidence 
that inflammatory cytokines are able to manipulate DNMT expression and DNMT protein levels in 
a number of cell lines including PBMCs, a clear rationale underpins the use of such an intense 
stimulus. The primary objective of this study, therefore, was to characterise the acute response of 
DNMT3A and DNMT3B nuclear concentrations in PBMCs when cultured in the presence of 
exercise-conditioned plasma isolated from participants before and after an ultra-endurance event. 
Furthermore, potential changes in hydroxymethylated DNA and TET activity would provide 
further insight into whether exercise-induced circulatory changes affect DNA demethylation. 
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5.2 Methods 
5.2.1 Setting and Participants  
Samples were collected during the 2011 and 2012 Glenmore24 Trail Race, a 24 hour ultra-
marathon over a 6km looped course, in the Cairngorms National Park situated in the Scottish 
Highlands. 18 (male = 15, female = 3) participants agreed to participate and gave fully informed 
consent. Mean (± SD) characteristics of participants at baseline are reported in table 5.1. The study 
received appropriate ethical approval from Coventry University Applied Research Committee and 
Northumbria University Ethics committee.  
5.2.1.1 Sample Size Estimation  
Similarly to chapter 4, power calculations were based upon initial findings presented in chapter 3 
that recombinant human IL-6 was able to significantly augment nuclear concentrations of these 
enzymes (appendix E). However, to account for a potential high number of drop outs given the 
extended duration of the exercise bout, a greater number of individuals were recruited for this 
study. Sample size was calculated using a spreadsheet accessed from the Boston University and 
Boston Medical Centre Research Compliance website (“Sample-Size Calculations”, 2014). 
5.2.2 Data Collection 
An hour prior to the start of the ultra-marathon (12:00), stature was measured using a stadiometer 
and body mass was measured using calibrated electronic scales (BF510, Omron Healthcare, Ukyo-
ku, Kyoto, Japan). Hip and waist circumferences were measured using standard procedures 
outlined in chapter 2 (2.2.1). Participants then sat for a period of 10 minutes prior to blood 
sampling, whereby blood was collected into one 6 ml Lithium Heparin vacutainer tube (Becton 
Dickinson, Oxford, UK) from a vein the antecubital fossa of the forearm (section 2.2.4). 
Participants wore a SenseWear (7.0, Bodymedia, Pittsburgh, PA, USA) armband monitoring 
system to track distance and energy expenditure during the race. Immediately following the end of 
the race (12:00), body mass was re-measured and a blood sample was taken using the same 
procedure as before the race. Pre- and post-run blood samples were centrifuged at 1700*g for 10 
minutes at 4 oC in order for plasma to be separated. Samples were immediately stored at -80 oC for 
later analysis. Plasma volume shift was determined as described in section 2.3.2. 
5.2.3 Lab Analyses 
As described in sections 2.3.4 and 2.3.5, a standardised sample of PBMCs were incubated with 
exercise-conditioned plasma isolated before and after exercise. Nuclear proteins were then 
extracted and quantified by Bradford assay prior to analysis of DNMT quantification.  
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5.2.3.1 Cytokine Assays 
Analysis of plasma IL-1β, IL-12p70, IFN-γ, IL-6, IL-8, IL-10 and TNFα was performed using the 
Human ProInflammatory 7-Plex Ultra-Sensitive Kit (Meso Scale Discovery, Gaithersburg, USA), 
which detects the cytokines in a sandwich immunoassay format. Samples and solutions containing 
labelled detection antibodies were added to wells. Sample analytes bind to capture antibodies that 
are immobilised on the working electrode surface. Bound analytes then recruit labelled detection 
antibodies. An M1250 Sector Imager (Meso Scale Discovery, Gaithersburg, USA) was used to 
measure intensity of emitted light in order to quantify concentrations of the cytokines present in the 
samples. Lower limits of detection for each cytokine were 0.58, 0.77, 0.80, 0.18, 0.10, 0.57, and 
0.28 pg∙ml-1, respectively. Intra-assay coefficient of variations for each cytokine, in the order first 
mentioned above, were 13.88%, 9.81%, 6.31%, 9.25%, 5.37%, 7.81%, and 6.45%. Inter-assay 
coefficient of variations were calculated as 19.41%, 19.97%, 9.02%, 17.05%, 5.50%, 32.41%, and 
21.87%.  
5.2.3.2 DNMT Quantification 
Quantification of nuclear DNMT3A and DNMT3B enzyme concentrations were performed as per 
manufacturer guidelines described in section 2.3.8 (Epiquik DNMT3A/B Assay Kit, Epigentek, 
New York, USA). All samples were assayed in duplicate on a single plate. Intra-assay coefficient 
of variations for DNMT3A and DNMT3B were calculated as 10.47% and 4.15%, respectively.  
5.2.3.3 Hydroxymethylated DNA and TET Activity  
Quantification of TET activity from nuclear extracts was performed as per manufacturer guidelines 
(Epigenase 5mC Hydroxylase TET Activity/Inhibition Assay Kit, Epigentek, New York, USA). 
The assay involves a methylated substrate being coated onto the microplate well, with TET activity 
calculated from the conversion of methylated to hydroxymethylated products. Microplates were 
scanned at 450 nm with a reference wavelength of 655 nm (Synergy HT, BioTek, Winooski, USA). 
The following equations were used to quantify amount of hydroxymethylated product and TET 
activity: 
Hydroxymethylated product (ng) = (sample OD – blank OD)/slope 
TET activity (ng∙min-1∙mg-1) = hydroxymethylated product (ng)/(protein amount (µg)*min)*1000 
OD is optical density/absorbance; Slope is generated from the standard curve; Protein amount (µg) as 
quantified by Bradford assay; ‘Min’ is incubation time. 
5.2.4 Statistical Analysis 
Data was analysed using IBM SPSS Statistics version 22. Prior to performing parametric testing of 
the data, the Shapiro-Wilk test of normality was utilised. Non-normally distributed data was 
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subsequently log10 transformed. Paired Samples T Tests were used to test for significance of 
repeated measures data. A Pearson product-moment correlation was also used. Multiple regression 
analysis was then run to investigate whether significant changes in pro-inflammatory cytokines 
predicted change in DNMT nuclear concentration. Statistical significance was set as p ≤ 0.05.  
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5.3 Results 
5.3.1 Participant Characteristics 
Mean characteristics of the participants are provided in Table 5.1. Mean body mass index shows 
that participants were within the normal healthy range of less than 25 kg∙m2. Waist circumference 
and waist to hip ratio classify the participants as healthy with low risk of disease (ACSM, 2014). 
Tables 5.2 shows the average distance covered, energy intake, and energy expenditure during the 
race. Table 5.3 provides a more detailed breakdown of macronutrient intake during the race.  
Table 5.1 - Mean (± SD) participant characteristics at baseline (n = 18). 
Variable Mean (± SD) 
Age (years) 40 (± 8) 
Stature (cm) 176.8 (± 8.1) 
Mass (kg) 78.9 (± 12.0) 
Body Mass Index (kg∙m2) 25.1 (± 2.7) 
Waist Circumference (cm) 83.4 (± 9.2) 
Hip Circumference (cm) 98.3 (± 6.1) 
Waist to Hip Ratio 0.85 (± 0.05) 
 
Table 5.2 - Mean (± SD) distance and energy expenditure, and intake (n = 18). 
Variable Mean (± SD) 
Distance Covered (km) 157.1 (± 27.0) 
Energy Expenditure (kcal) 13169 (± 2815) 
Energy Intake (kcal) 5062 (± 2880) 
 
Table 5.3 - Mean (± SD) macronutrient intake during the race (n = 16). 
Macronutrient Mean (± SD) 
Protein (g) 90.8 ± 41.7 
Fat (g) 121.5 ± 54.6 
Carbohydrate (g) 901.4 ± 617.3 
Protein (%) 7.8 ± 2.8 
Fat (%) 23.2 ± 8.7 
Carbohydrate (%) 69.0 ± 10.8 
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5.3.2 DNMT Concentrations 
The effects of cell stimulation with plasma isolated following a 24 hour ultra-endurance race on 
subsequent changes in nuclear concentrations of the de novo DNA methyltransferases DNMT3A 
and DNMT3B are illustrated visually in figures 5.1 and 5.2. Nuclear concentrations of DNMT3A 
significantly increased from 20.2 (± 36.7) to 86.6 (± 138.7) ng∙mg protein-1 (p = 0.031), despite the 
large variation in post-exercise concentrations. There was no significant change in DNMT3B 
nuclear concentration however (412.2 (± 107.2) to 441.9 (± 143.9) ng∙mg protein-1) (p = 0.514). 
Nuclear concentrations of DNMT3B were significantly greater than DNMT3A at both timepoints 
(p < 0.001). 
5.3.3 TET Activity  
No TET-converted hydroxymethylated product was detected for any of the experimental samples, 
indicating either a lack of TET activity, or that activity levels were lower than the sensitivity of the 
assay. Blank and standard controls verified that the assay functioned correctly.  
 
Figure 5.1 - Mean (± SD) nuclear DNMT3A concentrations following stimulation with exercise-
conditioned plasma. *significantly greater than ‘pre’ (p < 0.05). 
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Figure 5.2 - Mean (± SD) nuclear DNMT3B concentrations following stimulation with exercise-
conditioned plasma. 
5.3.4 Plasma Pro-inflammatory Cytokines Concentrations 
Significant increases in plasma IL-10 (4.36 to 11.98 pg∙ml-1; p < 0.001), IL-6 (0.41 to 13.12 pg∙ml-
1; p < 0.001), IL-8 (12.79 to 34.26 pg∙ml-1; p < 0.001) and TNFα (2.85 to 3.47 pg∙ml-1; p = 0.002) 
were observed following the race (figures 5.3 to 5.6). No significant changes were observed in 
plasma concentrations of IFN-γ, IL-12 p70 or IL-1β (p = 0.532, 0.663, 0.993) (see table 5.4). 
 
Table 5.4 - Mean (± SD) pre- and post-exercise plasma concentrations of IFN-γ, IL-12 p70, and 
IL-1β (n = 18). 
Timepoint 
Mean (± SD) IFN- γ  
Concentration (pg∙ml-1) 
Mean (± SD) IL-12 p70  
Concentration (pg∙ml-1) 
Mean (± SD) IL-1β 
Concentration (pg∙ml-1)  
Pre-exercise 1.01 (± 0.78) 22.04 (± 63.54) 0.10 (± 0.29) 
Post-exercise 1.11 (± 1.64) 19. 12 (± 53.78) 0.52 (± 1.01) 
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Figure 5.3 - Mean (± SD) pre- and post-exercise plasma concentrations of IL-10. *significantly 
greater than ‘pre’ (p < 0.05). 
 
Figure 5.4 - Mean (± SD) pre- and post-exercise plasma concentrations of IL-6. *significantly 
greater than ‘pre’ (p < 0.05). 
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Figure 5.5 - Mean (± SD) pre- and post-exercise plasma concentrations of IL-8. *significantly 
greater than ‘pre’ (p < 0.05). 
 
Figure 5.6 - Mean (± SD) pre- and post-exercise plasma concentrations of TNFα. *significantly 
greater than ‘pre’ (p < 0.05). 
5.3.5 Linear and Multiple Regression 
The elevation in IL-10 was significantly correlated with distance covered during the race (R = 
0.691, p = 0.002). Similarly, the significant augmentation of plasma IL-6 was also correlated with 
distance covered (R = 0.632, p = 0.005). IL-6 and IL-10 were strongly correlated with each other 
(R = 0.851, p < 0.001). However, distance was not correlated with the change in plasma 
concentrations of either IL-8 or TNFα. 
The augmentation of nuclear DNMT3A was not correlated with any of the significantly elevated 
plasma cytokines individually. Multiple regression analysis showed that significant elevations in 
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plasma concentrations of IL-10, IL-6, IL-8, and TNFα together were unable to predict the change 
in nuclear concentrations of DNMT3A (R = 0.598, R2 = 0.358, p = 0.477). 
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5.4 Discussion 
This is the first study to investigate epigenetic changes in response to circulatory proteins and 
molecules found in the plasma following an ultra-endurance event. Given the previously reported 
data showing that circulating inflammatory cytokines, in particular IL-6, appear to exert significant 
influence over nuclear localisation of the de novo DNMTs, it was hypothesized that ultra-
endurance exercise-conditioned plasma would also elicit significant changes in nuclear 
concentrations of DNMT3A and DNMT3B. In contrast to our previous study whereby DNMT3B 
nuclear concentrations, but not DNMT3A, were attenuated following stimulation with exercise-
conditioned plasma, we observed a significant augmentation of DNMT3A, with no significant 
change in DNMT3B. Data corroborated that DNMT3A is less abundant than DNMT3B within the 
nucleus at baseline. Furthermore, the amount of hydroxymethylated product was presumed to be 
out of the detection range of the assay used, and therefore, TET activity was unable to be measured. 
Manipulation of DNMT nuclear concentration following exercise has not yet been investigated 
following endurance exercise of extended duration, with the 120 minute protocol utilised in chapter 
4 being the only known example of this type of investigation. Since identical cells were utilised in 
both, there were no differences in cellular adaptation to previous training or genetic susceptibility 
to epigenetic modification. Differences between the studies, therefore, must be due to exercise-
induced circulatory changes.  
Post-exercise augmentation of IL-6, IL-10, and IL-8 plasma concentrations corroborates previous 
research into ultra-endurance events (Kim et al., 2014; Klapcinska et al., 2013; Mastaloudis et al., 
2004; Shin and Lee, 2013; Wallberg et al., 2011; Waśkiewicz et al., 2012). The response of TNFα 
to longer endurance events is inconsistent however; similarly to the present study, a small, but 
statistically significant augmentation occurred following a marathon (Nieman et al., 2001; Scherr et 
al., 2011) and 50km race (Mastaloudis et al., 2004). In contrast, Kim et al. (2014) and Wallberg et 
al. (2011) were unable to detect significant changes, although considering that all of the previously 
reported increases in TNFα were small, lack of significance may simply be due to differential 
statistical power between studies.  
The systemic IL-6 response is thought to be largely dependent on duration of exercise (Fischer, 
2006); depletion of muscle glycogen stores during a race of this length would be expected to cause 
upregulation of the IL6 gene in order to signal the liver to enhance hepatic glucose output (Keller et 
al., 2001). Furthermore, since the distance covered during the race and elevation in plasma IL-6 
concentration were significantly correlated, this also supports the fact that elevated plasma IL-6 is a 
product of extreme metabolic demand. Exercise-induced perturbations in Ca2+ and oxidative stress 
are also likely to have occurred, which are known to upregulate IL-6-activating transcription 
factors (Fischer, 2006).   
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IL-10 concentrations were correlated with both distance covered and IL-6, suggesting that the 
elevation in this anti-inflammatory cytokine could be due to a homeostatic mechanism by which 
the body attempts to resolve systemic inflammation, as previously shown in participants infused 
with recombinant IL-6 (Steensberg, Fischer, Keller, Møller, & Pedersen,  2003). 
Nieman et al. (2003) have previously reported that elevated circulating IL-8 is not due to local 
production, but likely due to augmented expression in PBMCs. Given the role of IL-8 in neutrophil 
chemotaxis and leukocyte activation, it is unsurprising that systemic concentrations were elevated 
following such an extreme exercise bout, in order to enhance neutrophil migration (Risoy et al., 
2003) which begins resolution of muscle damage immediately upon cessation of exercise (Peake, 
Nosaka, & Suzuki, 2005).  Conversely however, TNFα has been hypothesized to be released 
locally from exercising muscle, as Bernecker et al. (2013) reported no significant change in TNFα 
expression in PBMCs following a marathon. In line with previous research, it is clear that 
prolonged endurance exercise such as an ultra-marathon results in significant physiological 
demand, leading to a systemic inflammatory state. 
In contrast to the previous study whereby nuclear DNMT3A concentration remained unaltered, a 
significant augmentation was observed in the present investigation. Post-exercise IL-6 reached 
similar concentrations in both studies, and therefore, the differential response of the de novo DNA 
methyltransferase is unlikely to be due this cytokine alone. While plasma concentrations of other 
inflammatory cytokines were not quantified in the previous study, TNFα, IL-8, and the anti-
inflammatory IL-10 were significantly higher post ultra-marathon. A possible hypothesis could be 
that the combination of cytokines caused significant transcriptional upregulation of DNMT3A 
compared with each cytokine in isolation; Dhar et al. (2013) reported that 100 ng∙ml-1 of TNFα and 
IGF-1 in combination caused an augmentation in DNMT1 and DNMT3B mRNA compared with 
each cytokine alone, and DNMT3A compared with controls. Although this study was conducted 
using coronary artery cells, it highlights the possibility of differential DNMT regulation in response 
to combinations of cytokines. Another possible explanation for the lack of corroboration between 
studies is that although plasma IL-6 was augmented following the 120 minute protocol, IL-10, in 
its role in as an anti-inflammatory mediator, may not have been elevated at the time of the post-
exercise sample. In contrast, the post-exercise timepoint in the present study was 24 hours from 
initiation of exercise, and thus, a 2-fold increase in IL-10 most likely indicates the beginning of 
inflammatory resolution. Given that different signalling cascades control pro- and anti-
inflammatory pathways, at least with regard to IL-6 (Scheller, Chalaris, Schmidt-Arras, & Rose-
John, 2011), it is plausible that differential activation of these pathways due to the timeframe in 
which the samples were taken would be sufficient to elicit the contrasting downstream changes in 
nuclear DNMT concentrations. Multiple regression analysis demonstrated that the observed 
elevations in plasma concentrations of IL-6, IL-8, IL-10, and TNFα, at least alone, do not explain 
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the change in DNMT3A following exercise however, and thus, other exercise-induced circulatory 
changes must be accountable. 
Oxidative stress induced by accelerated oxygen radical generation during exercise can significantly 
alter the systemic environment. Neutrophil activation and subsequent infiltration into skeletal 
muscle in response to mechanical damage and acute oxidative stress, for example due to 
mitochondrial reactive oxygen species (ROS) production (Ji, 1999), is one of many sources of ROS 
during extended endurance exercise such as a marathon (Hessel, Haberland, Müller, Lerche, & 
Schmike, 2000; Knez, Coombes, & Jenkins, 2006). Consequently, aerobic activity has often been 
shown to alter GPx activity (Hessel et al., 2000; Tauler, Aguiló, Gimeno, Guix, Tur, & Pons, 2004) 
and GSH redox status (Sastre et al., 1992; Viña, Sastre, Asensi, & Packer, 1995), although not 
definitively, as Miyazaki et al. (2001) were unable to detect any changes in GPx activity following 
cycling to exhaustion. Although plasma GPx is only one of many indirect markers of oxidative 
stress, it is of interest within the present context given the overlap between GSH and SAM 
synthesis. As discussed in section 1.2.5, the methyl donor SAM and antioxidant enzyme GPx both 
require methionine in order to be resynthesized, and thus, exercise-induced oxidative stress may 
disrupt the methylation cycle via this competing demand for methionine (Hitchler & Domann, 
2007). Furthermore, the addition of adenosine to methionine to yield SAM is dependent on MAT 
activity, which itself is attenuated in an oxidised environment (Pajares et al., 1992). 
Wongpaiboonwattana et al. (2013) reported global (LINE-1) hypomethylation in bladder cancer 
cells treated with H2O2, which is consistent with this hypothesis. Seemingly paradoxically however, 
RUNX3 was hypermethylated, similar to the results of Barrès et al. (2012), who reported 
augmented promoter methylation of TFAM, MEF2A, and CS in rat skeletal muscle myotubes 
following H2O2 treatment. It is clear that a link exists between oxidative stress, and therefore 
exercise-induced ROS production, and methylating capacity, although it remains to be elucidated 
whether DNMT or TET localisation or transcription are affected, or whether DNA methylation is 
influenced solely by methyl group unavailability.  
Following aerobic exercise, changes to extracellular concentrations of Ca2+ occur in the form of 
elevated plasma or serum Ca2+ (Ljunghall et al., 1984; Salveson et al., 1994; Vora, et al., 1983). B 
cells sense extracellular Ca2+ which can activate the transcription factor NF-κB (Hammond, White, 
Tomic, Shi, & Spaner, 2007), while Ca2+ signalling in T cells promotes extracellular Ca2+ entry via 
specific channels, which also causes NF-κB activation (Feske, 2007). In turn, this can then cause 
downstream upregulation of IL6 (Shimizu, Mitomo, Watanabe, Okamoto, & Yamamoto, 1990). 
Furthermore, human peripheral blood monocytes possess extracellular calcium receptors 
(Yamaguchi et al., 1998); in vivo and in vitro treatment of these cells with extracellular Ca2+ has 
been shown to directly stimulate IL-6 release (Bornefalk, Ljunghall, Lindh, Bnegston, Johansson, 
& Ljunggren, 1997). Our observations that rIL-6 is able to augment nuclear concentrations of 
DNMT3A and DNMT3B, when combined with extracellular calcium signalling, highlights a 
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potential pathway by which exercise-conditioned plasma may regulate nuclear concentrations of 
DNMTs. Currently however, no data exists to support or refute this hypothesis.  
Exercise-induced modifications to circulating miRNAs could also influence the expression or 
transport of DNMTs. As highlighted in the previous chapter, acute aerobic (Nielsen et al., 2014), 
resistance (Sawada et al., 2013), and eccentric (Banzet et al., 2013) exercise elicit significant 
changes in plasma concentrations of a multitude of miRNAs. The role of IL-6 in the modification 
of DNMT1 expression (section 1.5.1), could be mediated by miRNA-148a and miRNA-152 
(Braconi et al., 2010; Huang et al., 2010a). Additionally, specific miRNAs display affinity for de 
novo DNA methyltransferases; miRNA-143 has been shown to target DNMT3A (Ng et al., 2009), 
miRNA-148 targets the DNMT3B protein coding region (Duursma et al., 2008), while miRNA-29 
appears to be involved in the regulation of both DNMT3A and DNMT3B (Fabbri et al., 2007; 
Garzon et al., 2009; Takada et al., 2009). When combining these data, it appears entirely possible 
that exercise-induced changes to plasma miRNAs could have a profound influence on nuclear 
DNMT transport and/or gene expression. More specifically within the domain of exercise and 
inflammation, Gonzalo-Calvo et al. (2015) demonstrated that circulatory inflammatory miRNA 
concentrations were altered in a duration/distance-dependent manner, which could begin to clarify 
the mechanisms behind the lack of corroboration between this study and the data presented in the 
previous chapter.  
No change in hydroxymethylated product (i.e. 5-hmC) was detected by our assay, thus we were 
unable to calculate TET activity based upon this. Expression of TET2 has previously been reported 
in monocytes (Klug et al., 2013) and T lymphocytes (Ichiyama et al., 2015), whilst Nicoletti et al. 
(2016) have successfully utilised a different method (Epigentek Methylflash fluorescence) for the 
calculation of hydroxymethylation in PBMCs, therefore, the results of the present investigation 
may be due to the utilisation of an ineffective method for quantifying 5-hmC and TET activity, as 
opposed to a lack of transcriptional activation. More sensitive techniques for the detection of TET 
must be applied before any assertions can be made regarding the role of these demethylation 
enzymes in exercise-induced epigenetic modification. 
Utilising our previously reported method of isolating cells from a resting participant, we have been 
able to control for polymorphisms which may affect susceptibility to epigenetic modification 
(Terruzzi et al., 2011) following exercise, in addition to exercise-induced changes to the cellular 
composition of PBMCs which would likely to change given the intensity of the exercise bout 
(Gonzalo-Calvo et al., 2015). As such, the methods have allowed us to isolate the effects of 
circulatory proteins on DNMT and TET concentrations in PBMCs, which are likely to be the 
mediators of exercise-induced epigenetic modifications.  
An ultra-endurance marathon is an extreme example of acute exercise, and thus, generalisability of 
the data to more common durations and intensities of exercise is difficult. In addition, although the 
use of a single set of cells controls for polymorphisms which may alter susceptibility to epigenetic 
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modification, it is unclear as to whether the results would be drastically different if utilising cells 
from a different individual. Finally, no measure of DNA methylation itself was included in the 
analyses, and therefore, it is not yet known as to whether changes in DNMT3A nuclear 
concentration of translate to functional alterations in DNA methylation itself.  
5.4.1 Conclusion 
This study, when combined with the data presented thus far, further supports the role of systemic 
changes in inflammatory markers on exercise-induced epigenetic modifications, specifically, the de 
novo DNA methyltransferases. There has been some inconsistency between the data presented in 
chapters 3, 4, and 5, which is likely explained by differing circulating concentrations of 
inflammatory cytokines and/or miRNAs associated with different durations or intensities of aerobic 
exercise.  
Whether the observed alterations in nuclear concentrations of these de novo DNA 
methyltransferases are due to cellular translocation or transcriptional changes has not yet been 
elucidated. Also of interest is whether the two enzymes exhibit a differential time course of change 
following exercise and into the recovery period. Furthermore, given that other types of exercise 
generally exhibit vastly differing systemic responses to endurance running, it seems logical to 
investigate a more diverse range of modalities.  
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CHAPTER 6 
 
 
 
 
 
 
THE EFFECTS OF EXERCISE-CONDITIONED PLASMA 
ON NUCLEAR AND CYTOPLASMIC CONCENTRATIONS 
OF DNMT3A, DNMT3B, AND GLOBAL DNA 
METHYLATION FOLLOWING DAMAGING ECCENTRIC 
EXERCISE 
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6  The Effects of Exercise-Conditioned Plasma on Nuclear and 
Cytoplasmic Concentrations of DNMT3A, DNMT3B, and Global 
DNA Methylation Following Damaging Eccentric Exercise 
6.1 Introduction 
In the previous chapters, in line with a plethora of in vitro data, results showed that exercise-
induced elevations in plasma concentrations of inflammatory cytokines, in particular IL-6, appear 
to regulate nuclear concentrations of DNMT3A and DNMT3B. However, the differential results 
between the exercise bouts utilised in chapters 4 and 5 highlights the distinct roles of the two de 
novo methyltransferases in response to exercise, and raises the question as to whether DNMT3A 
exhibits a delayed response to exercise-induced circulatory changes. Furthermore, discordance 
between rIL-6 and exercise-conditioned plasma conditions possibly suggests that other proteins or 
molecules located in the plasma exert a significant regulatory effect on DNA methylation in 
addition to inflammatory cytokines.  
To the author’s knowledge, there have been no investigations into the effects of other forms of 
acute exercise other than aerobic on DNA methylation thus far. Physiologically speaking, the 
demands of eccentric and plyometric exercise starkly contrasts with longer duration aerobic 
exercise. While prolonged endurance exercise is often associated with significant augmentation of 
circulating inflammatory cytokines, including IL-6 due to perturbations in calcium homeostasis, 
reactive oxygen species or reduced glucose availability (Fischer, 2006), short duration eccentric 
exercise with very little metabolic stress typically exhibits a dissimilar systemic response (Peake et 
al., 2005). Although changes to circulating white blood cell counts do occur, particularly following 
damaging exercise, it is uncommon for plasma concentrations of pro-inflammatory cytokines to be 
significantly elevated (Robson-Ansley, Cockburn, Walshe, Stevenson, & Nimmo, 2010) due to 
local anti-inflammatory regulation within the muscle itself (Peake et al., 2005). One study 
(Chatzinikolaou et al., 2010) did report a statistically significant elevation in plasma IL-6 
concentrations following 50 hurdle jumps and 50 box jumps, however, the mean value was only 
approximately 3 pg∙ml-1, in contrast to 14.9 and 13.1 pg∙ml-1 following the protocols in chapters 3 
and 4, respectively. Furthermore, the lowest concentration of rIL-6 utilised in the pilot 
investigations was 10 pg∙ml-1, thus, despite statistical significance, a post-exercise concentration of 
significantly lower than 10 pg∙ml-1 would not be considered to be clinically significant within this 
context.  
Another possible explanation for the lack of corroboration between studies thus far is the different 
timecourse in which blood samples were taken; as discussed in the previous chapter, following the 
120 minute protocol, IL-10 may not have been elevated at the time of the post-exercise sample, in 
contrast to the results of the 24 hour ultra-marathon. It is plausible, therefore, that the stark contrast 
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in DNMT responses between the two studies may be a product of differences in timing, as opposed 
to the underlying physiological demand itself. Within the context of this investigation, elevations in 
the plasma concentrations of IL-6 and IL-10 are likely to be small, however, other circulatory 
changes will occur, thus, blood samples taken over multiple timepoints throughout the study will 
aid in the elucidation of whether the two DNMTs differentially respond to exercise-conditioned 
plasma.  
The aim of the present study, therefore, was to elucidate the response of nuclear concentrations of 
DNMT3A and DNMT3B to exercise-conditioned plasma following a bout of eccentric exercise 
that would likely not elicit a large, transient increase in systemic inflammatory cytokines, despite a 
potential local inflammatory response.  Furthermore, given that the previously observed changes in 
nuclear concentrations could be due to two mechanisms, namely, cellular translocation or 
transcriptional regulation, it was decided to also quantify cytoplasmic concentrations of DNMT3A 
and DNMT3B as a marker of enzyme transport. This study also aimed to investigate whether 
modifications to nuclear concentrations of DNMTs translate to changes in global DNA 
methylation. Finally, the inclusion of further sample points over the three days post-exercise 
allowed characterisation of potential differential responses of the individual DNMTs to exercise-
conditioned plasma. 
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6.2 Methods 
6.2.1 Participants 
10 recreationally active males were recruited from Northumbria University. ‘Recreationally active’ 
was defined as regularly meeting the government’s exercise guidelines of 150 minutes of moderate 
intensity activity per week, but not currently undertaking vigorous resistance or plyometric training 
more than once per week. Mean (± SD) characteristics are reported in table 6.1. Participants gave 
fully informed written consent following the approval of all methods by the Northumbria 
University Ethics Committee. All PBMCs were isolated from a resting, recreationally active male 
who was recruited under the same criteria as the other participants, but did not take part in the 
remainder of the study. His characteristics fit within the standard deviation of the exercising 
participants’ age, height, weight and BMI. 
6.2.1.1 Sample Size Estimation  
The sample size in the present study mimicked that of the study presented in chapter 4, which in 
itself was based upon pilot investigations (chapter 3) that showed significant changes in nuclear 
concentrations of the DNMTs following stimulation with rIL-6 (see appendix E). Sample size was 
calculated using a spreadsheet accessed from the Boston University and Boston Medical Centre 
Research Compliance website (“Sample-Size Calculations”, 2014). 
6.2.2 Study Restrictions 
Participants were asked to abstain from any form of damaging exercise, such as resistance or 
plyometric training, or consuming any nutritional supplements or non-steroidal anti-inflammatory 
drugs (NSAIDs) for the seven days prior to the start of the study. They were asked to refrain from 
participating in any exercise, or consuming caffeine or alcohol for the two days immediately prior 
to the start of the study, until after the final measurements were taken. Participants were also 
required to fast for two hours immediately prior to the start of the trial, and were instructed to 
replicate their breakfast the morning of each day. Participants were instructed to not change their 
usual dietary habits during the study period, as to not cause alterations to intake of methionine, 
betaine, choline, and folate, which could have effects on DNA methylation. 
6.2.3 Experimental Protocol 
6.2.3.1 Familiarisation 
A familiarisation session was conducted at least 72 hours prior to the main trial. All experimental 
procedures were explained, and maximal voluntary contraction (MVC) and drop jump movements 
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(3 maximum) were practiced by the participants with coaching on correct technique where 
necessary.  
6.2.3.2 Main Trials 
All participants began the trial between 10am and 12pm. Immediately upon arrival on the first day, 
stature and mass were measured using standard procedures (section 2.2.1). Participants were asked 
to rate muscle soreness on a 200mm visual analogue scale ranging from ‘no pain’ to ‘extremely 
painful’ whilst performing a squat movement with a 90o knee angle. A 10 ml venous blood sample 
was then taken into vacutainers containing Lithium Heparin (section 2.2.4) from a vein in the 
antecubital fossa region of the forearm using standard procedures. The participants then completed 
a five minute warm up on a motorised treadmill (Pulsar, h/p/cosmos, Germany) at a self-selected 
low intensity of no more than 7 km∙hour-1. Participants were then asked to be seated whilst a strap, 
attached to a strain gauge, was positioned on the ankle of their dominant leg, above the malleoli. 
Using a goniometer, the straps were adjusted to ensure that the knee angle was exactly 90o. 3 
maximal contractions were performed with 60 seconds recovery, with the knee angle rechecked 
following each contraction. Following 3 MVC manoeuvres the participants completed 5 sets of 20 
drop jumps from a box measuring 0.6 m. 10 seconds recovery was given between jumps, and two 
minutes between sets. This protocol has previously been utilised to elicit muscle damage (Goodall 
& Howatson, 2008; Howatson, Goodall, & van Someron, 2009; Howatson, Hoad, Goodall, Tallent, 
Bell, & French, 2012; Kirby, Triplett, Haines, Skinner, Fairbrother, & McBride, 2012; Miyama & 
Nosaka, 2004) and given that Peake et al. (2005) concluded that high intensity eccentric exercise 
such as downhill running or eccentric cycling results in the greatest systemic inflammatory 
response, this protocol was deemed appropriate for this particular investigation as it would be 
unlikely to elicit a large elevation in plasma inflammatory cytokines. All baseline measures were 
then retaken as before. 
Participants then returned to the lab 2, 24, 48 and 72 hours following the completion of the drop 
jump protocol, and again repeated all baseline measures. 
All blood samples were immediately centrifuged at 1700*g for 10 minutes at 4 oC in order for 
plasma to be separated and aspirated. Samples were immediately stored at -80 oC for later analysis. 
6.2.4 Lab Analyses 
As described full in sections 2.3.4 and 2.3.5, a standardised sample of PBMCs were incubated with 
exercise-conditioned plasma isolated before and after exercise. Nuclear and cytoplasmic proteins 
were then extracted and quantified by Bradford assay prior to analysis of DNMT quantification.  
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6.2.4.1  DNMT Quantification 
Quantification of nuclear DNMT3A and DNMT3B enzyme concentrations were performed as per 
manufacturer guidelines described in section 2.3.8 (Epiquik DNMT3A/B Assay Kit, Epigentek, 
New York, USA). All samples were assayed in duplicate. Intra-assay coefficient of variations for 
DNMT3A and DNMT3B were calculated as 9.8% and 8.4%, respectively. 
6.2.4.2 DNA Extraction 
Separately, cell samples were diluted in order to yield 2*106 cells∙ml-1. 250 µl of PBMCs (0.5*106 
cells) were treated with 100 µl of plasma separated from whole blood of the exercising participants, 
and 150 µl of RPMI-1640 medium and Penicillin/Streptomycin/Glutamine solution (Sigma 
Aldrich, Missouri, USA), followed by incubation at 37 oC for four hours. Genomic DNA extraction 
was then performed as per manufacturer (Genomic DNA Extraction Kit, Abcam, Cambridge, UK) 
guidelines.  
6.2.4.3 DNA Quantification 
In order to accurately calculate the amount of methylated DNA in the next step, total amount of 
DNA contained in elution buffer was quantified using a spectrophotometer (Synergy HT, BioTek, 
Winooski, USA). UV-transparent microplates (Corning, New York, USA) containing 1 µl of DNA 
extract in elution buffer and 99 µl of deionised water were scanned at 260nm and 280nm, with 
automatic pathlength correction calculated by Gen5 software. 
6.2.4.4 Global Methylated DNA Quantification 
Global DNA methylation was analysed in a microplate format (Methylated DNA Quantification 
Kit, Abcam, Cambridge, UK), whereby DNA was bound to strip wells, and methylated DNA was 
detected using capture and detection antibodies which are optimised for 5-mC, with little or no 
cross-reactivity to hydroxymethylcytosine. All samples were assayed in duplicate, and various 
dilutions of the positive control (methylated polynucleotide containing 50% of 5-mC) were used to 
plot a standard curve. Microplates were read colorimetrically at 450nm. Intra-assay coefficient of 
variation was calculated as 9.7%. Lower limit of detection was 0.2 ng of methylated DNA. The 
following equation was used to quantify total amount of methylated DNA: 
5-mC (ng) = (sample ODa – negative control OD)/(slope * 2b) 
a OD is optical density/absorbance;b Factor to normalize 5-mC in the positive control to 100% 
 
The following equation was to use to calculate percentage of methylated DNA: 
5-mC (%) = (5-mC amount/input DNA)*100 
  
88 
 
6.2.4.5 Plasma Interleukin-6 Assay 
As outlined in section 2.3.9, a QuantiGlo Human IL-6 ELISA (R&D Systems, Minneapolis, USA) 
was used in order to quantify plasma concentrations of IL-6 as per standard manufacturer 
guidelines. Intra-assay coefficient of variation was calculated as 5.9%. 
6.2.4.6 Plasma Creatine Kinase 
Plasma concentrations of creatine kinase (CK) were quantified spectrophotometrically using an 
automated system (Roche Modular P, Roche Diagnostics, West Sussex, UK). Lower limit of 
detection was 7 U∙L-1, and coefficient of variation for the system was 1.93%. 
6.2.5 Statistical Analysis 
Data was analysed using IBM SPSS Statistics version 22. Prior to performing parametric testing of 
the data, the Shapiro-Wilk test of normality was utilised. Non-normally distributed data was 
subsequently log10 transformed. Following Mauchly’s test of sphericity, one-way repeated 
measures ANOVAs with post-hoc Bonferonni adjustment for multiple comparisons were used to 
analyse differences in all variables between timepoints. Differences between nuclear and 
cytoplasmic DNMT concentrations at each timepoint were analysed using independent samples T-
tests. A Pearson product-moment correlation was also run to determine the relationship between 
plasma IL-6 and epigenetic measures. 
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6.3 Results 
6.3.1 Participant Characteristics 
Mean characteristics of the participants at baseline are provided in table 6.1. Mean body mass 
index shows that participants were within the normal healthy range of less than 25 kg∙m2. 
Table 6.1 - Mean (± SD) participant characteristics at baseline (n = 10). 
Characteristic Mean (± SD) 
Age (years) 24 (± 5) 
Height (cm) 181.1 (± 5.6) 
Weight (kg) 81.6 (± 11.1) 
Body Mass Index (kg∙m2) 24.9 (± 3.4) 
 
6.3.2 Delayed Onset Muscle Soreness (DOMS) 
Subjective muscle soreness was significantly elevated at all timepoints when compared with 
baseline (p < 0.001 for all comparisons), and peaked at 24h post-exercise. Although still raised at 
72h post-exercise, soreness had begun to decline to pre-exercise levels. No statistical difference 
was observed between 24h and 48h post-exercise (figure 6.1). 
6.3.3 Maximal Voluntary Contraction  
Maximal force produced by the quadriceps was significantly attenuated immediately post-exercise 
(p = 0.02) and at 2h post-exercise (p = 0.011), which returned to pre-exercise levels by 72h (figure 
6.2). 
6.3.4 Plasma Creatine Kinase Activity 
Significant augmentation of plasma CK occurred 2h (p = 0.036) and 24h post-exercise (p = 0.035), 
returning to pre-exercise activity levels by 72h post-exercise (figure 6.3). 
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Figure 6.1 - Mean (± SD) subjective rating of muscle soreness on a visual analogue scale. 
*significantly greater than ‘pre’ (p < 0.05). 
 
Figure 6.2 - Mean (± SD) decrement from baseline in maximal voluntary contraction. 
*significantly greater than ‘pre’ (p < 0.05). 
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Figure 6.3 - Mean (± SD) plasma creatine kinase activity (n = 9).  
*significantly greater than ‘pre’ (p < 0.05). 
 
6.3.5 Plasma IL-6 Concentration 
A small, albeit statistically significant, elevation in plasma IL-6 concentrations occurred 
immediately post-exercise, returning to below baseline concentrations by 24h post-exercise (figure 
6.4). 
 
Figure 6.4 - Mean (± SD) plasma interleukin 6 concentration. 
*significantly greater than ‘pre’ (p < 0.05). 
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6.3.6 DNA Methyltransferase 3A Concentrations 
No statistically significant changes were observed in nuclear or cytoplasmic DNMT3A 
concentrations over time. 
Cytoplasmic concentrations of DNMT3A were significantly greater than nuclear concentrations at 
all time points (p = 0.018, 0.028, 0.02, 0.021, 0.001, 0.03). 
6.3.7 DNA Methyltransferase 3B Concentrations 
Similarly to DNMT3A, no statistically significant changes in nuclear or cytoplasmic concentrations 
of DNMT3B occurred at any timepoint. 
Cytoplasmic concentrations of DNMT3B were significantly greater than nuclear concentrations 
immediately post-exercise and 24h post-exercise (p = 0.01 and 0.02, respectively). 
Nuclear concentrations of DNMT3B were significantly higher than nuclear concentrations of 
DNMT3A at pre, post, 24h, 48h (p = 0.004, 0.002, 0.039, 0.035, respectively), while cytoplasmic 
DNMT3B concentrations were greater than DNMT3A at every timepoint (p = 0.005, 0.008, 0.001, 
0.01, 0.001, 0.001, respectively). 
Table 6.2 - Nuclear and cytoplasmic concentrations of DNMT3A and DNMT3B at each timepoint. 
 Mean (± SD) DNMT3A Concentration  
(ng∙mg protein-1) 
Mean (± SD) DNMT3B Concentration 
(ng∙mg protein-1)  
Timepoint Nuclear Cytoplasmic Nuclear Cytoplasmic 
Pre 24.94 (± 17.93) 148.97 (±101.67)α 270.57 (± 200.53)β 485.51 (± 235.85)γ 
Post 22.72 (± 16.64) 148.12 (± 114.91)α 188.03 (± 121.74)β 402.22 (± 177.15)αγ 
2h 15.93 (± 6.57) 151.61 (± 69.52)α 231.23 (± 305.31) 438.48 (± 160.24)γ 
24h 21.80 (± 7.14) 208.15 (± 158.27)α 213.52 (± 172.73)β 512.63 (± 208.71)αγ 
48h 18.54 (± 8.27) 182.81 (±78.94)α 225.68 (± 245.86)β 416.94 (± 112.79)γ 
72h 27.93 (± 16.62) 171.19 (± 78.20)α 278.18 (± 244.78) 418.93 (± 131.59)γ 
α significantly higher than nuclear concentrations at the same timepoint (p < 0.05); β significantly 
greater than DNMT3A nuclear concentrations (p < 0.05); γ significantly greater than DNMT3A 
cytoplasmic concentrations (p < 0.05) 
 
 
 
  
93 
 
6.3.8 Global DNA Methylation 
No statistically significant modifications to the amount of global DNA methylation were observed 
at any timepoint (table 6.3). When corrected as a percentage of the total amount of DNA used in 
the assay, all timepoints remained non-significant (table 6.4). 
Table 6.3 - Mean (± SD) Global DNA methylation (ng) at each timepoint. 
Timepoint Mean (± SD) Global DNA Methylation (ng) 
Pre 0.27 (± 0.21) 
Post 0.45 (± 0.46) 
2h 0.31 (± 0.21) 
24h 0.28 (± 0.18) 
48h 0.26 (± 0.20) 
72h 0.29 (± 0.27) 
 
Table 6.4 - Mean (± SD) Global DNA methylation (%) at each timepoint. 
Timepoint Mean (± SD) Global DNA Methylation (%) 
Pre 7.47 (± 9.95) 
Post 12.70 (± 8.92) 
2h 11.18 (± 13.89) 
24h 10.80 (± 7.74) 
48h 9.47 (± 7.50) 
72h 15.44 (± 16.35) 
 
Significant inverse relationships between plasma IL-6 and global methylation occurred at pre-
exercise (r = -0.687, p = 0.041) and 48h post-exercise (r = -0.696, p = 0.037).  
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6.4 Discussion 
All measures of muscle damage corroborate previous studies that also utilised the same drop jump 
protocol (Goodall & Howatson, 2008; Howatson et al., 2009; Howatson et al., 2012; Kirby et al., 
2012; Miyama & Nosaka, 2004). Significant elevations in muscle soreness and plasma CK activity 
were observed, both peaking at 24h post-exercise, whilst a large decrement in MVC score occurred 
immediately following the drop jumps. Despite the statistically significant post-exercise elevation 
in plasma IL-6, this would still be considered to be a relatively low concentration in comparison to 
the concentrations of rIL-6 utilised to treat PBMCs in chapter 3, or compared to the post-exercise 
concentrations observed in chapters 4 and 5. As such, the lack of significant changes in any of the 
epigenetic measures in the present investigation may suggest, as previously hypothesized, that 
large, transient exercise-induced increases in plasma inflammatory markers, such as IL-6, regulate 
cellular translocation and/or transcriptional regulation of DNMT3A and DNMT3B. Conversely, it 
appears that circulatory changes following an acute bout of damaging exercise exert very little 
influence over nuclear or cytoplasmic DNMT concentrations or on the methylation of DNA at a 
global level. 
Despite there not being any statistically significant alteration in nuclear or cytoplasmic 
concentrations of DNMT3B at any timepoint, the fact that cytoplasmic concentrations are 
significantly greater than nuclear concentrations immediately post- and 24h post-exercise may aid 
in the explanation of the previously observed post-exercise attenuation of nuclear DNMT3B 
protein concentration, hypothesized to be due to cytoplasmic translocation of the enzyme. As to 
whether transcriptional changes of the DNMT3B gene occur following exercise remains to be 
elucidated however. Furthermore, greater nuclear concentrations of DNMT3B, compared with 
DNMT3A at the majority of timepoints including at baseline, corroborates previous data (chapters 
4 and 5) that shows that DNMT3B appears to more abundant than DNMT3A within the nucleus.  
Given that no significant changes occurred to nuclear concentrations of either de novo DNMT, it is 
unsurprising that there was no observable change in the amount of globally methylated DNA, 
which appears to corroborate Robson-Ansley et al’s (2014) previous findings, albeit whilst utilising 
an exercise bout that exerts a distinct physiological demand. Potential gene-specific methylation 
alterations must also not be ruled out. Interestingly, strong inverse relationships between plasma 
IL-6 concentrations and the amount of globally methylated DNA were discovered at the pre-
exercise and 48h post-exercise timepoints. While this finding is difficult to interpret within the 
context of the other data, it could suggest that small fluctuations in plasma IL-6 concentrations may 
contribute to global hypomethylation, or at least, there is a shared underlying cause. Disruptions in 
Ca2+ homeostasis could be one such shared cause given that caffeine, which raises intracellular 
Ca2+, can cause promoter hypomethylation in skeletal muscle Barrès et al. (2012), while ionomycin 
has been shown to upregulate IL6 in L6 myotubes in vitro (Chan, McGee, Watt, Hargreaves, & 
Febbraio, 2004a).  
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Although much ambiguity remains over the effect of circulatory changes following exercise on 
regulatory epigenetic enzymes, one thing the data clearly shows is that aerobic and eccentric 
exercise differentially affect nuclear concentrations of the de novo DNMTs. It is well known that 
exercise results in acute perturbations in Ca2+ homeostasis, with damaging eccentric exercise 
generally causing an increased influx of Ca2+ into the cell via stretch-activated channels and/or 
disrupted cell membranes (Hyldahl and Hubal, 2014), whereas following aerobic exercise, changes 
to extracellular concentrations of Ca2+ occur in the form of increased plasma or serum Ca2+ 
(Ljunghall et al., 1984; Salveson et al., 1994; Vora et al., 1983). The method utilised within the 
present investigation was able to control for cellular perturbations in Ca2+ by using a standardised, 
‘resting’ cell sample in all conditions, however, exercise-conditioned plasma isolated following 
aerobic exercise as in the case of chapters 4 and 5 may have altered nuclear concentrations of 
DNMTs via the pathways discussed in section 5.4, thus helping to explain the differential response 
between the types of exercise.  
Again, as discussed in section 5.4, plasma miRNA concentrations have been shown to be 
differentially regulated by bouts of eccentric (Banzet et al., 2013), resistance (Sawada et al., 2013), 
and aerobic exercise (Nielsen et al., 2014). Adaptation to exercise is thought to occur as a result of 
repeated exposure to a stimulus, resulting in a steady-state level of a protein with a beneficial 
function. Aerobic and resistance or eccentric exercise elicit vastly different adaptations (Coffey & 
Hawley, 2007), and given that changes in gene transcription that cause more favourable phenotypes 
is an integral part of adaptation, it seems logical that differential epigenetic regulation would also 
occur following varying modes of exercise. Furthermore, it has been shown that contrasting plasma 
miRNA profiles are exhibited by endurance or strength trained athletes, indicating a further divide 
in the epigenetic response of different exercise modalities (Wardle et al., 2015). It is plausible, 
therefore, that exercise-induced changes to plasma miRNAs could be involved in exercise-induced 
modifications to DNMTs and DNA methylation, and could be a factor that helps to explain the 
varying responses of PBMCs stimulated with plasma isolated following different types of exercise.  
To the authors’ knowledge, no published data has yet reported links between epigenetic 
modifications and any form of exercise other than aerobic, thus, it is possible that the enzymes or 
cells that were investigated within this study are simply not responsive to systemic changes 
associated with eccentric exercise. For example, eccentric exercise may be specifically associated 
with gene-specific hypomethylation, in which case, the TET family of proteins, regulators of active 
demethylation, may be more sensitive markers. In addition, the cells that comprise the PBMC 
population play essential roles within the immune system, and thus, an exercise bout that elicits 
significant changes in systemic inflammation might also be expected to cause genetic or epigenetic 
changes, and vice versa, a lack of circulating inflammatory proteins may result in little to no 
change in these cells. These mechanisms are merely speculative due to the current lack of 
published findings within this field. 
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A limitation of the global methylation assay utilised within the present investigation was that it 
utilised a monoclonal anti-5mC antibody which recognises any methylcytosine, including 5-mC 
and 5-methyldeoxycytidine in both CpG and non-CpG sites, and therefore, lacks specificity toward 
5-mC i.e. methylation at CpG sites only. The assay did, however, distinguish between 5-mC and 5-
hmC, which is involved in the TET-mediated active demethylation process. 
Another potential limitation is that we did not include any measures of oxidative stress. There is a 
close link between GPx and DNA methylation; glutathione biosynthesis requires homocysteine, 
which itself is synthesised from methionine, the methyl group DNMTs transfer from SAM to 
cytosine to create 5-mC (Hitchler & Domann, 2007). This process seems unlikely to affect 
transcription or cellular transport of DNMT3A and DNMT3B, but unavailability of methionine due 
to an exercise-induced demand for GPx could have a subsequent knock on effect on methylation of 
DNA.  
Although participants were instructed to consume the same breakfast on all testing days, this was 
not provided, and therefore, not controlled for between participants. However, there was unlikely to 
be any acute changes in methionine, betaine, choline, or folate availability due to the instructed 
consumption of their regular diet on all days, and therefore, SAM availability as a methyl donor 
was also not likely to have been altered.  
The data presented in chapters 4 to 6 shows that considerable inter-individual variation exists in 
concentrations of the de novo DNA methyltransferases as quantified by ELISA-based methods. For 
example, within this chapter, despite visually much greater nuclear concentrations of DNMT3B 
compared with DNMT3A 2h and 72h post-exercise, the extremely large variation in DNMT3B 
concentrations has likely contributed to the lack of a statistically significant finding. Future 
research should look to incorporate other methods such as qPCR to provide a more definitive 
quantitative measure of changes in these enzymes.  
6.4.1 Conclusion 
This is the first study to investigate exercise-induced modifications to DNA methylation and the 
regulatory enzymes following an intense bout of damaging eccentric exercise, and suggests that 
small increases in systemic inflammation are likely to be insufficient to drastically alter nuclear or 
cytoplasmic concentrations of the de novo DNA methyltransferases or global DNA methylation in 
human PBMCs. Conversely therefore, large transient elevations in circulatory inflammatory 
markers associated with longer duration exercise may indeed be one of the most important 
regulators of DNMT localisation within the nucleus, however, as to whether these elevations, in 
plasma IL-6, for example, are merely a downstream consequence of other circulatory changes such 
as fluctuations in Ca2+  homeostasis, remains to be investigated. A tentative implication of this is 
that PBMCs may be a more useful biomarker of epigenetic change following aerobic exercise of a 
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longer duration whereby elevations in circulatory inflammatory markers are common, in contrast to 
eccentric exercise which is generally characterised by a localised inflammatory response.  
Thus far, only the effects of inflammatory cytokines on epigenetic regulation have been 
investigated. However, as previously postulated, there may in fact be a bi-directional relationship 
whereby exercise-induced epigenetic modifications directly influence inflammatory gene 
expression, thus explaining the commonly observed reduction in chronic low-grade inflammation 
with increasing PA or exercise. Furthermore, as to whether training status influences susceptibility 
to epigenetic change, be it transcriptional changes to DNMTs, or acute changes to promoter 
methylation causing transient gene upregulation, remain to be investigated. 
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CHAPTER 7 
 
 
 
 
 
 
ACUTE AND CHRONIC CHANGES TO INFLAMMATORY 
GENE PROMOTER METHYLATION AND DNMT 
TRANSCRIPTION FOLLOWING AN AEROBIC TRAINING 
INTERVENTION  
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7 Acute and Chronic Changes to Inflammatory Gene Promoter 
Methylation and DNMT Transcription Following an Aerobic 
Training Intervention  
7.1 Introduction  
In the previous chapter, it was shown that a single bout of damaging eccentric exercise was unable 
to elicit changes in nuclear or cytoplasmic concentrations of either de novo DNA 
methyltransferases, nor global DNA methylation. These data support the hypothesis that transient 
exercise-induced elevations of circulating inflammatory cytokines are likely to be the main, but not 
the only, regulator of DNMT relocalisation to the nucleus. Unfortunately, thus far, the cause of the 
previously observed changes in nuclear DNMT concentrations has not been elucidated and poses 
the question, are these changes due solely to cellular enzyme transport, transcriptional changes, or a 
combination of both? 
As with many bodies of literature in any scientific sub-discipline, it is common to see inconsistent 
results between studies. Often, this is due to differences in methodologies, including the population 
of interest. Trained or recreationally active individuals have been utilised in the studies presented 
thus far in order to try to understand the mechanisms that underlie exercise-induced modifications 
to the methylome. Of greater practical understanding to the wider scientific community may be the 
effects of regular exercise in a sedentary population on the DNA methylation status of genes that 
are commonly associated with chronic inflammation.  As postulated, the relationship between 
inflammation and epigenetic modification is complex; inflammatory cytokines appear to elicit 
significant alterations in DNA methylation-regulatory machinery, however, alterations in DNA 
methylation are also able to cause transient changes in the expression of inflammatory genes. Thus 
far, the studies within this thesis have focussed specifically on the role of inflammatory mediators 
on epigenetic modification and not the other direction of the relationship. 
Physical inactivity is not only associated with a significantly increased risk of stroke, 
atherosclerosis, and T2DM (Booth and Lees, 2012), but also, elevations in circulating 
inflammatory markers in a variety of populations. Physical inactivity has previously been 
associated with higher plasma CRP in adults (Abramson & Vaccarino, 2002; Autenrieth et al., 
2009; Ford, 2002; Henson et al., 2013; León-Latre et al., 2014), whilst time spent watching 
television was also associated with CRP in children (Gabel et al., 2015). In addition, sedentary 
behaviour has been correlated with elevated plasma IL-6 (Autenrieth et al., 2009; Henson et al., 
2013) and TNFα (Allison et al., 2012). Furthermore, it is postulated that the increased risk of 
various cancers associated with inactive behaviour is mediated in part by inflammatory 
mechanisms (Lynch, 2010).   
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From a non-epidemiological perspective, experimentally-induced physical inactivity in the form of 
nine days of bed rest is not only able to induce insulin resistance, but is also able to alter the 
expression of over 4,500 genes in the skeletal muscle of healthy young men. Differential 
expression of a number of inflammatory pathways was reported, demonstrating how swiftly and 
dynamically gene expression can be manipulated by activity level (Alibegovic et al., 2010).  
Similarly, increasing the amount of exercise results in an attenuation of this chronic inflammatory 
state, thereby reducing disease susceptibility (Gleeson, Bishop, Stensel, Lindley, Mastana, & 
Nimmo, 2011). A number of mechanisms have been postulated to mediate the anti-inflammatory 
effects of exercise such as augmented anti-inflammatory cytokines production, reduced fat mass, 
and attenuated Toll-like receptor expression on monocytes and macrophages. The effects of 
exercise on inflammatory gene expression must not be underestimated however. Differential 
expression of 63 genes in peripheral blood, many involved in inflammatory and immune responses, 
was reported following 17 weeks of half-marathon training in a previously sedentary sample of 
men (Vance et al., 2014). Similarly, a shorter and lower intensity training period, specifically, eight 
weeks of 10,000 steps per day for three days per week, was able to significantly augment peripheral 
blood leukocyte IL4 expression and attenuate IL6 expression (Yakeu et al., 2010). These data were 
corroborated by another study that utilised a 24 week training period, whereby serum IL-6 
concentrations fell, in addition to upregulation of IL4, which is known to be an inhibitor of IL-6 
(Thompson et al., 2010). IL-10 is another inhibitor of IL-6 production (Hempel et al., 1995) and 
has been shown to be significantly upregulated, at both mRNA and protein level, following eight 
weeks of resistance training in PBMCs of healthy elderly participants (Rodriguez-Miguelez et al., 
2014). Singular bouts of exercise are also able to elicit a number of transient transcriptional 
changes of inflammatory genes, with regular training able to attenuate this acute upregulation; eight 
weeks of eccentric training in an elderly population was sufficient to attenuate acute NFκB 
activation and IL6 upregulation that was observed following a single bout performed prior to the 
training period (Jiménez-Jiménez et al., 2008). 
The association, therefore, between a more physically active lifestyle and reduced inflammation, 
both at a transcriptional and circulatory level, is well established. Given the role of epigenetic 
modification in the regulation of gene expression, in addition to lifestyle-induced alterations to the 
epigenome, a logical postulation would be that regular exercise is able to attenuate inflammation 
via epigenetic mechanisms.  
7.1.1 IL-6 
One of the most commonly used biomarkers for systemic inflammation associated with inactivity is 
IL-6, possibly as it is associated with physical inactivity to a greater extent than other cytokines 
(Fischer, Bernsten, Perstrup, Eskildsen, & Pedersen, 2007). Furthermore, physical activity exerts a 
significant effect on IL-6 levels both directly, and indirectly via changes to body composition 
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(Fitzgerald, Macey, & Brecht, 2012). On a transcriptional level, 10 weeks of knee extensor training 
was able to attenuate contraction-induced increases in skeletal muscle IL6 mRNA, although resting 
levels remained unaltered (Fischer, Plomgaard, Hansen, Pilegaard, Saltin, & Pedersen, 2004). 
Within PBMCs however, trained swimmers were found to exhibit significantly greater IL6 mRNA 
levels at rest compared with controls. Despite appearing paradoxical at first due to regular 
exercise’s ability to attenuate circulating concentrations of IL-6 protein (El-Kader, 2010; Jankord 
& Jemiolo, 2004; Straub, Tankó, Christiansen, Larsen, & Jessop, 2008), this finding was suggested 
to be due to the protective, anti-inflammatory role of IL-6 within leukocytes, particularly, IL-10 
and IL-1ra upregulation (Capomaccio et al., 2008).  
These data demonstrate that regular exercise is closely linked to systemic and transcriptional 
changes to the IL6 gene. Most work undertaken in the exercise epigenetics discipline, however, has 
focussed on the effects of IL-6 protein on DNA methylation, but very little research has studied 
epigenetic regulation of the IL6 gene itself, particularly following exercise.  
Elevated IL6 promoter methylation has been reported in peripheral blood of obese Korean women 
(Na, Hong, Lee, Kim, & Kim, 2015). Similarly, positive associations between weight and DNA 
methylation at a number of CpG sites was reported in obese and lean control groups, in contrast to 
the negative correlation observed in T2DM sufferers (Aumueller, Remely, Baeck,Hippe, Brath, 
Haslberger, 2015). CpG hypomethylation has also been reported in PBMC samples of RA patients, 
which was related to IL6 mRNA (Nile et al., 2008). With these data in mind, it seems a plausible 
supposition that regular exercise would be able to significantly alter IL6 methylation, thus 
explaining previously observed transcriptional changes, resulting in an attenuation of chronic low 
grade inflammation. The pleiotropic nature of IL-6, combined with the inconsistency of 
transcriptional and epigenetic changes discussed thus far, makes it difficult to hypothesize the 
precise direction of epigenetic change within the promoter region of this gene.  
7.1.2 NF-κB2  
Another pathway of key importance in chronic inflammation is mediated by the transcription factor 
nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) which is activated by 
metabolic stress, in addition to pro-inflammatory cytokines such as IL-1 and TNFα (Lawrence, 
2009). Upon activation, NF-κB dissociates from the inhibitory molecule IκB, followed by nuclear 
translocation. The protein then binds to DNA sequences in order to upregulate a number of genes 
involved in inflammation, immunity and metabolism (Tornatore, Thotakura, Bennett, Moretti, & 
Franzoso, 2012). Consequently, chronic overactivation of NF-κB is associated with insulin 
resistance and T2DM (Kramer & Goodyear, 2007). Additionally, aberrant methylation patterns of 
genes involved in the NF-κB signalling cascade have been associated with celiac disease 
(Fernandez-Jimenez et al., 2013) and SLE (Zhao et al., 2014). 
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As already discussed briefly, exercise can acutely upregulate NFκB (Jiménez-Jiménez et al., 2008), 
which has been corroborated by Vider et al. (2001); one hour of running at 80% of ?̇?O2max was able 
to elicit transient NF-κB activation in peripheral blood leukocytes. Research also exists that 
supports this relationship in rat skeletal muscle (Ho et al., 2005; Ji, Gomez-Cabrera, Steinhafel, & 
Vina, 2004). In the context of regular exercise, 12 weeks of treadmill training was able to elicit to a 
44% increase in IκK phosphorylation in rat soleus muscle, as well as a 16% and 22% attenuation of 
IκBα expression in plantaris and soleus. These findings indirectly infer NF-κB activation, 
highlighting a possible mechanism by which the reported elevation of SOCS3 expression may then 
cause IL6 upregulation (Spangenburg, Brown, Johnson, & Moore, 2006). Vastus lateralis muscle 
biopsies taken from T2DM patients exhibited overactivation of the NF-κB pathway due to a 60% 
decrease in IκBβ protein compared with controls, which also correlated with insulin resistance 
(Sriwijitkamol et al., 2006). Following eight weeks of aerobic exercise however, IκBα and IκBβ 
protein levels were elevated so that they were comparable with control subjects, concomitantly 
with a 40% attenuation of muscle TNFα concentrations and improved insulin sensitivity. Thus, 
regular exercise in a clinical population is able to reverse chronic inflammatory pathways, although 
this study did not clarify the underlying genetic and epigenetic changes that mediated this. Unlike 
IL6, NFκB, specifically the NFκB2 isoform, has been shown to be regulated by exercise training-
induced epigenetic modifications in peripheral blood following six months of walking exercise 
(Zhang et al., 2015), but this interaction has not been examined in PBMCs or following a shorter, 
higher intensity training programme. The study utilised an elderly sample, however it was not 
elucidated whether the observed hypermethylation of NFκB2 contributed to attenuation of the age-
related inflammatory state. Therefore, the use of a younger, but still sedentary, study sample would 
aid in the clarification of whether exercise is able to ameliorate the inflammatory state directly via 
downregulation of NFκB2.  
7.1.3 ASC 
ASC, a protein that contains an N-terminal pyrin domain and a C-terminal caspase-recruitment 
domain, is involved in NF-κB activation, and thus, plays an important role in pro-inflammatory 
signalling pathways (Masumoto et al., 2003). The protein is able to trigger apoptosis upon 
overexpression, and is susceptible to methylation-induced silencing (Sarkar, Duncan, Hart, 
Hertlein, Guttridge, & Wewers, 2006). A plethora of literature confirms that aberrations in ASC 
methylation are linked with the pathogenesis of ovarian cancer (Akahira, Sugihashi, Ito, Niikura, 
Okamura, & Yaegashi, 2004), human melanoma (Guan et al., 2003), renal cell carcinoma (Liu et 
al., 2015b), invasive ductal breast carcinoma (Mirza et al., 2007), glioblastoma (Stone, Bobo, Brat, 
Devi, Van Meir, & Vertino, 2004), and experimentally induced autoimmune enceophalomyelitis 
(Shaw, Lukens, Burns, Chi, Maureen, McGargill, & Kanneganti, 2010). In the context of exercise, 
the study conducted by Nakajima et al. (2010 - section 1.6.2.4.2) demonstrated that while ASC was 
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hypomethylated in the elderly group, a six month walking programme was able to attenuate this 
age-related decline in methylation. It would have been of great interest to clarify whether this also 
attenuated systemic markers of inflammation, however, the study does still provide a plausible 
mechanism by which exercise-induced epigenetic changes can reverse ‘inflamm-aging’.  
To summarise, all three genes are involved in chronic inflammatory pathways and disease 
pathogenesis, have been documented to be epigenetically modified, and susceptible to 
transcriptional and/or epigenetic changes following exercise. It remains to be elucidated whether 
IL6 promoter methylation is altered following exercise training using a sedentary sample, or 
whether the reported training-induced changes in ASC and NFκB2 methylation are reproducible in 
a younger population.  
In addition to the potential for exercise-induced modifications to the methylome which may reverse 
unhealthy, inactivity-associated expression profiles of genes involved in chronic inflammation, it is 
also fair to claim that there is a considerable paucity of research regarding the role of 
transcriptional alterations in DNMT genes which may underpin these adaptations. A number of 
studies utilising rodents have demonstrated this (section 1.6.1), however, there is very little 
research using humans. Only one study was found upon a thorough literature search; three hours of 
cycling at 60% of ?̇?O2max was able to significantly attenuate DNMT3B mRNA by 50% immediately 
post-exercise (Laye & Pedersen, 2010). This gap in the literature appears worthy of further research 
attention. 
7.1.4 Aims 
The aims of the present study, therefore, were to investigate whether a progressive seven week 
moderate intensity aerobic training programme elicits significant changes in methylation of IL6, 
NFκB2, and ASC, around the respective transcription start sites. It was hypothesized that ASC and 
NFκB2 methylation would be elevated following the intervention, however, the IL6 promoter may 
become hypomethylated in this region, which would be consistent with the previously reported 
elevation of basal IL6 mRNA level associated with training status (Capomaccio et al., 2008). 
From a more mechanistic standpoint, investigation into how expression of DNMTs may be 
chronically altered following the intervention, and whether any chronic changes will affect the 
acute responsiveness to a single maximal bout, will aid in the elucidation of data thus far.  
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7.2 Methods  
7.2.1 Participants 
Sedentary, defined in this case as participating in less than one hour of organised exercise per week 
for the previous six months, but otherwise healthy men between the ages of 25 and 40 were 
recruited by advertising materials posted around Northumbria University, emails sent to 
Northumbria University students and staff, in addition to Newcastle and Gateshead council staff 
newsletters. Participant demographic information is provided in table 7.1.  20 participants were 
recruited, and randomly split into two groups; an exercise group and a control group. During the 
course of the study, two members of the exercise group (ExG) and one member of the control 
group (CoG) dropped out due to time commitments. 
7.2.2 Sample Size Estimation 
As with all other studies presented with this thesis, sample size was calculated using a spreadsheet 
accessed from the Boston University and Boston Medical Centre Research Compliance website 
(“Sample-Size Calculations”, 2014) (see appendix E).   
7.2.3 Data Collection  
7.2.3.1 Initial Screening 
Upon confirmation that each participant fit the inclusion criteria of the study, they were contacted 
to verbally confirm that they were not suffering from any major conditions or musculoskeletal 
injuries that may contraindicate their ability to participate. They then attended a screening session 
whereby they also completed a Physical Activity Readiness Questionnaire (PAR-Q) (appendix F) 
to ensure that they were healthy enough to begin a new exercise regime. Anyone that answered yes 
to any of the questions were informed that they were to confirm with their General Practitioner that 
the programme was safe for them to engage in. Following a rest period of at least 10 minutes, 
resting BP was measured on the right arm using an automatic BP monitor. Two measurements were 
taken five minutes apart, with the mean value calculated for both. Finally, they were asked to 
complete a mdFFQ, outlined in section 2.2.3. 
7.2.3.2 Habitual Physical Activity and Dietary Assessment 
For the following seven days, participants were asked to record their daily food and drink intake in 
as much detail as possible in a food record diary that was provided (appendix G). Any participants 
that did not own electronic kitchen scales were provided with some so that they were able to 
accurately weigh their food. Food diaries were analysed using Nutritics Professional Nutrition 
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Analysis software (Dublin, Ireland). For the same period of time, each participant wore a tri-axial 
accelerometer (Actigraph GT3X+, Florida, USA) on their dominant hip. Participants were asked to 
wear the accelerometer for the entire seven day period, removing only to shower or bathe. Prior to 
the calculation of physical activity energy expenditure using the Freedson VM3 combination 
algorithm (Sasaki, John, & Freedson, 2011), age, sex, height, and weight was entered into the 
Actilife software for each participant. Sixty second sampling epochs were collected at a 60Hz 
sample rate. Participants were instructed to maintain their usual dietary habits and physical activity 
habits during the assessment period and for the entire period of the intervention, as to not elicit any 
changes due to calorie restriction or excess, or significant changes to nutrient intake. 
7.2.3.3 Main Trial  
Prior to the first testing session, participants were asked to abstain from caffeine, alcohol and the 
use of NSAIDs for 24 hours prior to each visit, and until the final blood sample was taken at 24 
hours post-exercise. Participants were also instructed to not engage in any exercise other than 
minimal habitual physical activity for the 72 hours prior to participation. On the day of the first 
testing session, participants arrived having fasted for at least two hours. All visits occurred between 
10:00 and 15:00, with the time and day replicated at the post-training testing session for each 
participant.  
Firstly, height, weight, hip circumference and waist circumference were measured using standard 
procedures outlined in chapter 2 (section 2.2.1). Following this, a 30 ml venous blood sample was 
taken from a vein in the antecubital fossa region of the forearm using standard procedures outlined 
in chapter 2 (section 2.2.4). 10 ml was immediately centrifuged, the plasma aspirated into 
microcentrifuge tubes, and store at -80 oC for until further analysis. The remaining 20 ml of whole 
blood was used in order to isolate PBMCs using the procedure outlined in section 2.3.4.  
An incremental treadmill walking test to volitional exhaustion, defined by rating of perceived 
exertion (RPE) on a standard Borg scale, was utilised. The modified Bruce protocol (table 7.1) was 
used as it was developed for sedentary and clinical populations (Bruce, Kusumi, & Hosmer, 1973; 
Hill & Timmis, 2002). A maximal test was preferred to a submaximal test as to mimic previous 
research (Barrès et al., 2012). An online breath by breath gas analyser (Metalyzer 3B, Cortex, 
Germany) measured inspired and expired gases. RPE and HR, via short range telemetry (Polar 
RS400, Finland), were recorded during the last 10 seconds of each minute. The test was considered 
maximal if the following criteria were fulfilled; a change in ?̇?O2 of less than 2 ml∙kg∙min-1 was 
observed despite an increase in intensity, a minimum respiratory exchange of 1.15, or a HR greater 
than 90% of age predicted maximum. Due to the sedentary nature of the study population, some 
participants reached exhaustion prior to a plateau in ?̇?O2 due to local fatigue in the legs; however, 
all participants reached at least 90% of their age-predicted maximum HR and a RER of 1.15. The 
values were, therefore, deemed to be ?̇?O2peak. 
  
106 
 
Table 7.1 - Modified Bruce protocol. 
Stage Minutes Gradient (%) Speed (km∙h-1) 
i 3 0 2.7 
ii 3 5 2.7 
1 3 10 2.7 
2 3 12 4.0 
3 3 14 5.4 
4 3 16 6.7 
5 3 18 8.0 
6 3 20 8.8 
7 3 22 9.6 
 
A further 10 ml blood sample was taken immediately upon cessation of exercise. The participant 
then remained in a rested state in the laboratory with ad libitum access to water until a final sample 
for that day was taken two hours following cessation of exercise. As discussed, the participants 
continued all restrictions until the next day, including a two hour fast, when a final blood sample 
was taken 24 hours following completion of the maximal exercise test.  
Participants were then randomly assigned to control (CoG) or exercise groups (ExG). The control 
group were instructed to maintain their usual activity and dietary habits during the entire study 
period. The exercise group were provided with a progressive seven week training plan as 
previously utilised by Barwell et al. (2008) and Moran et al. (2011). Participants were asked to 
walk or jog on a treadmill at a speed or incline that would allow them to maintain their HR between 
65 and 80% of their individual age-predicted maximum HR. They were provided with a trackable 
HR monitor (Polar RS400) in order to do this. Participants were required to perform one session 
each week in the laboratory so that the HR data could be downloaded to ensure compliance to the 
programme. The full details of the training programme are provided below in figure 7.1 and table 
7.2.  
 
Figure 7.1 - Schematic of training study timelime (red arrows indicate blood samples). 
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Following the intervention and a three to five day rest period, participants returned to the lab to 
repeat all testing measures as before. They were informed to replicate the food they consumed the 
day before and the morning of the pre-intervention trial.  
Table 7.2 - Seven week training intervention. 
Week Session Details 
1 3 x 30 mins 
2 2 x 30 mins; 2 x 45 mins 
3 3 x 30 mins; 2 x 45 mins 
4 5 x 45 mins 
5 3 x 45 mins; 2 x 60 mins 
6 5 x 60 mins 
7 5 x 60 mins 
 
7.2.4 Lab Analyses 
7.2.4.1 Flow Cytometry  
Flow cytometry was used in order to ensure that any observable changes in DNA methylation were 
not due to changes to the fractional composition of the PBMC samples. 
PBMC samples were thawed quickly in a waterbath at 37 oC and washed using 1x PBS by 
centrifugation at 400*g for five minutes. Supernatants were discarded and cells were counted using 
a Casey TT cell counter and analyser system (Roche, Basel, Switzerland). Cells were diluted with 
1x PBS to yield 20*106∙ml-1. 50 µl of cells (1*106∙ml-1) were then incubated at room temperature 
for 15 minutes in the dark with the antibody composition outlined in table 7.3 in order to identify T, 
B, and NK cell population. All antibodies were purchased from eBioscience (Affymetrix, Chesire, 
UK) unless indicated. Following incubation, cells were washed with 1x PBS and centrifuged as 
before. In order to exclude dead cells from the analysis, the stained PBMCs were then resuspended 
in 1 ug∙ml-1 of DAPI solution (BD Biosciences, Oxford, UK) and incubated for a further 10 
minutes at room temperature in the dark before being acquired on a BD FACSCanto II flow 
cytometer (BD Biosciences, Oxford, UK). Data were analysed using BD FACSDiva software.  
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Table 7.3 - Details of antibodies used for flow cytometric analysis. 
Cell Surface Receptor Clone Flourochrome Laser EM-maxa 
CD19 MB19-1 FITC 488 525 
CD3 OKT3 PE 488 575 
CD16b 3G8 PerCP-Cy5.5 488 695 
CD8 RPA-T8 PE-Cy7 488 785 
CD4b RPA-T4 APC 633 660 
CD56 CMSSB APC-H7 633 785 
a Maximum emission wavelength (nm) 
b BD Biosciences, Oxford, UK 
7.2.4.2 Bisulfite-conversion of DNA 
Cells were thawed, washed and counted using the procedure outlined in chapter 2. Cells were then 
diluted in R0 medium to yield 4*105∙ml-1. In individual wells, 250 µl of cells (i.e. 1*105 cells) were 
incubated for four hours at 37 oC with 100 µl of exercise-conditioned plasma from each timepoint 
and 150 µl of R0 medium. In contrast to previous chapters, participants’ own cells were used 
instead of a standardised cell sample in all conditions. Therefore, pre-training exercise-conditioned 
plasma was used to stimulate pre-training cell samples, and post-training exercise-conditioned 
plasma was used to stimulate cell samples isolated following the programme. Similarly, in the 
CoG, exercise-conditioned plasma from the first bout was used to stimulate cells isolated at the first 
visit and so forth for the subsequent bout, despite a lack of a training intervention in between. 
Separately, a sample of PBMCs isolated from a resting participant that was not involved with the 
study but met all inclusion criteria were stimulated with various cytokines in duplicate; 10 mg∙ml-1 
stock solutions of IL-6, TNFα and IL-1β were diluted with R0 medium to yield 1 pg∙ml-1 (‘Low’) 
and 10 pg∙ml-1 (‘High’) concentrations. These cytokines were selected due to previous literature 
that reported their influence over DNA methylation and regulatory enzymes, in addition to their 
key roles in inflammatory processes.  
After the incubation period, cells were again washed with 1x PBS by centrifugation, then DNA was 
bisulfite converted (bsDNA) (EpiTect Fast Bisulfite Conversion Kit, Qiagen, Germany). Bisulfite 
treatment of DNA results in all unmethylated cytosines being converted to uracils, while 
methylated cytosines are protected from this modification. Briefly, the procedure involved 
preparation of DNA from cell samples, bisulfite-mediated conversion of unmethylated cytosines 
with a highly concentrated bisulfite solution, binding of single-stranded DNA to a spin column 
membrane, repeated washing, desulfonation of DNA bound to the column membrane, further 
washing, and finally, elution of the converted DNA. The bisulfite conversion itself was performed 
using 0.2 ml PCR tubes and thermal cycling (CFX96, BioRad, California, USA) with the following 
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settings: five minutes at 95 oC, 10 minutes at 60 oC, five minutes at 95 oC, and 10 minutes at 60 oC. 
BsDNA was eluted in 20 µl of elution buffer and stored at -20 oC for later analysis of DNA 
methylation. 
7.2.4.3 Methylation Sensitive High Resolution Melting 
Methylation sensitive High Resolution Melting (msHRM) is a PCR-based method for quantifying 
locus-specific DNA methylation changes that amplifies templates regardless of methylation status, 
in contrast to methylation-specific PCR which preferentially amplifies methylated or 
unmethylated templates and cannot, therefore, quantitatively distinguish between low and high 
levels of methylation (Balic et al., 2009). MsHRM is able to detect 1% methylated DNA in a 
background of unmethylated DNA, indicating that it is a sufficiently sensitive measure (Krypuy, 
Wojdacz, & Dobrovic, 2008). Amplified methylated DNA results in a higher melting temperature 
than unmethylated, and vice versa, resulting in differential melt curves. 
Appropriate primers were first designed and tested. Using the 1000 Genomes browser (“1000 
Genomes”, 2015), sequences that included the first exon and the 1000 bp flanking region were 
identified in the IL6, NFκB2, and ASC genes. These sequences were pasted into Methprimer, a 
program used for designing PCR primers for methylation analysis (Li and Dahiya, 2002). A 
number of potential assays were selected and ordered from IDT (Integrated DNA Technologies, 
Iowa, USA). All primer pairs were checked for product specificity and dimerisation using gel 
electrophoresis (BioRad PowerPac HC, California, USA). Optimal annealing temperatures were 
also testing using gel electrophoresis (see appendix H).  
All utilised primer pairs overlapped a CpG island in the first exon or promoter region (see mapped 
sequences in appendix I), given that first exon methylation is also linked with transcriptional 
silencing (Brenet et al., 2011). Furthermore, EpiTect HRM PCR guidelines state that PCR product 
lengths should be between 70 and 200 bps, and primer pairs should have similar annealing 
temperatures. In line with these recommendations, the amplicons of the selected assays were 
between 110 and 180 bps, and annealing temperatures of the primer pairs within 2 oC.  
5 µl of HRM-PCR master mix, 0.75 µl of 10 µM forward and 0.75 µl of 10 µM reverse primer, 2 
µl of bsDNA, and 1.5 µl RNase-free water were added to each well of a 384-well plate, with a total 
well volume of 10 µl. Methylated and unmethylated bsDNA controls (EpiTect PCR Control DNA 
set, Qiagen, Germany) (100, 50, 25, 12.5, 6.25, 3.125, 0% methylated DNA) were included, in 
addition to blank controls which did not include any DNA. Each sample or control was assayed in 
triplicate using the Roche LightCycle 480 qPCR System (Roche, Basel, Switzerland) (Krypuy et 
al., 2008). PCR settings are outlined in table 7.4.  
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Table 7.4 - qPCR Settings for High Resolution Melting Analysis. 
 
No. Cycles Temperature (oC) Hold (mins:secs) 
Pre-incubation 1 95 05:00 
Amplification 50 
- 
- 
- 
- 
95 
55 
72 
- 
00:10 
00:30 
00:10 
HRM 1 
- 
- 
- 
60 
58* 
- 
00:01 
Continuous increase 
Cooling 1 40 00:01 
*NFκB2 ran at 55oC 
7.2.4.4 Isolation and Purification of RNA 
Due to limitation of resources only pre- and post-training cells isolated from the ExG were 
incubated in the presence of pre, post, and 2h-post exercise-conditioned plasma for four hours at 37 
oC. Cells were then diluted in R0 medium to yield 4*106∙ml-1. 250 µl of cells (i.e. 1*106 cells) were 
incubated for four hours at 37 oC with 100 µl of exercise-conditioned plasma from each timepoint 
and 150 µl of R0 medium. 
After the incubation period, cells were again washed with 1x PBS by centrifugation, then RNA 
isolated and purified (RNeasy Mini Kit, Qiagen, Germany). Briefly, the protocol involved 
homogenisation of lysate using centrifugation of QIAshredder spin columns, transferral of the 
sample to the provided MinElute spin columns and centrifugation, complete removal of DNA using 
RNase-free DNase set (Qiagen, Germany), and further centrifugation of spin columns. RNA was 
eluted in 50 µl of elution buffer and aliquoted in 0.2 ml PCR tubes for storage at -80 oC. 
7.2.4.5 Reverse Transcription of RNA to cDNA 
Prior to reverse transcription of RNA to complementary DNA (cDNA), concentrations of RNA 
were quantified using the Nanodrop ND1000 spectrophometer (ThermoFisher Scientific, 
Massachusetts, USA) which was first calibrated using CF-1 fluid (see figure 7.2). All RNA 
samples were between 1 and 4 ng∙ml-1. A 14 µl reaction mix, including 2 µl of gDNA wipeout 
buffer, was required, therefore, 12 µl (12 to 48 ng of RNA) was utilised for reverse transcription 
(QuantiTect Reverse Transcription, Qiagen, Germany). The mix was incubated at 42 oC for two 
minutes then reverse transcriptase added followed by further incubation at 42 oC for 20 minutes 
and 95 oC for three minutes to inactivate the reverse transcriptase. Reactions were then stored at     
-20 oC. 
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Figure 7.2 - ND1000 spectrophotometer calibration check. 
 
7.2.4.6 DNMT3A and DNMT3B Gene Expression  
Using the 1000 Genomes browser (“1000 Genomes”, 2015), protein coding transcripts were 
identified for DNMT3A and DNMT3B. These transcripts were then cross-referenced with those 
recognised by the National Centre for Biotechnology Information (NCBI) (appendix J). Using the 
Roche assay design centre, a common assay was designed which includes all coding transcripts, in 
addition to primers for each individual protein coding transcript. All primers were selected to be 
intron spanning to avoid amplification of genomic DNA. All primers are presented in appendix J; 
duplicate sequences were eliminated immediately, and using cDNA pooled from all samples to be 
tested, qPCR was used to check that each pair successfully amplified the cDNA. The common 
assay for DNMT3A successfully amplified the cDNA. None of the DNMT3B primers were 
successful. RPLP0 was used as a control gene (Wang et al., 2012a). 2.5 µl of ABsolute blue qPCR 
mix (Thermo-Fisher Scientific, Massachusetts, USA), 0.5 µl of 10 µM forward and 0.5 µl of 10 
µM reverse primer, 0.15 µl of a relevant Universal ProbeLibrary probe (Roche, Basel, 
Switzerland), 0.35 µl RNase-free water, and 1 µl of cDNA were added to each well of a 384-well 
plate, with a total well volume of 5 µl. Dilutions (1 in 2, 1 in 4, 1 in 8, 1 in 16, 1 in 32, 1 in 64 or 
50, 25, 12.5, 6.25, 3.125, 1.5625, 0% cDNA) of pooled cDNA samples were included as controls 
on each 384-well plate. Each sample or control was assayed in triplicate using the Roche 
LightCycler 480 qPCR System (Roche, Basel, Switzerland) (Krypuy et al., 2008). PCR settings are 
outlined in table 7.5.  
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Table 7.5 - qPCR Settings for analysis of gene expression. 
 
No. Cycles Temperature (oC) Hold (mins:secs) 
Pre-incubation 1 95 10:00 
Amplification 55 
- 
- 
- 
60 
95 
- 
01:00 
00:15 
Cooling 1 40 00:30 
 
7.2.5 Statistical Analysis  
Data was analysed using IBM SPSS Statistics version 22. Prior to performing parametric testing of 
the data, the Shapiro-Wilk test of normality was utilised. Non-normally distributed data was 
subsequently log10 transformed. Levene’s Test for Equality of Variances and Independent Samples 
T Tests were used to analyse baseline differences between the exercising and control groups. 
Paired Samples T Tests were used to test for significant differences between pre- and post-
intervention data and cytokine-stimulated cell data. 
For msHRM analysis, Roche Gene Scanning software (Roche, Basel, Switzerland) was utilised. 
Raw melt curves were normalised for fluorescence intensity by calculation of two normalisation 
regions before and after the major fluorescence decrease representing the melting of the PCR 
product. A temperature shift was applied to correct for different Ct (threshold cycle) values between 
samples. The software automatically deselects which did samples did not function correctly; 
however, this was also performed manually, with any samples that exhibited a vastly different 
amplification curve also removed from further analysis. Normalised and temperature shifted melt 
curve data was then exported to Microsoft Excel (Office 2016, Microsoft, USA). For each of the 
three genes, the temperature at which the 0% methylation standard flattened and where all other 
methylated DNA samples appear in the correct order was marked. The mean relative signal of each 
standard at this temperature ± 0.2oC was used in order to generate a standard curve. Linearity of the 
standard curves was checked using Pearson’s correlation coefficient prior to generation of 
methylation data from the samples. Statistical significance was calculated using a linear mixed 
model using Bonferonni adjustment for multiple comparisons, as a standard repeated measures 
ANOVA would exclude a participants’ entire dataset due to a single missed datapoint. Samples 
were considered as hyper- or hypomethylated when the methylation level exceeded the mean 
methylation level of baseline samples by two times the standard deviation (Naghitorabi, Asl, 
Sadeghi, Rabbani, Jafarian-Dehkordi & Javanmard, 2013). Mean intra-plate CoVs for IL6, NFκB2, 
and ASC were 1.71%, 0.28%, and 0.32%, respectively. 
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For analysis of gene expression, the ∆∆Ct method was utilised. This is a comparative quantification 
method using the Ct of the gene of interest and a housekeeping gene, in this instance, RPLP0. The 
average Ct value was calculated for the three wells, and fold difference in expression, relative to the 
control, was calculated using 2-∆∆Ct (Livak & Schmittgen, 2001). Mean intra-plate CoV was 
calculated 1.23%. 
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7.3 Results 
7.3.1 Pre- and Post-intervention Data 
Baseline characteristics of both groups are presented in table 7.6. There were no statistically 
significant differences between groups at baseline for any variables (age, mass, BMI, waist and hip 
circumference, waist to hip ratio, systolic or diastolic BP, ?̇? O2peak, energy intake or energy 
expenditure). According to the American College of Sports Medicine, BP values would define 
participants as pre-hypertensive (Pescatello, Arena, Riebe, & Thompson, 2014, p.46). Furthermore, 
BMI would classify participants as overweight, although waist circumference and waist to hip ratio 
would not place the participants in a high risk classification (Pescatello et al., 2014, p.66). 
Table 7.6 - Mean (± SD) articipant characteristics at baseline (ExG = 8; CoG = 9). 
Variable ExG (Mean ± SD) CoG (Mean ± SD) 
Age (years) 32 (± 4) 29 (± 4) 
Stature (cm) 177.7 (± 5.8) 182.8 (± 9.1) 
Mass (kg) 89.3 (± 16.6) 86.8 (± 12.5) 
Body Mass Index (kg∙m2) 28.2 (± 4.4) 25.9 (± 2.9) 
Waist Circumference (cm) 93.9 (± 11.0) 89.9 (± 7.7) 
Hip Circumference (cm) 106.0 (± 8.4) 103.6 (± 6.1) 
Waist to Hip Ratio 0.88 (± 0.05) 0.87 (± 0.04) 
Systolic BP (mmHg) 130.0 (± 11.7) 136.8 (± 7.4) 
Diastolic BP (mmHg) 85.5 (± 6.4) 84.8 (± 8.9) 
?̇?O2peak (ml∙kg-1∙min-1) 43.69 (± 5.59) 47.19 (± 4.72) 
Energy Intake (kcal∙day-1) 1984.3 (± 373.9) 2175.3 (± 277.9) 
Energy Expenditure (kcal∙day-1) 767.5 (± 307.2) 686.2 (± 229.4) 
 
There were no statistically significant differences between groups in terms of habitual dietary 
intake of the methyl-donors methionine, folate, betaine, and choline.  
Table 7.7 - Estimated habitual dietary intake of methyl-donors. 
Methyl-donor ExG (Mean ± SD) CoG (Mean ± SD) 
Methionine (mg∙day-1) 1606.3 (± 579.2) 1633.5 (± 649.8) 
Folate (µg∙day-1) 246.2 (± 169.9) 223.9 (± 111.7) 
Betaine (mg∙day-1) 91.5 (± 46.2) 147.2 (± 77.6) 
Choline (mg∙day-1) 287.2 (± 123.8) 280.8 (± 105.1) 
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As intended, no significant changes occurred from baseline to follow up in the control group for 
any of the variables (see table 7.8).  
Table 7.8 - Mean (± SD) control group data pre- and post-intervention period. 
Variable Pre (Mean ± SD) Post (Mean ± SD) 
Mass (kg) 86.8 (± 12.5) 87.1 (± 12.1) 
Body Mass Index (kg∙m2) 25.9 (± 2.9) 26.1 (± 2.9) 
Waist Circumference (cm) 89.9 (± 7.7) 90.7 (± 7.4) 
Hip Circumference (cm) 103.6 (± 6.1) 104.2 (± 5.8) 
Waist to Hip Ratio 0.87 (± 0.04) 0.87 (± 0.03) 
Systolic BP (mmHg) 136.8 (± 7.4) 134.6 (± 6.2) 
Diastolic BP (mmHg) 84.8 (± 8.9) 84.1 (± 7.2) 
?̇?O2peak (ml∙kg-1∙min-1) 47.19 (± 4.72) 46.1 (± 4.5) 
Energy Intake (kcal∙day-1) 2175.3 (± 277.9) 1984.9 (± 219.1) 
Energy Expenditure (kcal∙day-1) 686.2 (± 229.4) 590.1 (± 234.5) 
 
Following the exercise intervention, there was a statistically significant reduction in mass, BMI, 
waist and hip circumferences, and a significant increase in ?̇?O2peak of 12.2%. As instructed, no 
significant changes occurred in terms of energy intake and habitual energy expenditure (see table 
7.9).  
Table 7.9 - Mean (± SD) exercise group data pre- and post-intervention period. 
Variable Pre (Mean ± SD) Post (Mean ± SD) 
Mass (kg) 89.3 (± 16.6) 87.2 (± 17.2)* 
Body Mass Index (kg∙m2) 28.2 (± 4.4) 25.9 (± 2.9)* 
Waist Circumference (cm) 93.9 (± 11.0) 91.2 (± 11.1)* 
Hip Circumference (cm) 106.0 (± 8.4) 104.4 (± 7.7)* 
Waist to Hip Ratio 0.88 (± 0.05) 0.87 (± 0.06) 
Systolic BP (mmHg) 130.0 (± 11.7) 126.9 (± 8.8) 
Diastolic BP (mmHg) 85.5 (± 6.4) 80.5 (± 6.8) 
?̇?O2peak (ml∙kg-1∙min-1) 43.69 (± 5.59) 49.01 (± 7.75)
* 
Energy Intake (kcal∙day-1) 1984.3 (± 373.9) 1961.5 (± 499.0) 
Energy Expenditure (kcal∙day-1) 767.5 (± 307.2) 643.7 (± 231.1) 
*significantly different from ‘pre’ (p < 0.05). 
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Participants were provided with a trackable HR monitor so that they would be able to exercise at 
the prescribed 65 to 80% of age predicted maximum HR. As shown in table 7.10, the mean HR 
attained throughout all of the sessions equated to approximately 75% of age predicted maximum 
HR. Furthermore, throughout the entire intervention period, 95% of sessions were successfully 
completed. 
Table 7.10 - Mean (± SD) compliance to the prescribed sessions and subsequent recorded heart 
rate. 
Variable (Mean ± SD) 
Compliance (%) 94.5 (± 2.6) 
HR (beats∙min-1) 140 (± 7) 
HR (age predicted max.) 186.8 (± 3.6) 
HR (% of age predicted max.) 74.9 (± 3.9) 
 
7.3.2 Flow Cytometric Analysis 
Table 7.11 shows that there were no time effects for either group for any of the cell populations 
that were analysed. A statistically greater percentage of overall lymphocytes was observed in the 
control group compared with the exercise group at baseline. In both groups at both timepoints, live 
lymphocytes represent the overall majority of cells present in the PBMC samples, with T cells the 
most present sub-population.  
Table 7.11 - Mean (± SD) fractional composition of pre- and post-intervention PBMC samples. 
 ExG (Mean ± SD) CoG (Mean ± SD) 
 Pre Post Pre Post 
Lymphocytes 55.2 (± 8.0) 56.3 (± 4.9) 63.4 (± 6.4)* 62.2 (± 7.4) 
Single Cells 99.3 (± 0.3) 99.5 (± 0.1) 99.2 (± 0.2) 99.2 (± 0.2) 
Live Cells 98.2 (± 0.92) 98.0 (± 2.5) 97.5 (± 1.8) 98.5 (± 0.6) 
T cells (CD3+) (% of lymph.) 66.3 (± 9.9) 67.8 (± 10.8) 62.8 (± 13.9) 66.0 (± 13.0) 
CD4+ (% of CD3+) 53.7 (± 10.6) 53.9 (±10.4) 51.3 (± 15.0) 46.5 (± 21.5) 
CD8+ (% of CD3+) 32.6 (± 8.4) 34.5 (± 9.3) 39.8 (± 17.8) 42.6 (± 21.5) 
NK cells (CD3-CD56+) (% of lymph.) 20.9 (± 8.6) 20.6 (± 8.2) 26.8 (± 12.9) 23.2 (± 11.5) 
CD56dim (% of NK) 19.3 (± 8.2) 18.7 (± 8.2) 25.2 (± 12.5) 21.6 (± 10.9) 
CD16+ (% of CD56dim NK) 78.7 (± 21.9) 85.9 (± 8.5) 80.3 (± 9.1) 74.8 (± 17.1) 
CD56bright (% of NK) 1.375 (± 1.3) 1.2 (± 0.4) 0.7 (± 0.4) 0.9 (± 0.7) 
CD16+ (% of CD56bright NK) 40.8 (± 18.5) 38.0 (± 14.5) 26.9 (± 18.1) 32.8 (± 11.8) 
B Cells (CD3-CD19+) (% of lymph.) 8.6 (± 3.2) 8.6 (± 2.3) 6.2 (± 2.6) 5.6 (± 4.5) 
*significantly different from ‘ExG pre’ (p < 0.05). 
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Figure 7.3 - Example flow cytometry plots from one participant (from left to right, top to bottom): 
lymphocytes; single cells; live cells; CD3+ T cells; CD4+ T helper cells; CD8+ cytotoxic T cells; 
total CD3-CD56+ NK cells; CD56bright and CD56dim NK cells; CD16+ CD56bright NK cells; 
CD16+ CD56dim NK cells; CD3-CD19+ B cells. 
7.3.3 Gene-specific DNA Methylation  
Pearson’s correlation coefficients demonstrate that the standard curves for all genes were highly 
linear (R > 0.97 for all genes). Appendix K shows the normalised and temperature shifted melt 
curves for the standards with and without samples for IL6, NFκB2, and ASC. 
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No statistically significant changes occurred in IL6, NFκB2, or ASC methylation at any timepoint. 
Data are presented in figures 7.4 to 7.6 (PreTR = Pre-training; PostTR = Post-training. PreEX = 
Pre-acute exercise; PostEX = Post-acute exercise; 2hEX = 2h post-acute exercise; 24hEX = 24h 
post-acute exercise).  
Unfortunately, all samples including standards on the left side of the IL6 control sample plate were 
unsuccessful, suggesting a systematic error with this particular plate. Methylated standard melt 
curves on the NFκB2 and ASC control sample plates were not sufficient to generate a linear 
standard curve from which participant sample methylation data could be quantified.  
 
 
Figure 7.4 - Mean (± SD) % IL6 promoter methylation at each timepoint.  
 
10 pg∙ml-1 (‘High’) of IL-6 caused a statistically significant attenuation in IL6 methylation in 
contrast to a low dose of 1 pg∙ml-1 (p = 0.010). This 9.4% decrease in methylation was twice the 
standard deviation of the low dose, and thus, can be classified as hypomethylated under the 
definition outlined in section 7.2.5. 10 pg∙ml-1 (‘High’) of IL-1β caused a statistically significant 
augmentation of IL6 methylation in contrast to a low dose of 1 pg∙ml-1 (p = 0.011), however, this 
difference did not exceed the predefined value to be classified as hypermethylated. All other 
cytokine experiments did not result in significant alterations in gene methylation. Data are 
presented in figures 7.7 to 7.9. 
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Figure 7.5 - Mean (± SD) % NFκB2 first exon methylation at each timepoint. 
 
 
 
Figure 7.6 - Mean (± SD) % ASC first exon methylation at each timepoint. 
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Figure 7.7 - Mean (± SD) % IL6 promoter methylation following cytokine stimulation. 
*significantly greater than ‘Low’ (p < 0.05). 
 
 
 
Figure 7.8 - Mean (± SD) % NFκB2 first exon methylation following cytokine stimulation. 
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Figure 7.9 - Mean (± SD) % ASC first exon methylation following cytokine stimulation. 
7.3.4 DNMT Gene Expression  
No statistically significant changes occurred in expression of DNMT3A relative to the control gene 
RPLP0 at any timepoint. Data are presented in figure 7.10 (PreTR = Pre-training; PostTR = Post-
training. PreEX = Pre-acute exercise; PostEX = Post-acute exercise; 2hEX = 2h post-acute 
exercise).  
 
Figure 7.10 - Mean (± 95% CI) DNMT3A expression relative to control. 
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7.4 Discussion  
In corroboration with previous studies that have also used the same seven week aerobic exercise 
intervention, a 12% increase in ?̇?O2peak was observed (Barwell et al., 2008), in addition to a 
significant attenuation of body mass, and waist and hip circumferences, similarly to the reported 
reduction in fat mass by Moran et al. (2011). No significant alterations in promoter or first exon 
methylation of IL6, NFκB2, or ASC occurred following cell stimulation with exercise-conditioned 
plasma isolated before and after the exercise intervention or acute maximal bout. Similarly, there 
was no significant alteration in the expression of DNMT3A at any timepoint. In vitro stimulation 
with IL-6 caused significant hypomethylation of the IL6 promoter, while IL-1β elicited a 
significant augmentation of methylation, although not classified as hypermethylation by pre-define 
criteria.  
The positive physiological adaptations, combined with the high compliance to the semi-supervised 
intervention, highlights that this particular intervention was efficacious, and in addition to the 
progressive nature of the programme, could be an ideal way for sedentary overweight men to 
improve cardiovascular fitness and body composition. These benefits were not due to changes in 
increased habitual activity outside of the exercise sessions or changes to dietary (methyl-donor or 
calorie) intake, therefore, it can be concluded with relative confidence that it was indeed the 
exercise intervention that elicited these salubrious physiological changes. 
Despite this, it was surprising that no significant alterations in DNA methylation occurred. Denham 
et al. (2015b) have demonstrated that as little as four weeks of training can elicit a number of gene-
specific methylation changes in leukocytes. With a focus on genes involved in inflammation, 
Zhang et al. (2015) have previously shown that a regular low intensity exercise programme over six 
months caused hypermethylation of a number of sites within the NFκB2 promoter region. 
Similarly, following the same intervention, Nakajima et al. (2010) demonstrated that exercise was 
able to cause CpG island hypermethylation in the first exon of the ASC gene compared with 
sedentary controls. There are, however, some clear distinctions between these data and the data 
presented in this chapter; firstly, although assays were designed for both NFκB2 promoter and first 
exon regions in the present study, the latter primers were deemed to be optimal, which contrasts the 
region analysed by Zhang et al. (2015). This might help to explain why previous studies have 
clearly shown that exercise can acutely induce NFκB activation, and exercise training can attenuate 
this acute induction of NFκB and IL6; it is plausible that changes in methylation did indeed occur 
in regions of these genes associated with transcriptional changes, however, the primers that were 
utilised did not capture the locus of these modifications. Since protein or mRNA levels were not 
quantified, it is uncertain whether any functional downstream changes did indeed occur. 
Additionally, the vast difference in the ages of the study populations clouds interpretation; both of 
the above studies utilised a sedentary aging population, in contrast to the younger sedentary sample 
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that participated in the intervention in this study. It is possible that the participants’ age or lifestyle 
had not yet induced aberrant epigenetic modifications that would cause a chronic inflammatory 
state, and thus, could explain the lack of the expected differential DNA methylation in the genes 
that were analysed.  
While systemic concentrations of IL-6 and expression of the IL6 gene have been relatively robustly 
shown to be manipulated by sedentary behaviour and reversed with regular exercise, no data thus 
far has been able to link this to epigenetic modifications in the form of differential DNA 
methylation. Since IL6 methylation is closely linked with weight and inflammatory diseases, it 
seemed entirely logical that an intervention that reduced body mass and waist circumference, and 
therefore, likely subcutaneous fat, would elicit significant changes to the methylation of the gene 
concomitantly with modified transcription. As discussed in reference to NFκB2 above, the CpG 
island under investigation by the primers that were designed specifically for this study may not 
have been modified, but as to whether other regions of the gene exhibited differential methylation 
cannot be elucidated at this time. It can be concluded, however, that exercise-induced changes to 
the fractional composition of the PBMC samples did not mask any true changes in DNA 
methylation over time given that flow cytometry data demonstrates that there were no significant 
changes in the relative proportion of any of the major cellular subsets.  
Unfortunately, it was not possible to quantify whether changes between training and control groups 
occurred given that the methylated standards did not amplify on the control sample plates. Every 
effort was made to ensure that the experiments would function correctly; primers were designed in 
accordance with guidelines, which were then tested using gel electrophoresis to check for primer 
dimer formation and optimal annealing temperatures. There is a possibility that assay design was 
suboptimal, resulting in unsuccessful amplification of a large number of samples.  It may have been 
beneficial to have conducted the experiments with various primer pairs designed for a similar 
region to increase the likelihood of adequate data, although constraints such as sample yield did not 
allow this approach. While msHRM has been shown to be a sensitive technique for measurement of 
DNA methylation, optimisation of each assay is evidently required which was unfortunately not 
possible within the scope of this project.   
The primary focus of this study was to investigate the potential exercise-induced modifications to 
the DNA methylome following a progressive training intervention. Also of interest was the effect 
that training would have on the subsequent acute to response to a single bout of maximal exercise. 
Denham et al (2015b) reported training-induced changes to miR21 and miR210 CpG methylation 
concomitantly with altered expression of the genes, both at rest following the intervention, and 
acutely following a ?̇?O2max test, suggesting that chronic epigenetic adaptations to exercise can 
indeed influence the subsequent transient response to exercise. However, they did not report 
whether DNA methylation was altered following the ?̇? O2max test itself, only following the 
intervention. While it is likely that the intervention in the present study was a sufficient stimulus to 
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elicit longer term adaptations, the duration of the acute bout may not have been enough to elicit an 
acute change in DNA methylation within the genes and regions of interest. The studies in chapters 
4 and 5 were able to show that a single bout of exercise is able to elicit significant alterations to the 
nuclear concentrations of de novo DNMTs, however, these bouts were much longer in duration, 
which could support this supposition.  
An underlying aim throughout the entirety of this thesis has been whether manipulation of DNMT 
nuclear concentrations is due to cellular relocalisation, transcriptional changes, or both. The lack of 
change in relative DNMT3A expression following the training programme or acute bout suggests 
that previously observed modifications to nuclear concentrations of DNMT3A may not be due to 
transcriptional changes but rather cellular relocalisation of the protein, although it must be noted 
that two out of the three acute exercise bouts examined thus far within this thesis did not elicit 
changes to cellular concentrations of DNMT3A protein, and therefore may suggest that DNMT3A 
is not susceptible to exercise-induced modification. Unfortunately, the DNMT3B assay was not 
successful therefore, no data on DNMT3B expression is available to aid interpretation in this 
investigation.  Post-transcriptional and translational modifications can lead to large discrepancies 
between mRNA and protein abundance (Vogel & Marcotte, 2013), however, the lack of DNMT3B 
primer amplification in this instance is likely due to poor assay design given that previous studies 
have successfully quantified the relative expression of the DNMT3B gene, rather than low 
expression of the gene. Future experiments should include measurements of PCR amplification 
efficiency in order to ensure accurate calculation of relative gene expression. 
Even though an attempt was made to ensure that the sample size of the study was sufficient, a lack 
of data within this sub-discipline and inconsistencies in findings due to a vast number of 
methodological differences between studies meant it was difficult to ensure statistical power, and 
thus, it cannot be ruled out that the inconclusive findings may be due to sample size.  
Despite a lack of significant effects of exercise-conditioned plasma on DNA methylation, in vitro 
stimulation with cytokines alone elicited a vastly different response. The high dose of IL-6 (10 
pg∙ml-1), similar to typical post-endurance exercise plasma concentrations, caused significant 
promoter hypomethylation of the IL6 gene compared with a lower dose of 1 pg∙ml-1. Previous data 
has shown that IL-6 can cause promoter hypermethylation; however, gene and cell line specificity 
mean that this does not directly contradict the IL6 hypomethylation observed in this investigation. 
Given the previously reported significant elevation in DNMT3A and DNMT3B nuclear 
concentrations following stimulation with IL-6 (see chapter 3), it was surprising to observe 
promoter hypomethylation, and not vice versa. DNMT-independent mechanisms must have caused 
this reduction therefore, and since protein concentrations or expression of the active demethylase 
TET were not included in analyses, it is difficult to elucidate how this hypomethylation occurred.  
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In contrast, the same concentrations of IL-1β caused significant an elevation in IL6 promoter 
methylation, which appears counterintuitive; promoter methylation is closely correlated with 
transcriptional silencing, however, IL-1β is widely regarded to induce IL-6 production in a number 
of cell types including monocytes (Tosato & Jones, 1990). Mechanistically, IL-1β has been shown 
to up- and down-regulate both DNMT3A and DNMT1 expression in lung fibroblasts and RA 
fibroblast-synoviocytes, respectively. In this instance, it would be logical to assume that nuclear 
concentrations, activity, or transcription of the de novo DNMTs were elevated, resulting in the 
observed hypermethylation which is consistent with the findings presented in chapter 3. 
Functionally, when combined with other results presented in this thesis, these data support the 
supposition that inflammatory cytokines are significant regulators of both DNMTs, and at certain 
loci, modifications to DNA methylation itself. 
Unexpectedly, TNFα did not elicit changes in DNA methylation of any of the genes, despite a body 
of experimental data demonstrating that TNFα is able to alter expression of all three functional 
DNMTs and SOCS3 promoter methylation, although as previously alluded to, considerable cell 
specificity exists, potentially accounting for the lack of significant effects.  
Of note is that each experimental condition was only performed in duplicate and analysed in 
triplicate, therefore this low number and relatively large variation could explain the lack of 
statistical significance with regard to NFκB2 methylation following stimulation with IL-6 or IL-1β, 
although there does appear to be a visual elevation and reduction, respectively. Furthermore, 
msHRM has only been shown to be sensitive to 1% methylation, whereas a lot of samples were 
below this threshold, and therefore, these data would need to be interpreted with caution even in the 
event of a statistically significant outcome.  
7.4.1 Conclusion 
Overall, it is difficult to make any firm conclusions based on the data presented within this chapter. 
In vitro cytokine stimulation data, do however, corroborate results outlined in section 1.5, and 
support the posit that inflammatory cytokines are able to significantly alter DNA methylation in 
PBMCs, plausibly via cellular relocalisation of DNMTs. As to whether TET-dependent active 
demethylation or passive demethylation due to cytoplasmic transport of DNMTs accounted for the 
IL-6 induced hypomethylation of the IL6 gene has not been elucidated. 
Quantification of the relative expression of the genes would have yielded important information as 
to whether methylation changes did indeed result in functional changes to mRNA or protein 
concentrations. Furthermore, Human Methylation 450k or EPIC beadchips, which analyse over 
485,000 and 850,000 methylation sites in the genome, respectively, would allow characterisation of 
the greater picture in terms of exercise-induced methylation changes. 
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CHAPTER 8 
 
 
 
 
 
 
GENERAL DISCUSSION, CONCLUSIONS AND FUTURE 
DIRECTIONS 
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8 General Discussion, Conclusions and Future Directions 
8.1 General Discussion  
8.1.1 Overview 
Much research focus is given to genetic polymorphisms associated with sporting performance and 
disease susceptibility, however, epigenetic mechanisms which possess an essential role in 
transcriptional regulation are only starting to be acknowledged within exercise physiology research. 
As such, the study of epigenetics is still relatively contemporary, but is certainly a worthwhile area 
for investigation in order to fully understand how exercise exerts a multitude of changes at a 
transcriptional level.   
The research presented within this thesis attempted to elucidate the underlying molecular 
mechanisms that govern exercise-induced epigenetic modifications. Existing data suggest that a 
number of proteins, in particular inflammatory cytokines, are able to regulate the expression and 
cellular localisation of DNMTs. Based on this, the objective was to characterise acute changes that 
occur to the de novo DNMTs following a single bout of exercise, and the involvement of exercise-
induced systemic inflammation in this process. How changes in nuclear concentrations of these 
methylation-regulatory enzymes then translate into functional changes to the DNA methylome was 
also of interest. Furthermore, regular exercise appears to reduce inactivity-associated systemic 
inflammation, suggesting a cyclic relationship between exercise, inflammation, and epigenetic 
modification. Based upon this, the final overall objective was to elucidate whether regular exercise 
would exert significant modifications to promoter or first exon methylation of a number of genes 
associated with chronic low-grade inflammation in a sample of previously sedentary participants.  
The pilot investigation presented in chapter 3 corroborated previous in vitro data that recombinant 
IL-6 is able to manipulate nuclear concentrations of DNMT3A and DNMT3B in human PBMCs. 
PBMCs that were cultured with plasma isolated from exercising participants before and after a 
number of acute exercise bouts exerted contrasting effects on cellular concentrations of the de novo 
DNMTs; following 120 minutes of treadmill running interspersed with short sprint periods, nuclear 
concentrations of DNMT3B were significantly attenuated concomitantly with an elevation in 
plasma IL-6 concentrations, whereas in contrast, circulating changes following a 24 hour ultra-
endurance event elicited a significant augmentation of DNMT3A, in addition to plasma 
concentrations of IL-10, IL-6, IL-8, and TNFα. Despite the stark contrast in results, both studies 
strongly support the supposition that large, transient elevations in inflammatory cytokines are 
important regulators of exercise-induced epigenetic modifications. In support of this, exercise-
conditioned plasma following eccentric exercise which did not elicit a transient elevation in 
inflammatory cytokines resulted in no significant alterations to nuclear or cytoplasmic DNMT 
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concentrations, or global DNA methylation. It is also of interest that the data presented in chapters 
3 to 6 consistently shows that DNMT3A is less abundant within the nuclei of PBMCs, possibly 
suggesting that DNMT3B may be a more important regulator of DNA methylation in immune 
cells. Furthermore, as previously alluded to, this relationship between inflammation and epigenetic 
modification is likely to be bidirectional, and with that in mind, methylation within the IL6 
promoter, and NFκB2 and ASC first exon regions was investigated following a seven week exercise 
intervention. No significant methylation changes were observed following the training programme, 
or following the subsequent acute maximal bout. Inflammatory cytokines did elicit significant 
alterations to the methylation of the IL6 promoter region however.  
8.1.2 Influence of Exercise-conditioned Plasma on DNMTs 
The large decrement in DNMT3B and elevation in DNMT3A nuclear concentrations following 
stimulation with exercise-conditioned plasma could have been due to cellular relocalisation or 
transcriptional up- or downregulation, either alone or in combination. IL-6 has previously been 
shown to cause nuclear translocation of DNMT1 (Hodge et al., 2007) and high concentrations of 
glucose can cause cytoplasmic translocation of DNMT3A (Zhang, Li, Zhang, Huang, Wang, & Yi, 
2016), while a number of inflammatory mediators and even muscular contraction can alter DNMT 
transcription. 
The contrasting effect of exercise-conditioned plasma on nuclear concentrations of DNMT3A and 
DNMT3B following the two endurance exercise bouts is difficult to explain. Post-exercise IL-6 
reached similar concentrations in both studies, and therefore, the differential response is unlikely to 
be due this cytokine alone. Plasma concentrations of other inflammatory cytokines were not 
quantified following the 120 minute protocol, but TNFα, IL-8, and the anti-inflammatory IL-10 
were found to be significantly elevated following the ultra-marathon. Given that 100 ng∙ml-1 of 
TNFα and IGF-1 in combination caused an increase in DNMT1 and DNMT3B mRNA compared 
with each cytokine alone, and DNMT3A compared with controls, albeit using coronary artery cells 
(Dhar et al., 2013), it could be hypothesized that a combination of exercise-induced systemically 
elevated cytokines causes differential DNMT regulation in contrast to each individual cytokine 
alone. It is also plausible that although plasma IL-6 was augmented following the 120 minute 
protocol, the anti-inflammatory mediator IL-10 may not have been significantly elevated by the 
post-exercise sample point. In contrast, the ultra-marathon post-exercise sample was taken 24 hours 
after the initiation of exercise, and therefore the two-fold increase in IL-10 at this point likely 
indicates the beginning of inflammatory resolution. Given that different signalling cascades control 
pro- and anti-inflammatory pathways, at least with regard to IL-6 (Scheller, Chalaris, Schmidt-
Arras, & Rose-John, 2011), it is entirely possible that differential activation of these pathways due 
to the timeframe in which the samples were taken would be sufficient to elicit the contrasting 
downstream changes in nuclear DNMT concentrations. 
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It must be noted that multiple regression analysis revealed that the elevations in the inflammatory 
cytokines following the ultra-marathon were unable to predict the augmentation in nuclear 
DNMT3A, and thus, other circulatory factors likely contributed. Not only do circulating 
inflammatory profiles differ between endurance and eccentric exercise bouts, plasma miRNA 
concentrations have also been shown to be differentially regulated by acute eccentric (Banzet et al., 
2013), resistance (Sawada et al., 2013), and aerobic exercise (Nielsen et al., 2014). While a number 
of miRNAs have been shown to target and alter the transcription of all three DNMTs (section 
1.2.2), it is currently unclear as to whether miRNAs located in the plasma possess similar 
regulatory roles. Contrasting plasma miRNA profiles have been reported in endurance and strength 
trained athletes (Wardle et al., 2015), which also highlights the potential for different exercise 
modalities to elicit contrasting epigenetic responses to an acute bout. 
In vitro stimulation of mesangial cells with high concentrations of glucose causes cytoplasmic 
translocalisation of DNMT3A via ERK/MEK signalling without altering DNMT3A expression, 
consequently causing increased CTGF expression (Zhang et al., 2016). Given that hyperglycaemia 
can elicit an elevation in inflammatory gene expression in various cell types (Wasinksi et al., 2014; 
Witkowski, Guhanarayan, & Burgess, 2016), the IL-6/ERK/MEK pathway could explain Zhang et 
al’s finding. In the context of exercise, Marliss and Vranic (2002) reported that cycling at 100% of 
?̇? O2max caused a significant augmentation of plasma glucose. Conversely, Coyle, Coggan, 
Hemmert, and Ivy (1986) showed that cycling to fatigue at 70% of ?̇?O2max was preceded by a 
decline in both plasma glucose and muscle glycogen, which was only delayed for an hour when fed 
additional carbohydrates.  Thus, it was concluded that intense exercise can result in elevations in 
plasma glucose due to a mismatch between glucose production and utilisation, but only at 
intensities over 80% of ?̇?O2max, whereas plasma glucose concentrations tend to remain constant 
during moderate intensity exercise (Marliss & Vranic, 2002). It is likely, however, that the exercise 
bouts utilised throughout this thesis did not result in plasma hyperglycaemia; it is extremely 
probable that the 24 hour ultra-marathon resulted in a significant drop in muscle glycogen by the 
end of the race, thereby limiting glucose production. The drop jump protocol utilised in chapter 6 
did not involve a large metabolic demand, and therefore, it is plausible that plasma glucose 
remained constant. Furthermore, the protocol utilised in chapter 4 was previously shown to not 
alter plasma glucose immediately following exercise (Walshe et al., 2011). As such, within the 
context of the data presented in this thesis, perturbations in plasma glucose concentrations would 
not appear to explain the exercise-conditioned plasma induced alterations to the nuclear 
concentrations of DNMTs.  
It is well documented that epigenetic alterations do not occur in isolation, and that DNA 
methylation and histone modifications are closely linked. Another mechanism that could explain 
the documented effects of exercise on DNA methylation concerns the overlap between these two 
modifications, as DNMTs have been known to bind and correlate with HDACs (Fuks et al., 2000; 
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Gu et al., 2013; Rountree et al., 2000); attenuated nuclear HDAC concentrations following 60 
minutes of cycling (McGee, Fairlie, Garnham, & Hargreaves, 2009) could have been due to 
enhanced nuclear export via CaMK signalling (McKinsey, Zhang, Lu, & Olson, 2000). Since 
muscular contractions can augment CaMKII activity (Rose, Kiens, & Richter, 2006) and induce 
DNA hypomethylation in skeletal muscle (Barrès et al., 2012; Lucas et al., 2012), cytoplasmic 
relocalisation of HDACs and bound DNMTs may be a mechanism by which exercise causes 
attenuated nuclear concentrations of these epigenetic enzymes and subsequent DNA 
hypomethylation. However, this pathway has been documented in skeletal muscle and not 
circulating immune cells. 
While the data presented in chapters 3, 4, and 5 differs dramatically, all three studies support the 
hypothesis that exercise-induced changes to circulating inflammatory cytokines are able to cause 
significant changes to the nuclear concentrations of the de novo DNMTs. However, since no 
changes in nuclear or cytoplasmic concentrations of either DNMT occurred following the 
damaging eccentric protocol, it was not possible to elucidate whether they exhibit a differential 
time course of modification as hypothesized.  
These data alone were unable to clarify whether changes in nuclear concentrations were due to 
cellular relocalisation or transcriptional changes. As previously alluded to, alterations in cellular 
concentrations of DNMT3A and DNMT3B could also be due to transcriptional up- or 
downregulation; a 50% attenuation of skeletal muscle DNMT3B mRNA has been reported 
following three hours of cycling at 60% of vV̇O2max (Laye & Pedersen, 2010). The Ca2+ ionophore 
ionomycin elicited an approximate 40% reduction in both DNMT3A and DNMT3B mRNA in 
differentiated myotubes. Results presented in chapter 7 showed that expression of DNMT3A was 
unaltered following stimulation with exercise-conditioned plasma following a progressive exercise 
intervention, which appears to contradict the aforementioned studies. Relative DNMT3B expression 
data from this investigation is not available, and thus, inferences must be made cautiously.  
Despite this, in vitro data suggests that transcriptional changes due to inflammatory proteins are 
highly likely. Exercise-induced elevations in PGE2 concentrations have been reported following a 
marathon (Demers et al., 1981) and run to exhaustion at 80% of V̇O2max (Venkatraman et al., 2001). 
Given the duration and intensity of the two endurance exercise bouts, increased plasma PGE2 
concentrations were likely to have occurred. When combined with the in vitro data discussed in 
section 1.5.3, manipulations in circulating PGE2 could also have elicited changes to DNMT 
expression. IL-6, TNF-α, IL-1β, IGF-1 also exert significant alterations to the transcription of 
DNMT1, DNMT3A, and DNMT3B in a variety of cell types (section 1.5), further substantiating this 
supposition. 
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8.1.3 Influence of Exercise-conditioned Plasma on DNA Methylation 
As expected, due to a lack of change in nuclear DNMT concentration, no significant alterations in 
the amount of global DNA methylation occurred following the damaging eccentric protocol. This 
corroborates previous data that global methylation remained unchanged in PBMCs following the 
same protocol (Robson-Ansley et al., 2014), and in NK cells following a marathon (Zimmer et al., 
2015). Global DNA methylation may be a useful measure in epidemiological studies, however the 
effects of an acute stimulus such as exercise appears to require more sensitive measures. Moreover, 
it is difficult to isolate the functional downstream consequences of altered global methylation, 
given that hypermethylation, for example, within different regions of the same gene can promote 
such contrasting effects.  
Evidence suggests that regular exercise can favourably alter the methylation profile of genes 
involved in inflammatory pathways such as NFκB (Zhang et al., 2015) and ASC (Nakajima et al., 
2015), while Denham et al. (2015b) have shown that four weeks of training, albeit at a higher 
intensity, elicited a number of gene-specific methylation alterations in leukocytes. Conversely, 
Duggan et al. (2014) did not report any significant effects of 12 months of training on leukocyte 
methylation, however global methylation was the outcome measure, the weaknesses of which have 
been discussed already within this thesis. Results reported herein were unable to corroborate these 
previous findings. As discussed in chapter 7, despite the positive physiological effects of the 
training in terms of improved cardiovascular fitness and body composition, methodological 
limitations such as small sample size and possible suboptimal assay design may have masked the 
true gene-specific modifications to the methylome, and thus, it would be unwise to conclude that 
regular exercise simply does not cause any changes to methylation within these genes.   
8.1.4 Influence of Inflammatory Cytokines on DNMTs and DNA Methylation  
Physiological and supra-physiological concentrations of rIL-6 were shown to significant augment 
nuclear concentrations of both DNMT3A and DNMT3B in chapter 3. An abundance of in vitro 
research has previously investigated the effect IL-6 on DNMTs, and the associated pathways by 
which these proteins interact. IL-6 may augment DNMT1 expression via JAK2/STAT3 signalling 
(Huang et al., 2016; Liu et al., 2015a;Zhang et al., 2006). Additionally, STAT3 has been shown to 
bind to DNMT1 and causes epigenetic silencing by targeting DNMT1 to promoters (Lee et al., 
2012; Zhang, Wang, Marzec, Raghunath, Nagasawa, & Waski, 2005). The PI3K/AKT signalling 
pathway also appears to regulate at least DNMT1 in a variety of cell lines; Sun et al. (2007) 
reported a positive correlation between DNMT1 protein levels and AKT phosphorylation in a large 
number of human cell lines and bladder cancer tissues. Inhibition of AKT resulted in DNA 
hypomethylation, presumably due to a reduction in DNMT1 protein stability or abundance, given 
that AKT enhanced DNMT1 protein stability and elevated protein concentrations independently 
from changes in mRNA.  
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While much of the literature utilises supra-physiological concentrations of IL-6 and disease-
specific cell lines, the data presented in this thesis is novel in that normal physiological ranges of 
rIL-6 were used to stimulate healthy human PBMCs. Furthermore, a lot of these previous studies 
focus specifically on the effects of the ‘maintenance’ DNMT, DNMT1, with little evidence 
reported thus far linking IL-6 with the de novo DNMTs. In hepatocellular carcinoma cell lines 
however, PI3K signalling regulates DNMT3B expression (Mei et al., 2010), whereas in prostate 
cancer cells, PI3K/AKT inactivation attenuates both DNMT1 and DNMT3B expression (Agarwal et 
al., 2013). Nuclear DNMT concentrations can also be augmented via cellular relocalisation; 
PI3K/AKT signalling mediates the phosphorylation of DNMT1’s nuclear localisation signal, 
thereby causing translocation into the nucleus from the cytoplasm (Hodge et al., 2007).  
The data presented in chapter 3 is difficult to interpret in isolation, but provides support to the 
hypothesis that IL-6 does indeed cause elevations in nuclear concentrations of DNMT3A and 
DNMT3B in PBMCs, either by transcriptional upregulation or cellular translocation. The obvious 
concern with making comparisons between the data presented herein and the literature is that 
physiological responses differ dramatically between healthy and diseased cells, and much of the 
data describes mechanistic links between IL-6 and DNMT1, not DNMT3A or DNMT3B. Thus, in 
isolation, any conclusions regarding the signalling pathways by which rIL-6 is able to exert 
significant influence of the nuclear concentrations of DNMT3A and DNMT3B, must be made with 
caution. These results do, however, support the exercise-conditioned plasma data, and the original 
supposition that IL-6 is clearly a mediator of epigenetic-regulatory machinery.  
In addition to the ability to elicit significant changes to nuclear concentrations of these enzymes, 
inflammatory cytokines were shown to exert downstream functional effects in the form of modified 
DNA methylation. While IL-6 is able to modify DNMTs in vitro, as previously discussed, in 
addition to promoter methylation of tumour suppressor genes, IL-1β has only thus far been shown 
to affect DNMT1 and DNMT3A expression. It is unsurprising that these cytokines would result in 
altered DNA methylation as reported in chapter 7, although it did appear paradoxical that IL-1β 
induced IL6 promoter hypermethylation, as this modification is typically associated with 
transcriptional silencing whereas IL-1β has robustly been shown to experimentally induce IL-6 
production in immune cells. This highlights the complexity of epigenetic modifications in differing 
genomic regions, and supports the necessity to quantify concomitant protein or mRNA levels in 
addition to methylation changes across a number of CpG islands within a gene’s upstream 
regulatory regions such as the transcription start site.  
With all of the above discussion points in mind, a complex cascade of events linking exercise-
induced circulatory changes and epigenetic modification clearly exists. Figure 8.1 represents a 
hypothetical pathway, based upon data presented and discussed thus far within the entire thesis, by 
which these transient systemic changes alter nuclear protein concentrations of DNMTs leading to 
epigenetic modifications. 
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8.1.5 Strengths and Limitations 
As previously discussed, the use of a standardised cell sample in all experimental conditions means 
that interpretation of these data is difficult in terms of generalisation to a wider population. 
However, in order to fully elucidate the role of exercise-induced circulatory changes on subsequent 
alterations in cellular concentrations of epigenetic markers, it was essential that individual 
differences in polymorphisms which may alter susceptibility to epigenetic change were controlled 
for. Therefore, within the scope of this line of investigation, it was deemed an appropriate 
experimental decision to make. Furthermore, PBMCs represent a more homogenous cell population 
than whole blood or peripheral blood leukocytes which are often utilised, yet still maintain the 
advantage of being a relatively non-invasive and inexpensive sample for investigation. 
A strength of the series of studies presented herein is that a wide range of exercise bouts were 
utilised, each with their own unique physiological demand, thus allowing a more complete 
characterisation of exercise-induced epigenetic changes. Further quantification of the vast number 
of exercise-induced changes to circulatory proteins and molecules would have greatly aided in the 
interpretation of data. 
A hypothesis driven targeted approach to DNA methylation investigation meant that a strong 
rationale was developed for the genes that were selected to be investigated. Nonetheless, the use of 
a complex contemporary technique such as msHRM resulted in a large number of missing 
datapoints; the lack of data for the control group from chapter 7 meant that it was not possible to 
fully interpret the effects of a training intervention on gene-specific methylation. Although 
extremely costly, a methylation sequencing approach would have allowed more complete 
characterisation of the genome-wide effects of exercise on the DNA methylome. Had changes in 
DNA methylation occurred following stimulation with exercise-conditioned plasma, concomitant 
quantification of gene expression would also have been beneficial. 
Measurement of protein concentrations of DNMTs within the cellular compartments, and not 
protein activity, could also be deemed to be a limitation. The decision to quantify abundance was 
based primarily on in vitro data that shows that rIL-6 is able to elicit nuclear translocation of 
DNMTs, and the subsequent hypothesis that exercise-induced elevations in plasma IL-6 would 
produce a similar alteration in cellular DNMT concentrations. In order to compare data between 
studies it was deemed necessary to continue utilising the same approach.  
Finally, the signalling cascades by which inflammatory cytokines elicit modifications to the 
methylome could be clarified using targeted RNA sequencing technologies, such as the NFκB 
panel offered by Illumina. Thus far, it has been difficult to hypothesize the pathways by which IL-
6, for example, causes nuclear translocation of DNMTs and subsequent methylation changes, as 
such a vast array of cell types are utilised within the available literature.  
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8.2 Conclusions and Future Directions 
The data presented in this thesis builds upon the study conducted by Robson-Ansley et al. (2014) 
and furthers the understanding of the mechanisms underlying exercise-induced epigenetic 
modifications. The data consistently demonstrate that exercise-induced changes to circulating 
inflammatory cytokines exert significant influence over the nuclear localisation of the de novo 
DNMTs, DNMT3A and DNMT3B, and is the first data to demonstrate the molecular mechanisms 
by which exercise can elicit modifications to the methylome in PBMCs. Furthermore, despite 
inconclusive results on the effects of exercise-conditioned plasma on DNMT expression and DNA 
methylation itself following exercise training, previous literature suggests that exercise can indeed 
modify inflammatory gene methylation, albeit in different populations. Firm conclusions within 
this context are therefore confounded by a number of methodological issues.  
This is preliminary research into the mechanisms that underpin the complex relationship between 
physical activity and inflammation. Promoter or first exon methylation of select genes involved in 
key inflammatory pathways may in future become a useful biomarker by which to measure the 
effectiveness of exercise interventions on chronic inflammation and disease susceptibility. The 
postulation that over the long term, moderate amounts of exercise may indeed be more health-
beneficial than intense and excessive training volumes (Radak, Chung, Koltai, Taylor, & Goto, 
2008) could be tested by measuring inflammatory gene promoter methylation and protein levels 
longitudinally following varying exercise programmes.  
Due to the paucity of literature within the ‘exercise epigenomics’ domain, a vast number of 
potential research avenues remain. Given the complex nature and overlap of different epigenetic 
modifications, when combined with genetic factors such as polymorphisms which may alter 
susceptibility to epigenetic change, collaborative approaches appear necessary in order to fully 
elucidate the mechanisms by which exercise alters phenotypes.  
With a focus on the scope of the research presented in this thesis, it would be beneficial to further 
characterise the role of exercise-induced circulatory changes on epigenetic modification, and the 
underlying pathways which mediate changes. Specifically, the inclusion of other inflammatory 
measures, in particular TNFα, IL-1β, and PGE2, based on in vitro data, may aid in the interpretation 
of how transient inflammation may elicit changes to the methylome. Furthermore, miRNAs are 
well known to interact with epigenetic-regulatory enzymes, and recent evidence suggests that 
exercise can alter the circulatory miRNA profile. Exercise-induced changes to intra- or 
extracellular Ca2+ may significantly contribute to inflammatory gene upregulation within immune 
cells, and thus, warrants further investigation also.  
In addition to the above recommendations, more in vitro studies, using techniques such as 
chromatin immunoprecipitation, may allow elucidation of the interaction between proteins in the 
complex cascade of events that mediate epigenetic modifications, which in turn may help to 
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explain the precise pathways involved. The inclusion of TET in these analyses would also aid the 
understanding of the methylation/demethylation process which is both dynamic and complex.  
 
 
 
Figure 8.1 - Schematic representing a hypothetical pathway, based on data from a variety of cell 
types, by which exercise may cause circulatory changes that elicit epigenetic modifications 
(Numbers indicate references which can be found in full in appendix L).  
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Study Cell Line/Tissue Cytokine/ Stimulus 
(concentration) 
Epigenetic Modification/Enzyme Notes 
IL-6     
Hodge et al. (2001) K562 (leukaemia) cell line IL-6 (100 ng∙ml-1) ↑ DNMT1 expression  
Hodge et al. (2005) KAS 6/1 (multiple myeloma) cell line IL-6 (10 ng∙ml-1) ↑ DNMT1 expression IL-6 maintains PM of p53 
Wehbe et al. (2006) Mz-ChA-1 (cholangiocarcinoma) cell line Cells transfected with 
IL-6 = IL-6 
overexpressing cell line, 
Mz-IL-6 
 PM not altered for most genes; PM↑ CASP8, 
Survivin, HoxA2; PM↓ TFF1, Tastin 
Zhang et al. (2006) PB-1, 2A, 2B (T cell lymphoma) cell lines   STAT3 (activated by IL-6) induces DNMT1 
expression 
Hodge et al. (2007) HEK293 (embryonic kidney) cell line IL-6 (100 ng∙ml-1) DNMT1 nuclear translocation Phosphorylation of nuclear localisation signal by 
AKT 
Braconi et al. (2010) 
 
KMCH-1, Mz-ChA-1, TFK-1 (human 
cholangiocarcinoma), and H69 (human 
non-malignant cholangiocyte) cell lines 
Cells transfected with 
IL-6 = IL-6 
overexpressing cell lines, 
KM-IL-6 and Mz-IL-6 
 
↑ DNMT1 expression in Mz-IL-6 
and KM-IL-6 cells compared with 
controls 
IL-6 regulated activity of DNMT1 by 
modulation of miR-148a and miR-152 
 
↓ expression of tumour suppressor genes 
Rassf1a, p16INK4a, MGMT 
Foran et al. (2010) IBD-CRC tumours 
 
 ↑ DNMT1 expression compared 
with sporadic CRC tumours 
DNMT3B overexpression in CRC tumours 
 
 HT29, HCT15, HCT116 (colon cancer) 
cell lines 
 
IL-6 (100 ng∙ml-1) ↑ DNMT1 expression ↑ PM of tumour suppressor genes 
Appendix A – Summary of literature in section 1.5. 
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Li et al. (2012) CRC patient colon biopsies  IL-6 associated with ↑ DNMT1 
expression 
IL-6 induced DNMT1 expression correlated with 
SOCS3 PM, resulting in ↑ STAT3 signalling  
Liu et al. (2015a) A549 (lung cancer) cell line IL-6 (10 ng∙ml-1) ↑ DNMT1 expression; no change in 
DNMT3A/3B 
IL-6/JAK2/STAT3 pathway upregulates 
DNMT1 
Huang et al. (2016) Pancreatic cancer cells IL-6 (100 ng∙ml-1) ↑ DNMT1 activity  IL-6/STAT3 promotes SOCS3 PM via DNMT1 
expression and recruitment to promoter region 
Other Cytokines     
Barrès et al. (2009) Human myotube cells TNFα (1 µM) ↑ non-CpG methylation  PGC1α promoter 
Acharyya et al. (2010) Mouse myoblast cells TNFα (unspecified 
concentration) 
DNMT3B recruitment Inhibition of Notch-1 (transmembrane protein), 
attributed to Ezh2 (histone methyltransferase) 
and DNMT3B recruitment via NF-κB, resulting 
in hypermethylation 
Huang et al. (2012) IMR-90 (normal human lung fibroblast) IL-1β (10 ng∙ml-1) 
 
↑ DNMT3A expression 
↑ DNMT1 expression 
Effects of IL-1β blocked by aspirin 
  Aspirin (200 µM) ↓ DNMT3A expression  
Nakano et al. (2013) Fibroblast-like synoviocytes (RA patients) 
 
IL-1β (2 ng∙ml-1) 
 
↓ DNMT3A expression 
↓ DNMT1 expression 
 
  TNFα (50 ng∙ml-1) ↓ DNMT3A expression  
Dhar et al. (2013) Human coronary artery smooth muscle 
cells 
TNFα (100 ng∙ml-1)  
 
↑ SOCS3 expression at 24 hours 
TNFα activated NK-κB 
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  IGF-1 (100 ng∙ml-1) 
 
 ↑ SOCS3 expression at 24 hours 
IGF-1 phosphorylated STAT3 
  TNFα + IGF-1 ↑ DNMT1, DNMT3A, and 
DNMT3B expression vs control 
Knockdown of DNMT1 = ↑ SOCS3 
expression 
↑ SOCS3 PM 
↓ SOCS3 expression at 12 hours 
 
Prostaglandin E2     
Huang et al. (2012) Fibroblasts (fetal and adult) 
 
 
PGE2 (10-6 to 10-9 M i.e. 1 
µM to 1nM) 
↑ DNMT3A expression/activity GM ↑ at 48h (not 24h) 
↑ expression and activity of Sp1 and Sp3 
transcription factors 
 RAW macrophages PGE2 (10-6 to 10-9 M     
i.e. 1 µM to 1nM) 
↓ DNMT3A expression 
↓ DNMT1 expression 
 
Xia et al. (2012) CRC specimens PGE2  Positively correlated with DNMT1 
and DNMT3B 
 
 
 3 human CRC cell lines (unspecified) PGE2 (unspecified 
concentration) 
Direct upregulation of DNMT1 and 
DNMT3B  
 
 
 LS-174T (human colorectal carcinoma) 
cell line 
PGE2 (unspecified 
concentration) 
 ↑ PM and ↓ expression of CNR1, MGMT, 
CDKN2B, MLH1 
 ApcMin/+ mice PGE2 (unspecified 
concentration) 
↑ DNMT1 and DNMT3B 
expression in colonic tumour 
epithelial samples. 
↑ PM and ↓ expression of CNR1, MGMT, 
CDKN2B, MLH1 
 
  
166 
 
Caffeine/Ionomycin 
(Ca2+) 
    
Laye & Pedersen (2010) Vastus lateralis skeletal muscle 3 hours cycle @60% 
?̇?O2max  
50% ↓ DNMT3B mRNA  
 Proliferating myoblasts 
 
Ionomycin (0.1 µM) No change in DNMT3A or 
DNMT3B mRNA 
 
 
 
Differentiated myotubes Ionomycin (0.1 µM) ↓ DNMT3A and DNMT3B mRNA 
(~40%) 
 
Barrès et al. (2012) L6 myotubes (rat skeletal muscle) Caffeine (5mM) 
 
 ↓ PM of PGC1α, TFAM, MEF2A, CS, PDK4; ↑ 
mRNA of PGC1α, TFAM, MEF2A, CS, PDK4 
  H2O2 (1mM)  ↑ PM of TFAM, MEF2A, CS 
  Ionomycin (1 µM)  ↑ mRNA of PGC1α, TFAM, MEF2A; No 
change in PM 
 
Anti-Oxidants     
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Blaschke et al. (2013) Mouse embryonic stem cells Vitamin C (100 µg∙ml-1) ↑ TET activity 
TET1 binding is enriched near TSS 
of genes affected by treatment 
 
No change in TET and DNMT gene 
expression 
 
Glutathione does not change TET1 
activity 
Global ↑ in 5-hmC (lost after 3 days of 
withdrawal) 
Most methylated promoters gain 5-hmC at 12hrs 
and return to baseline by 72hrs 
 
5-mC is progressively lost at 12 and 72hrs (2-
fold ↓ PM at 61% of analysed promoters by 
72hrs) 
 
5-hmC gain and 5-mC loss occur at same 
genomic locations near TSS 
 
Attenuated increase in 5-hmC in TET1 knockout 
cells 
 
Vitamin C treatment does not affect 5-mC or 5-
hmC in TET1/2 double knockout cells 
Yin et al. (2013) TET-transfected HEK-293T (human 
embryonic kidney) cell line 
 
 
 
 
Ascorbic acid (various 
concentrations) 
↑ TET1 catalytic domain activity 5-hmC ↑ 4 (50 µM) and 7 (500 µM) fold 
5-fC ↑ 4.6 (50 µM) and 8.9 (500 µM) fold 
 
↑ in 5-hmC and 5-fC accompanied by ↓ in 5-mC 
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 Mouse embryonic stem cells    5-hmC ↑ 3.7 fold (100 µM over 24hrs) 
5-fC ↑ 10.6 fold 
 
5-caC ↑ 20 fold 
 
5-mC ↓ 13% after 1 day; 32-40% after 2-3 days 
 
No sig. change in TET1 expression, therefore 
AA influences the catalysis of TET 
 
5-hmC, 5-fC, and 5-caC barely detectable in 
TET1/2  double knockout cells 
 
↓ in 5-mC replicated in vivo (mouse 
liver/cerebrum) 
Minor et al. (2013) Mouse embryonic fibroblasts 
 
 
 
Ascorbate (various 
concentrations) 
TET Dose-dependent ↑ in 5-hmC (24hrs; 0-1000 µM) 
 
No change in TET expression (5-hmC still 
enhanced in TET-deficient cells) 
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 HEK-293T (human embryonic kidney 
cells – transformed with large T 
antigen)/HeLa cell line 
Ascorbate (various 
concentrations) 
 ↑ 5-hmC (10 µM) 
Contraction     
Lucas et al. (2012)  Mouse soleus muscle Ex vivo contraction  ↓ PM of PPARδ, PDK4, CS, PGC1α (at 30mins 
and 270mins post-contraction) 
 
↑ mRNA PPARδ, PDK4, CS, PGC1α (at 
180mins) 
Barrès et al. (2012) Mouse soleus muscle Ex vivo contraction   ↓ PM of PGC1α, PPARδ, PDK4, MYOD1, 
MEF2A @45 mins post-contraction 
 
↑ mRNA PGC1α, PPARδ, PDK4 @180 mins 
post-contraction 
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Study Population Activity Measurement/Tissue Results 
Habitual PA – Global 
Methylation 
    
Zhang et al. (2011) 131 men/women, >45 years, various 
ethnicities, no history of 
heart/kidney disease or cancer 
PA assessed over 4 days using 
accelerometry 
GM (LINE-1) in peripheral blood >30 minutes of PA per day = ↑ LINE-1 
methylation compared with those who 
performed <10 minutes per day 
Gomes et al. (2012) 126 men and women. Elderly (aged 
60-88) 
PA assessed by steps per day over 1 
week 
GM (Imprint Methylated DNA 
Quantification Kit) of peripheral 
blood leukocytes 
No sig. correlation between PA and GM 
Luttropp et al. (2013) 509 men/women, aged 70, healthy Self-reported weekly PA participation 
assessed 
GM (LUMA) in leukocytes GM significantly correlated with 
activity level (after adjustment for 
gender, SBP, DBP, LDL and HDL 
cholesterol, serum triglycerides, 
smoking status, and BMI) 
White et al. (2013) 647 women, aged 35-74, non-
Hispanic, sister diagnosed with BC 
PA (hours per week) retrospectively 
recalled for ages 5-12, 13-19 and 
previous 12 months 
GM (LINE-1) in peripheral blood PA levels above median for all 3 time 
periods = significantly ↑ GM vs. those 
below median 
Habitual PA – Gene-
Specific Methylation 
    
Coyle et al. (2007) 106 women without BC diagnosis, 
mean age = 43 years 
Interviewer-administered lifetime PA 
questionnaire 
PM of APC and RASSF1A genes in 
biopsied breast tissue using 
methylation-specific PCR 
Lifetime, previous 5 years, and previous 
year PA inversely correlated with PM 
of APC but not RASSF1A 
Slattery et al. (2007) 1154 colon cancer patients Recall of activity level for previous 
year, and 10/20 years ago 
Methylation-specific PCR of 
MINT1, MINT2, MINT31, p16 and 
hMLH1 following tumour biopsy 
No sig. correlation between PA and 
selected markers 
Appendix B – Summary of literature in section 1.6. 
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Yuasa et al. (2009) 106 male/female primary gastric 
carcinoma patients 
Self-administered pre-cancer PA 
history questionnaire 
Methylation-specific PCR of 6 
tumour-related genes; CDX2, 
BMP-2, p16, CACNA2D3, GATA-
5, ER following tumour biopsy 
PA inversely correlated with CACNA2D 
methylation 
Pirola et al. (2012) 
 
45 non-alcoholic fatty liver patients Questionnaire covering all forms of 
PA (hours per week) 
Methylation-specific PCR of MT-
ND6, MT-CO1 and D-loop genes 
in liver mitochondrial DNA 
Inverse correlation between PA and 
MT-ND6 methylation 
 
Ren et al. (2012) 237 female tai chi practitioners 
compared with 263 female 
beginners, aged 45-88 
Experienced practitioners defined as 
>3 years, while beginners had just 
enrolled in beginner classes 
Saliva DNA isolated from 
mouthwash, with methylation 
quantified at 60 CpG sites using 
Sequenom EpiTYPER platform  
Differential methylation of 6 CpG sites 
in the experienced, compared with 
beginner, group 
Zhang et al. (2012) 
 
 
165 men/women, aged 18-78, 
college commuters 
Block adult energy expenditure survey 
(assesses frequency and duration of 26 
activities within the past year) 
GM (LINE-1) and IL6 PM in 
leukocytes 
 
No association between PA and LINE-1 
methylation, or PA and IL6 PM 
 
Morabia et al. (2012) 
 
 Block adult energy expenditure survey 
(assesses frequency and duration of 26 
activities within the past year) 
GM (LINE-1) and IL6 PM in 
leukocytes 
 
Public transportation users did not have 
lower levels of LINE-1 methylation or 
IL6 PM vs car drivers 
Lott et al. (2013) 85 men/women, aged 22-70, 
schizophrenia diagnosis 
Questionnaire covering duration and 
intensity of PA over the week prior to 
the DNA sample being obtained 
Pyrosequencing used to analyse 2 
methylation sites of COMT-s 
promoter region in peripheral 
blood 
Significant negative correlation between 
COMT promoter methylation and PA in 
Val/Val homozygous patients 
Clarke-Harris et al. 
(2014) 
40 mixed-sex children, measured at 
5 and 14 years old 
Measured annually (7 consecutive 
days) by accelerometry 
PGC1α promoter CpG loci 
analysed by pyrosequencing of 
whole blood DNA 
No interaction between PA and 
methylation at several PGC1α promoter 
CpG loci, however, methylation at 4 
loci predicted adiposity independently 
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from gene or PA 
Shaw et al. (2014) 
[abstract] 
253 elderly white males, 137 elderly 
white females 
Self-reported PA energy expenditure 
assessed over 8 years 
Quantitative methylation-specific 
PCR of leukocytes 
Hypermethylation of TNF in those who 
increased PA energy expenditure by 
500 kcal or more per week. 
Hypomethylation of IL-10 in those who 
increased vs. those who decreased by 
500 kcal or more per week 
Acute Exercise      
Laye & Pedersen (2010) 
[abstract] 
8 healthy young men 3 hours of cycling at 60% ?̇?O2max Vastus lateralis skeletal muscle 
biopsy and expression (PCR) of 
DNMT3A and DNMT3B 
DNMT3B mRNA decreased by 50% 
immediately post-exercise 
Barrès et al. (2012) 14 sedentary, healthy men/women Cycle ergometer ?̇?O2peak test GM (MeDIP) of vastus lateralis 
skeletal muscle (PM of selected 
genes also quantified) 
GM reduced following the acute 
exercise bout. PM decreased at PGC1α, 
PDK4 and PPARδ. No change in PM of 
MEF2A or MYoD1 
Robson-Ansley et al. 
(2014) 
8 healthy, trained men 120 minutes of treadmill running at 
60% v?̇?O2max followed by 5km time 
trial 
HumanMethylation27 Beadchip 
analysis of PBMC samples 
GM and CpG site-specific methylation 
remained unchanged. IL-6 protein 
levels correlated with CpG methylation 
at 11 CpG sites  
Lane et al. (2015) 7 trained male cyclists Evening session of HIIT(8x5min 
@82.5% PPO, 1min active recovery), 
followed by 120 mins (steady state 
@50% PPO) in the morning (having 
eaten either 8 g∙kg-1 BM of CHO 
before the session and slept with 
without eating, or 4 g∙kg-1 BM of 
CHO before the session and 4 g∙kg-1 
Vastus lateralis skeletal muscle 
biopsy 
 
Bisulfite converted DNA amplified 
by PCR then pyrosequenced 
(Qiagen Q24 Advanced Pyromark 
Following 120min morning session, PM 
↑ 4h post-120min in COX4I1 (vs. post-
120min/fasted group only) and FABP3 
(vs pre-120min/both groups) 
 
Only FABP3 mRNA ↑ post-120min vs 
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BM of CHO before sleeping) 
 
System) rest 
 
PM of PPARδ increased only in fasted 
group vs baseline 
 
mRNA ↑ 4h post-120min vs baseline 
and post-120min in fed group only 
Zimmer et al. (2015) 14 cancer survivors (male and 
female; breast/colon/prostate) and 
14 controls 
Half-marathon Global methylation of NK cells 
using primary monoclonal 
antibodies 
No change 
Exercise Interventions     
Alibegovic et al. (2010) 10 young, healthy men 9 days bed rest followed 4 weeks of 
retraining (cycle ergometry for 30 
mins per day, 6 days per week at 70% 
?̇?O2max) 
Sequencing PCR of vastus lateralis 
skeletal muscle 
Sig. hypermethylation of 1 (of 3) CpG 
site in PGC1α promoter following 9 
days bed rest 
 
PGC1α methylation not fully restored 
to baseline following 4 weeks retraining 
 
PGC1α mRNA ↓ following bed rest, 
which did not return to baseline 
following retraining 
Nakajima et al. (2010) 
 
 
 
162 controls (aged 40-87), 274 
exercise group (aged 41-86), 37 
young controls (aged 18-22), 
healthy, Japanese 
6 months of several sets of 3 minute 
low-intensity walking at 40% of 
?̇?O2peak, followed by 3 minutes of high 
intensity walking above 70% ?̇?O2peak, 
at least 2 days per week 
Peripheral blood ASC gene 
methylation (pyrosequencing) 
 
ASC methylation decreased with age, 
while the exercise intervention 
attenuated this age related decrease 
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Tracked by accelerometry 
Zhang et al. (2015) 6 control, 7 exercise 
 
 
 
 
 
20 exercise subjects 
6 months of several sets of 3 minute 
low-intensity walking at 40% of 
?̇?O2peak, followed by 3 minutes of high 
intensity walking above 70% ?̇?O2peak, 
at least 2 days per week 
 
Tracked by accelerometry 
 
Genome-wide microarray assay 
(Agilent Human CpG Island Array 
244K) of peripheral blood 
 
 
 
Pyrosequencing (Pyromark Q24ID) 
of peripheral blood 
Over 40 differentially methylated genes 
after training, including NFκB2 
 
 
 
 
Confirmed genome-wide results of 
NFκB2. Methylation increased at probe 
12, CpG sites 1, 5, and 6. Probe 5 
(several important transcription factor 
binding sites) CpG sites 1, 2, and 5 
increased in methylation 
Zeng et al. (2012) 12 women (6 = exercise 
intervention, 6 = control), BC 
diagnosis 
6 months of 150 minutes of moderate 
intensity treadmill exercise 
HumanMethylation27 Beadchip of 
peripheral blood leukocytes/tumour 
samples 
Methylation of 43 genes were altered, 6 
were associated with overall survival 
(IFT172, EPS15, GLUD1, PPP2R3A, 
MSX1, L3MBTL1). Concordance 
between blood and tumour samples 
Nitert et al. (2012) 15 men with a first-degree FH of 
T2DM, and 13 men without 
6 months of 1 hour of spinning and 
2x1 hour aerobic class per week 
Genome wide analysis (MeDIP) of 
vastus lateralis muscle biopsy 
Hypomethylation of 115 genes, and 
hypermethylation of 19 genes 
(independent of FH) - those with a FH, 
compared with no FH, had 38 
differentially methylated genes (18↓, 
20↑), in contrast to 65 before the 
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intervention 
Bryan et al. (2013) 64 sedentary men/women, mean age 
= 29 years 
Psychologically tailored materials 
designed to increase PA participation 
over 12 months 
HumanMethylation27 Beadchip of 
saliva samples 
Post-intervention, self-reported PA 
score inversely correlated with 
methylation (after controlling for age, 
BMI and baseline ?̇?O2max) 
Rӧnn et al. (2013) 15 men with a first-degree FH of 
T2DM, and 16 men without 
6 months of 1 hour of spinning and 
2x1 hour aerobic class per week 
HumanMethylation450 Beadchip 
of subcutaneous adipose tissue of 
the right thigh  
No difference in DNAme. at baseline 
between groups. Changes in 
methylation of 24 CpG sites in 18 
candidate obesity genes, and 45 CpG 
sites in 21 candidate T2DM genes 
Duggan et al. (2014) Postmenopausal, healthy, 
overweight women aged 50-75 (70 = 
exercise intervention, 59 = control) 
12 months of 3 supervised aerobic 
sessions (treadmill walking, cycling) 
per week, with encouragement to 
complete at least 2 more sessions at 
home 
GM (LINE-1) of leukocytes No sig. change in GM 
Lindholm et al. (2014) 23 young participants (12 men, 11 
women), not regularly performing 
intense exercise 
3 months of one-legged knee 
extension exercise (4 sessions per 
week, 45 mins per session) 
GM (LUMA) and 
HumanMethylation450 Beadchip 
of vastus lateralis skeletal muscle 
Validated using bisulfite 
pyrosequencing 
LUMA revealed no global changes in 
GM. Training caused significant 
methylation changes at 4919 sites (839 
changed by at least 5%) of 4076 
differentially expressed genes 
 
Rowlands et al. (2014) 18 obese, sedentary, middle-aged 
Polynesian men (5) and women (13) 
with T2DM 
16 weeks of training, 3 days per week 
 
Endurance group: 40-60 minutes of 
cycle ergometer exercise (progressing 
from 65 to 85% of HR reserve during 
the 1st 2 weeks 
DNAme:HumanMethylation450 
Beadchip of vastus lateralis 
skeletal muscle 
 
miRNA: Affymetrix GeneChips 
2.0 and TaqMan miRNA assay 
Both training modalities caused global 
hypomethylation, with a number gene-
specific DNAme. changes 
 
Endurance:  
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Resistance group: 2-3 sets, 6-8 reps of 
8 exercises using machine weights to 
fatigue (loads increased by 5% when 
participants could perform 10 reps) 
 
 
↓ PM NRF1  
↑ PM FASN 
↓ TSS methylation SLC27A4 
↓ GBM PFKFB3, HDAC4, GSK3A 
 
Resistance:  
↓ upstream CpGi methylation SLC2A4 
↓ genomic region methylation ACSl1, 
LRP1, LRP10, SLC27A1 
Denham et al. (2015b) 26 healthy young men not already 
engaging in intense training 
4 weeks, 3x per week, 30sec sprints 
(athletics track) - sessions increased 
from 3/4/5 sprints in week 1 to 6/7/8 
sprints in week 4 
HumanMethylation450 Beadchip 
of whole blood leukocytes 
Hypermethylation at 81.576 CpG sites 
 
Hypomethylation at 124,411 CpG sites. 
19 sites exhibited a ≥20% change (8↑, 
11↓)  
 
↓ PM of EGF and ↓ mRNA 
 
↓ PM of  UNG and ↑ mRNA 
 
Methylation changes at various sites in 
miR21 and miR210 (the former did not 
remain sig. after FDR), with ↑ and ↓ 
mRNA, respectively 
Denham et al. (2015a) 24 healthy young men not already 
engaging in intense training (13 
cases, 11 control) 
3 months (one human 
spermatogenesis cycle), 2x per week, 
30sec sprints (athletics track) - 
GM determined with ELISA, 
followed by 
HumanMethylation450 Beadchip 
↓ GM (-6.63%)  
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sessions increased from 3 sprints in 
week 1 to 6 sprints in week 12 
of sperm DNA 7,509 CpG islands in 4,602 genes had 
sig. methylation changes 
 
16 paternally imprinted genes were 
differentially methylated after training 
Rodent Studies     
Gomez-Pinilla et al. 
(2011) 
Adult male Sprague-Dawley rats (~3 
months old) 
Exercising rats given access to a 
running wheel for 7 days. 
Bisulfite conversion and 
sequencing of hippocampal brain 
tissue 
Methylation assessed in 230bp 
region from -148 to +82 of BDNF 
exon IV promoter (14 CpG sites) 
-148bp (associated with MeCP2 
binding) was sig. ↓ methylated 
 
BDNF mRNA and protein ↑ by 41% 
and 30%, respectively 
 
Abel & Rissman (2013) 10 exercising 46 day old C57BL/6J 
mice, 10 sedentary 
10 mice were given access to a freely 
moving wheel for 7 days. 10 
sedentary 
Expression (PCR) of DNMT1, 
DNMT3A and DNMT3B in 
hippocampus and cerebellum 
DNMT1 showed a ↓ in expression of 
19% and 14% in cerebellum and 
hippocampus 
 
DNMT3A and DNMT3B expression 
decreased by 17% and 19% in 
hippocampus 
Elsner et al. (2013) Male Wistar rats of different ages; 3 
and 20 months old 
Running on adapted motorised 
treadmill at 60% of ?̇?O2max (acute 
bout: 20 mins; chronic: 2 weeks of 20 
mins per day) 
DNMT1 and DNMT3B ELISAs of 
hippocampal brain tissue 
At baseline, 25% lower DNMT1 in 
aged vs young. No difference in 
DNMT3B 
 
Chronic exercise didn’t alter either 
DNMT in either group 
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Acutely, 30%↓ 1-h post in DNMT3B in 
young group compared with young 
sedentary control sedentary, returning to 
baseline by 18-h 
 
45%↓ 1-h post in DNMT1 in young 
group compared with young sedentary 
control sedentary, returning to baseline 
by 18-h 
 
No acute changes in either DNMT in 
aged group 
Carter et al. (2015) 
[abstract] 
6 and 35-month old Fischer 34BN 
rats  
Contractile activity (CA) Tibialis anterior skeletal muscle. 
No details on methods for 
methylation analysis 
↑ methylated DNA and 50% ↓ PGC-1α 
transcription in aged vs young muscle 
(at rest) 
 
1.9x ↑ in DNMT3B protein in aged 
Following CA, PGC-1α transcription ↑ 
2.5x in young muscle, but ↓ 7x in aged 
Kanzleiter et al. (2015) 24 exercising 9 week old male 
C57BL/6J mice, 10 sedentary 
Progressive motorised treadmill 
protocol from 30 to 50 mins per day, 5 
days per week, 4 weeks 
Reduced representation bisulfite 
sequencing (Illumina HiSeq2000) 
of genomic DNA isolated from 
quadriceps muscle (n=3/group) 
 
Transcriptional changes also 
quantified by Agilent 4x44k whole 
genome microarray and validated 
by PCR (n=6/group) 
3692 differentially methylated CpGs 
(5% or > change), distributed among 
2762 promoter regions 
 
3020 differentially expressed genes, 361 
(479 CpGs) associated with differential 
methylation. 66 hypomethylated genes 
= ↑ expression, 134 hypermethylated 
genes = ↓ expression 
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MyoD and myogenin (plus 4 more) 
transcription factor binding sites were 
enriched  
Lochmann et al. (2015) 6 exercising 3 month old female 
C57BL/KaLwRij mice, 6 sedentary 
Rotarod training performed over 15 
min, with 3.0cm rotarod increasing in 
speed from 15-35 RPM. After 1 days 
rest, an acute bout was performed at 
35-45 RPM for 1 hour 
Gene expression (PCR) of PGC-1α 
(-a, -b, -c  transcripts, or total) in 
quadriceps muscle 
 
Tet-assisted bisulfite sequencing 
also performed 
Total, ‘-b’, and ‘-c’ (promoter B), but 
not ‘-a’ (promoter A) PGC-1α ↑ 
following acute bout 
 
DNA hydroxymethylation correlated to 
↑ mRNA from promoter A, but 
DNAme. appeared to play no role in 
exercise-induced promoter B activation 
Rodrigues et al. (2015) 4-6 male Wistar rats in each group: 
1) stress group; 2) exercise and 
stress group; 3) control group 
Exercise consisted of stimuli/task-free 
swimming. 60 mins per session, 5 
days per week, 4 weeks 
 
Imprint Methylated DNA 
quantification kit of genomic DNA 
isolated from brain (hypothalamus, 
frontal cortex region, PAG, 
hippocampus) 
 
Expression (PCR) of DNMT1 and 
BDNF 
No change in GM with exercise + stress 
in any tissue 
 
Stress alone caused a decrease in GM in 
hippocampus, cortex, and PAG 
compared with control 
 
↓ DNMT1 expression was observed in 
the cortex following exercise + stress 
Kashimoto et al. (2016) 4 groups of 4-10 52 day old male 
Wistar rats (exercise, stress, exercise 
and stress, or control) 
Exercise consisted of 60 mins 
swimming per day, 5 days per week 
(stimulus or task-free) from 53rd to 
78th day of life 
 
 
Imprint Methylated DNA 
quantification kit of genomic DNA 
isolated from brain (hypothalamus, 
frontal cortex region, 
hippocampus) 
Expression (PCR) of DNMT1 gene 
Exercise ↑ GM in hypothalamus.  
 
DNMT1 expression was ↓ in 
hippocampus and hypothalamus in 
exercise and stress group, compared to 
just stress group 
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Appendix C – Informed Consent Form 
 
 
                                                                    
 
INFORMED CONSENT FORM 
Title:  
Principal Investigator: Steven Horsburgh  
 
 
I have carefully read and understood the Participant Information Sheet.  
 
I have had an opportunity to ask questions and discuss this study and I have received satisfactory answers.  
 
I understand I am free to withdraw from the study at any time, without having to give a reason for withdrawing, and 
without prejudice. 
 
 
I agree to take part in this study.  
 
I would like to receive feedback on the overall results of the study at the email address given below.   
 
Email address…………………………………………………………………… 
 
 
 
 
 
Signature of participant.......................................................    Date.....……………….. 
 
(NAME IN BLOCK LETTERS)....................................................………………………………………….. 
 Signature of Parent / Guardian in the case of a minor  
......................................................................................... 
 
 
Signature of researcher.......................................................    Date.....……………….. 
 
(NAME IN BLOCK LETTERS)....................................................…………………………………………. 
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FOR USE WHEN TISSUE IS BEING REMOVED AND STORED 
 
Title:  
 
Principle Investigator: Steven Horsburgh  
 
Participant ID: 
 
 
I agree that the following tissue or other bodily material may be taken and used for the study:  
 
Tissue/Bodily material Purpose Removal Method 
Venous Blood DNA methyltransferase 
DNA methylation 
Venepuncture  
 
I understand that if the material is required for use in any other way than that explained to me, then my consent to this will be 
specifically sought. I understand that I will not receive specific feedback from any assessment conducted on my samples, but should 
any kind of abnormality be discovered then the investigator will contact me.  
 
I understand that the University may store this tissue in a Licensed Tissue Bank only for the duration of the study, it will then be 
destroyed. 
 
Method of disposal:    
Clinical Waste              
Other                             
If other please specify........................................................... 
 
I consent to the University distributing this tissue to partners in this research study, outside of the University, for further testing 
(please tick the box if you agree).                                                                     
                                                      
 
Signature of participant.......................................................    Date.....……………….. 
 
(NAME IN BLOCK LETTERS)....................................................………………………………………….. 
 Signature of Parent / Guardian in the case of a minor  
......................................................................................... 
 
 
Signature of researcher.......................................................    Date.....……………….. 
 
(NAME IN BLOCK LETTERS)....................................................…………………………………………. 
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Appendix D – Methyl-donor Food Frequency Questionnaire 
Supplementary material 1 Food-Frequency Questionnaire 
 
Name:.................................. 
Date:        /        / 
In this food-frequency questionnaire we inquire about your food habits of the past 3 months. In the 
following table a variety of food products (food groups) is listed. Please describe (as exact as possible) how 
often you eat or drink the listed products and indicate the average daily portion. Consider also the meals 
taken away from home. 
How often (frequency)? 
In the column with the heading ‘How often do you consume the following product?’ there are 6 possible 
answers. 
- Never or less than once per month 
- 1-3 days per month 
- 1 day per week 
- 2-4 days per week 
- 5-6 days per week 
- Every day 
Indicate your choice by filling in the circle near the answer that is most suitable for you. 
 
How much?  
In the column with the heading 'What is the average portion per day?' 3 to 5 portion size options are given. 
In the column with the heading 'Example portion sizes', a number of directive weights and measures are 
given. These can help you to quantify the average portion sizes. Indicate your choice by filling in the circle 
near the answer that is most suitable for you. 
 
Which type do you usually use? 
In the last column you should indicate for some food products (food groups) the type you usually use. Please 
choose only one answer, unless options are equally frequent. In the latter case you may indicate more 
options. 
 
In case you would fill in the wrong option, you may cross it out and color another option. Please indicate in 
such case the right answer with an arrow. Make sure you always fill in something, even when you consume a 
product rarely or never. In such case, choose the option 'Never or less than once per month' without 
indicating a portion size or type. 
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Food groups How often do you 
consume the 
following 
product? 
What is the 
average 
portion per 
day? 
Example portion sizes Which type do you 
usually use? 
Coffee/tea ○ Never or less 
than once per 
month 
○ 1-3 time per 
month 
○ 1 time per week 
○ 2-4 days per 
week 
○ 5-6 days per 
week 
○ Every day 
○ 125 mL or 
less 
○ 125 - 250 mL 
○ 250 - 375 mL 
○ 375 - 500 mL 
○ 500 mL or 
more 
 
1 cup = 125 mL 
1 beaker  = 225 mL 
○ Coffee 
○ Tea 
 
Beer/wine ○ Never or less 
than once per 
month 
○ 1-3 time per 
month 
○ 1 time per week 
○ 2-4 days per 
week 
○ 5-6 days per 
week 
○ Every day 
○ 200 mL or 
less 
○ 200 - 400 mL 
○ 400 - 600 mL 
○ 600 - 800 mL 
○ 800 mL or 
more 
 
 1 bottle/glass beer                = 
250 or 330 mL 
1 can = 330 or          500 mL 
1 glass of wine      = 125 mL 
 
○ Alcohol free beer 
○ Regular beer       ( pils, 
Palm,...) or strong beer  
(Duvel, trapist,...) 
○ Wine 
Soup ○ Never or less 
than once per 
month 
○ 1-3 time per 
month 
○ 1 time per week 
○ 2-4 days per 
week 
○ 5-6 days per 
week 
○ Every day 
○ 200 mL or 
less 
○ 200 - 400 mL 
○ 400 - 600 mL 
○ 600 mL or 
more 
 
1 bowl = 250 mL 
1 beaker = 225 mL 
 
 
Fruit juice ○ Never or less 
than once per 
month 
○ 1-3 time per 
month 
○ 1 time per week 
○ 2-4 days per 
week 
○ 5-6 days per 
week 
○ Every day 
○ 150 mL or 
less 
○ 150 - 300 mL 
○ 300 - 450 mL 
○ 450 mL or 
more 
 
1 glass = 150 mL 
1 carton = 200 mL 
1 bottle (Looza)              = 200 
mL 
 
○ Orange juice 
○ Grapefruit juice 
○ Other 
 
Vegetable juice 
 
 
 
○ Never or less 
than once per 
month 
○ 1-3 time per 
month 
○ 1 time per week 
○ 2-4 days per 
week 
○ 5-6 days per 
week 
○ Every day 
○ 150 mL or 
less 
○ 150 - 300 mL 
○ 300 - 450 mL 
○ 450 mL or 
more 
 
1 glass = 150 mL 
1 carton (V8)               = 330 
mL 
1 bottle (Looza)     = 200 mL 
 
 
Softdrinks (cola, 
lemonade,...) 
○ Never or less 
than once per 
month 
○ 1-3 time per 
month 
○ 1 time per week 
○ 2-4 days per 
week 
○ 5-6 days per 
week 
○ Every day 
 
 
 
 
 
○ 150 mL or 
less 
○ 150 - 300 mL 
○ 300 - 450 mL 
○ 450 mL or 
more 
1 glass = 150 mL 
1 can = 330 mL          1 bottle  
= 200 mL 
 
○ Cola 
○ Other 
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Soy milk/ drinks and yoghurt 
drinks 
(Dan ’Up, Fristi) 
○ Never or less 
than once per 
month 
○ 1-3 time per 
month 
○ 1 time per week 
○ 2-4 days per 
week 
○ 5-6 days per 
week 
○ Every day 
○ 125 mL or 
less 
○ 125 - 250 mL 
○ 250 - 375 mL 
○ 375 mL or 
more 
 
1 glass = 150 mL 
1 beaker = 225 mL 
1 soy drink            = 250 mL               
1 bottle (Dan’Up)                  = 
600 mL 
 
○ Soy milk/  soy drinks 
○ Yoghurt drinks 
Milk/    chocolate milk ○ Never or less 
than once per 
month 
○ 1-3 time per 
month 
○ 1 time per week 
○ 2-4 days per 
week 
○ 5-6 days per 
week 
○ Every day 
○ 125 mL or 
less 
○ 125 - 250 mL 
○ 250 - 375 mL 
○ 375 mL or 
more 
 
1 cup = 125 mL              1 
beaker = 225 mL 
1 bowl = 250 mL 
1 glass = 150 mL 
1 carton = 200 mL 
 
 
Yogurt, cottage cheese, white 
cheese, and curd 
○ Never or less 
than once per 
month 
○ 1-3 time per 
month 
○ 1 time per week 
○ 2-4 days per 
week 
○ 5-6 days per 
week 
○ Every day 
○ 125 g or less 
○ 125 - 250 g 
○ 250 - 375 g 
○ 375 g or more 
 
1 pot yoghurt         = 125 g 
1 pot cottage cheese = 200 g 
1 cup = 125 g 
1 dish = 150 g             1 bowl 
= 250 g 
○ Yogurt 
○ Yogurt with fruit 
○ Cottage cheese/ white 
cheese/curd 
 
Eggs ○ Never or less 
than once per 
month 
○ 1-3 time per 
month 
○ 1 time per week 
○ 2-4 days per 
week 
○ 5-6 days per 
week 
○ Every day 
○ 1 piece or less 
○ 2 pieces 
○ 3 pieces or 
more 
 
  
Cheese spread  (type 
Philadelphia) and melted 
cheese/cheese spread (Kiri, 
Ziz,...) 
○ Never or less 
than once per 
month 
○ 1-3 time per 
month 
○ 1 time per week 
○ 2-4 days per 
week 
○ 5-6 days per 
week 
○ Every day 
○ 15 g or less 
○ 15 - 30 g 
○ 30 - 45 g 
○ 45 g or more 
15 g per slice of a big bread 
10 g per slice of a small bread 
○ Cheese spread type 
Philadelphia 
○ Melted cheese/cheese 
spread 
 
Feta, goat cheese, mozzarella, 
and Parmesan cheese 
○ Never or less 
than once per 
month 
○ 1-3 time per 
month 
○ 1 time per week 
○ 2-4 days per 
week 
○ 5-6 days per 
week 
○ Every day 
○ 15 g or less 
○ 15 - 30 g 
○ 30 - 45 g 
○ 45 g or more 
 
15 g goat cheese per slice of a 
big bread 
1 small block of feta = 5 g 
1 Mozzarella ball        = 125 g 
1 tablespoon of  grated 
Parmesan    = 10 g 
 
 
 
 
 
○ Feta/goat cheese 
○ Mozzarella/ Parmesan 
 
Other cheese (Brie, 
Camembert, Roquefort) 
○ Never or less 
than once per 
month 
○ 1-3 time per 
month 
○ 1 time per week 
○ 2-4 days per 
week 
○ 15 g or less 
○ 15 - 30 g 
○ 30 - 45 g 
○ 45 g or more 
 
15 g per slice of a big bread 
10 g per slice of a small bread 
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○ 5-6 days per 
week 
○ Every day 
Hard cheese/ semi-hard 
cheese    (Gouda, 
Emmentaler, Cheddar, 
Gruyère,...) 
○ Never or less 
than once per 
month 
○ 1-3 time per 
month 
○ 1 time per week 
○ 2-4 days per 
week 
○ 5-6 days per 
week 
○ Every day 
○ 20 g or less 
○ 20 - 40 g 
○ 40 - 60 g 
○ 60 g or more 
 
1 slice of cheese (10x10cm) = 
25 g 
 
 
Pâté/liver sausage ○ Never or less 
than once per 
month 
○ 1-3 time per 
month 
○ 1 time per week 
○ 2-4 days per 
week 
○ 5-6 days per 
week 
○ Every day 
○ 20 g or less 
○ 20 - 40 g 
○ 40 - 60 g 
○ 60 g or more 
 
20 g pâté per slice of bread 
 
 
Other meat products (ham, 
salami, chicken ham,...) 
○ Never or less 
than once per 
month 
○ 1-3 time per 
month 
○ 1 time per week 
○ 2-4 days per 
week 
○ 5-6 days per 
week 
○ Every day 
○ 20 g or less 
○ 20 - 40 g 
○ 40 - 60 g 
○ 60 g or more 
 
15 g  per slice of bread 
 
 
Canned fish, smoked fish, 
and salted fish             
○ Never or less 
than once per 
month 
○ 1-3 time per 
month 
○ 1 time per week 
○ 2-4 days per 
week 
○ 5-6 days per 
week 
○ Every day 
○ 50 g or less 
○ 50 - 100 g 
○ 100 - 150 g 
○ 150 g or more 
 
1 spoon of canned 
tuna/salmon = 25 g 
1 slice of smoked salmon = 30 
g 
1 young herring     = 50g 
1 drained can of  mackerel/ 
sardines = 120 g 
 
Breakfast cereals: muesli 
(normal and crispy) and 
oatmeal 
○ Never or less 
than once per 
month 
○ 1-3 time per 
month 
○ 1 time per week 
○ 2-4 days per 
week 
○ 5-6 days per 
week 
○ Every day 
 
○ 30 g or less 
○ 30 - 60 g 
○ 60 - 90 g 
○ 90 g or more 
 
1 bowl = 40 g 
 
 
Breakfast cereals: All Bran 
(Kellogs) and wheat bran 
○ Never or less 
than once per 
month 
○ 1-3 time per 
month 
○ 1 time per week 
○ 2-4 days per 
week 
○ 5-6 days per 
week 
○ Every day 
○ 30 g or less 
○ 30 - 60 g 
○ 60 - 90 g 
○ 90 g or more 
 
1 bowl = 40 g 
 
○ All Bran 
○ Wheat Bran 
 
Breakfast cereals: Special K 
and others (Type Smaks, 
Honey Pops, Frosties) 
○ Never or less 
than once per 
month 
○ 1-3 time per 
month 
○ 1 time per week 
○ 2-4 days per 
○ 30 g or less 
○ 30 - 60 g 
○ 60 - 90 g 
○ 90 g or more 
 
1 bowl = 40 g 
 
○ Special K 
○ Others 
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week 
○ 5-6 days per 
week 
○ Every day 
Rusk, crisp bread, and rice 
wafer 
○ Never or less 
than once per 
month 
○ 1-3 time per 
month 
○ 1 time per week 
○ 2-4 days per 
week 
○ 5-6 days per 
week 
○ Every day 
○ 10 g or less 
○ 10 - 20 g 
○ 20 - 30 g 
○ 30 g or more 
 
1 piece = 8 g 
 
 
Fantasy bread (sugar bread, 
raisin bread, brioche) and 
Danish pastry 
○ Never or less 
than once per 
month 
○ 1-3 time per 
month 
○ 1 time per week 
○ 2-4 days per 
week 
○ 5-6 days per 
week 
○ Every day 
○ 50 g or less 
○ 50 -  100 g 
○ 100 -  150 g 
○ 150 g or more 
 
Croissant = 50 g 
1 Danish pastry      = 100 g 
1 slice of bread       = 25 g 
 
○ Fantasy bread 
○ Danish pastry 
 
Types of white bread (bread 
roll, baguette) and yeast 
bread 
○ Never or less 
than once per 
month 
○ 1-3 time per 
month 
○ 1 time per week 
○ 2-4 days per 
week 
○ 5-6 days per 
week 
○ Every day 
○ 60 g or less 
○ 60 -  120 g 
○ 120 -  180 g 
○ 180 -  210 g 
○ 210 g or more 
½ baguette = 120 g 
1 slice of a big bread = 30 g 
1 slice of a small bread = 20 g 
1 slice of yeast bread = 45 g 
 
Types of brown bread (whole 
grain, multigrain, rye, brown 
baguette) 
○ Never or less 
than once per 
month 
○ 1-3 time per 
month 
○ 1 time per week 
○ 2-4 days per 
week 
○ 5-6 days per 
week 
○ Every day 
○ 60 g or less 
○ 60 -  120 g 
○ 120 -  180 g 
○ 180 -  210 g 
○ 210 g or more 
 
½ baguette = 120 g 
1 slice of a big bread = 30 g 
1 slice of a small bread = 20 g 
 
Dried fruit ○ Never or less 
than once per 
month 
○ 1-3 time per 
month 
○ 1 time per week 
○ 2-4 days per 
week 
○ 5-6 days per 
week 
○ Every day 
○ 15 g or less 
○ 15 - 30 g 
○ 30 - 45 g 
○ 45 g or more 
1 prune, apricot, date = 8 g 
1 tablespoon raisins        = 12 
g 
 
Orange, mandarin, grapefruit, 
kiwi, strawberries, and 
banana 
○ Never or less 
than once per 
month 
○ 1-3 time per 
month 
○ 1 time per week 
○ 2-4 days per 
week 
○ 5-6 days per 
week 
○ Every day 
○ 100 g or less 
○ 100 - 200 g 
○ 200 - 300 g 
○ 300 g or more 
 
 
1 mandarin = 60 g 
1 kiwi = 75 g 
1 banana, orange    = 130 g 
1 grapefruit           = 210 g 
1 strawberry = 15g 
○ Orange, mandarin, and 
grapefruit 
○ Kiwi 
○ Banana 
○ Strawberry 
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Chocolate ○ Never or less 
than once per 
month 
○ 1-3 time per 
month 
○ 1 time per week 
○ 2-4 days per 
week 
○ 5-6 days per 
week 
○ Every day 
○ 25 g or less 
○ 25 -  50 g 
○ 50 -  75 g 
○ 75 g or more 
 
1 Mignonette          = 10 g 
1 individual bar of chocolate = 
50g 
1 bar of a big package = 25g 
Easter egg or figure in 
chocolate  = 50 g 
 
Salty snacks (crisps, tortillas, 
salted biscuits) 
○ Never or less 
than once per 
month 
○ 1-3 time per 
month 
○ 1 time per week 
○ 2-4 days per 
week 
○ 5-6 days per 
week 
○ Every day 
○ 20 g or less 
○ 20 -  40 g 
○ 40 -  60 g 
○ 60 g or more 
 
1 small packet of crisps  = 30 
g 
1 Tuc biscuit = 3 g 
 
○ Crisps/tortilla 
○ Salted biscuits 
 
Nuts/seeds en  nut-seed-paste  
(peanut butter and sesame 
paste) 
○ Never or less 
than once per 
month 
○ 1-3 time per 
month 
○ 1 time per week 
○ 2-4 days per 
week 
○ 5-6 days per 
week 
○ Every day 
○ 15 g or less 
○ 15 -  30 g 
○ 30 -  45 g 
○ 45 g or more 
 
 
 
10 cashews = 20 g 
1 tablespoon nuts 
 = 25g 
1 tablespoon peanut butter         
= 15 g 
 
 
Olives en sundried tomatoes ○ Never or less 
than once per 
month 
○ 1-3 time per 
month 
○ 1 time per week 
○ 2-4 days per 
week 
○ 5-6 days per 
week 
○ Every day 
○ 15 g or less 
○ 15 - 30 g 
○ 30 -45 g 
○ 45 g or more 
5 olives = 20 g 
1 sundried tomato = 12 g 
○ Olives 
○ Sundried tomatoes 
Cereal bar, granola bar, dry 
biscuits and biscuits with 
chocolate 
○ Never or less 
than once per 
month 
○ 1-3 time per 
month 
○ 1 time per week 
○ 2-4 days per 
week 
○ 5-6 days per 
week 
○ Every day 
 
 
 
 
 
 
 
○ 20 g or less 
○ 20 -  40 g 
○ 40 -  60 g 
○ 60 g or more 
 
1 Special K bar      =  20 g 
1 petit beurre biscuit = 13 g 
1 Evergreen cookie       = 40 g 
1 chocolate chip cookie = 20 g 
○ Cereal bar, granola bar 
○ Biscuits without 
chocolate 
○ Biscuits with chocolate 
 
Cake/muffin ○ Never or less 
than once per 
month 
○ 1-3 time per 
month 
○ 1 time per week 
○ 2-4 days per 
week 
○ 5-6 days per 
week 
○ Every day 
○ 20 g or less 
○ 20 -  40 g 
○ 40 -  60 g 
○ 60 g or more 
 
1 slice of cake       = 30 g 
1 cupcake = 30 g 
1 muffin = 75 g 
 
○ Cake 
○ Muffin 
 
Pancakes ○ Never or less 
than once per 
month 
○ 1-3 time per 
○ 60 g or less 
○ 60 -  120 g 
○ 120 -  240 g 
○ 240 g or more 
1 pancake = 60 g 
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month 
○ 1 time per week 
○ 2-4 days per 
week 
○ 5-6 days per 
week 
○ Every day 
 
Potatoes (cooked, steamed, 
baked, mashed...) 
○ Never or less 
than once per 
month 
○ 1-3 time per 
month 
○ 1 time per week 
○ 2-4 days per 
week 
○ 5-6 days per 
week 
○ Every day 
○ 75 g or less 
○ 75 -  150 g 
○ 150 -  225 g 
○ 225 -  300 g 
○ 300 g or more 
 
1 cooked potato     = 50 g 
1 tablespoon of mashed 
potatoes     =  50 g 
20 French fries or 3-4 
croquettes       = 100 g 
 
Rice and other grains 
(bulgur, quinoa, couscous) 
○ Never or less 
than once per 
month 
○ 1-3 time per 
month 
○ 1 time per week 
○ 2-4 days per 
week 
○ 5-6 days per 
week 
○ Every day 
○ 25 g 
uncooked or 
less 
= 62 g  cooked 
or less 
○ 25-50 g 
uncooked 
= 62 -125 g 
cooked 
○ 50 -75 g 
uncooked 
= 125 - 187 g 
cooked 
○ 75 - 100 g 
uncooked 
= 187-250 g 
cooked 
○ 100 g 
uncooked or 
more 
= 250 g cooked 
or more 
60 g uncooked rice = 150 g 
cooked rice 
 
1 tablespoon cooked rice = 25 
g 
 
1 bag of rice for 2 persons  = 
125 g uncooked rice 
○ White rice 
○ Brown rice 
○ Other grains 
 
Pasta (penne, spaghetti ,...) ○ Never or less 
than once per 
month 
○ 1-3 time per 
month 
○ 1 time per week 
○ 2-4 days per 
week 
○ 5-6 days per 
week 
○ Every day 
○ 40 g 
uncooked or 
less 
= 100 g  cooked 
or less 
○ 40 - 80 g 
uncooked 
= 100 - 200 g 
cooked 
○ 80 - 120 g 
uncooked 
= 200 - 300 g 
cooked 
○ 120 - 160 g 
uncooked 
= 300 - 400 g 
cooked 
○ 160 g  
uncooked or 
more 
= 400 g cooked 
or more 
50 g uncooked pasta = 125 g 
cooked pasta 
 
1 tablespoon cooked pasta         
= 25 g 
 
○ White pasta 
○ Wholemeal pasta 
 
Crustaceans, shellfish 
(scampi, crab, shrimps, 
lobster, mussels, ...) 
 
 
○ Never or less 
than once per 
month 
○ 1-3 time per 
month 
○ 1 time per week 
○ 2-4 days per 
week 
○ 5-6 days per 
week 
○ Every day 
○ 50 g or less 
○ 50 -  100 g 
○ 100 -  150 g 
○ 150 g or more 
 
1 scampi = 15 g 
1 portion mussels with shells 
= 1200g 
 
 
Fish/fish sticks ○ Never or less 
than once per 
month 
○ 1-3 time per 
○ 60 g or less 
○ 60 -  120 g 
○ 120 -  180 g 
○ 180 -  240 g 
1 fish stick = 30 g 
1 serving of fish    = 175 g 
 
○ Fish 
○ Fish sticks 
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month 
○ 1 time per week 
○ 2-4 days per 
week 
○ 5-6 days per 
week 
○ Every day 
○ 240 g or more 
 
Beef (steak, roast beef,…) 
and veal (leg, steak,…) 
○ Never or less 
than once per 
month 
○ 1-3 time per 
month 
○ 1 time per week 
○ 2-4 days per 
week 
○ 5-6 days per 
week 
○ Every day 
○ 60 g or less 
○ 60 -  120 g 
○ 120 -  180 g 
○ 180 -  240 g 
○ 240 g or more 
 
1 steak = 175 g 
1 slice of roast beef    = 40 g 
1 vealsteak/leg      = 150 g 
 
 
Pork (bacon, pork chop,...)  
and lamb (leg, chop,...) 
○ Never or less 
than once per 
month 
○ 1-3 time per 
month 
○ 1 time per week 
○ 2-4 days per 
week 
○ 5-6 days per 
week 
○ Every day 
○ 60 g or less 
○ 60 -  120 g 
○ 120 -  180 g 
○ 180 -  240 g 
○ 240 g or more 
 
 
1 portion of pork belly =  75 g 
1 hamburger          = 110 g 
2 lamb chops          (boneless ) 
= 150 g 
 
○ Pork 
○ Lamb 
Other meat (horse, rabbit, 
wild,...) 
○ Never or less 
than once per 
month 
○ 1-3 time per 
month 
○ 1 time per week 
○ 2-4 days per 
week 
○ 5-6 days per 
week 
○ Every day 
○ 60 g or less 
○ 60 -  120 g 
○ 120 -  180 g 
○ 180 -  240 g 
○ 240 g or more 
 
1 rabbit leg (boneless)  = 160 
g 
 
Dear steak = 100 g 
 
○ Horse 
○ Other 
Poultry (chicken and turkey) ○ Never or less 
than once per 
month 
○ 1-3 time per 
month 
○ 1 time per week 
○ 2-4 days per 
week 
○ 5-6 days per 
week 
○ Every day 
○ 60 g or less 
○ 60 -  120 g 
○ 120 -  180 g 
○ 180 -  240 g 
○ 240 g or more 
 
1 fillet = 160 g 
1 chicken leg          = 160 g 
1 chipolata = 70 g 
 
 
Organ meats (liver, kidney) 
and tongue 
○ Never or less 
than once per 
month 
○ 1-3 time per 
month 
○ 1 time per week 
○ 2-4 days per 
week 
○ 5-6 days per 
week 
○ Every day 
○ 60 g or less 
○ 60 -  120 g 
○ 120 -  180 g 
○ 180 -  240 g 
○ 240 g or more 
 
1 slice of foie gras = 40 g 
1 porcine kidney    = 140 g 
 
○ Liver 
○ Kidney 
○ Tongue 
 
Vegetarian products (tofu, 
quorn, burgers) 
 
 
NO vegetable burgers,... 
○ Never or less 
than once per 
month 
○ 1-3 time per 
month 
○ 1 time per week 
○ 2-4 days per 
week 
○ 5-6 days per 
week 
○ Every day 
 
○ 50 g or less 
○ 50 -  100 g 
○ 100 -  150 g 
○ 150 g or more 
 
1 large burger        = 95 g 
1 small burger        = 55 g 
1 box of quorn minced meat          
= 175 g 
 
Raw vegetables ○ Never or less 
than once per 
month 
○ 60 g or less 
○ 60 -  120 g 
○ 120 -  180 g 
1 serving of leafy vegetables = 
50 g 
1 tablespoon shredded carrots    
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○ 1-3 time per 
month 
○ 1 time per week 
○ 2-4 days per 
week 
○ 5-6 days per 
week 
○ Every day 
○ 180 -  240 g 
○ 240 g or more 
 
= 20 g 
1 tomato = 150 g 
 
Cabbages (Brussels sprouts, 
cauliflower, red cabbage, 
savoy) and spinach 
 
 
○ Never or less 
than once per 
month 
○ 1-3 time per 
month 
○ 1 time per week 
○ 2-4 days per 
week 
○ 5-6 days per 
week 
○ Every day 
○ 60 g or less 
○ 60 -  120 g 
○ 120 -  180 g 
○ 180 -  240 g 
○ 240 g or more 
 
1 tablespoon Brussels sprouts    
= 40 g 
1 tablespoon red cabbage  = 
25 g 
1 tablespoon cauliflower = 30 
g 
1 tablespoon spinach = 45 g 
○ Cabbages 
○ Spinach 
 
Other winter vegetables 
(Belgian endive, broccoli, 
beet, leek, carrot, turnip,...) 
○ Never or less 
than once per 
month 
○ 1-3 time per 
month 
○ 1 time per week 
○ 2-4 days per 
week 
○ 5-6 days per 
week 
○ Every day 
○ 60 g or less 
○ 60 -  120 g 
○ 120 -  180 g 
○ 180 -  240 g 
○ 240 g or more 
 
 
1 chicory = 85 g 
1 tablespoon cooked 
vegetables = 30 g 
 
 
Summer/ Spring vegetables        
(corn, pepper, soy beans, 
asparagus, mushroom,...) 
○ Never or less 
than once per 
month 
○ 1-3 time per 
month 
○ 1 time per week 
○ 2-4 days per 
week 
○ 5-6 days per 
week 
○ Every day 
○ 60 g or less 
○ 60 -  120 g 
○ 120 -  180 g 
○ 180 -  240 g 
○ 240 g or more 
 
1 asparagus = 50 g 
1 tablespoon of cooked 
vegetables = 30 g 
 
 
Legumes          (chickpeas, 
beans, green beans, lentils, 
peas,...) 
○ Never or less 
than once per 
month 
○ 1-3 time per 
month 
○ 1 time per week 
○ 2-4 days per 
week 
○ 5-6 days per 
week 
○ Every day 
○ 60 g or less 
○ 60 -  120 g 
○ 120 -  180 g 
○ 180 -  240 g 
○ 240 g or more 
 
1 tablespoon peas/ green beans  
= 25 g 
1 tablespoon chickpeas/lentils/ 
beans = 35 g 
 
 
Sauces (warm and cold) ○ Never or less 
than once per 
month 
○ 1-3 time per 
month 
○ 1 time per week 
○ 2-4 days per 
week 
○ 5-6 days per 
week 
○ Every day 
 
 
 
 
 
 
○ 12 g or less 
○ 12 - 25 g 
○ 25 - 50 g 
○ 50 g or more 
1 tablespoon mayonnaise = 25 
g 
1 tablespoon gravy = 12 g 
1 tablespoon white sauce = 20 
g 
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Do you occasionally use haddock liver, caviar or seaweed? ○ Yes  ○ No 
In case your answer is yes, please clarify how much you use of these products. 
- Haddock liver:................................................................................................... 
- Caviar:............................................................................................................  
- Seeweed:.......................................................................................................... 
Do you use enriched products like breakfast cereals enriched with folic acid (see the package for 
information).  
○ Yes  ○ No 
 In case your answer is yes, please specify the product: 
........................................................................................................... 
Do you use food supplements (vitamins and/or minerals)? Fe.  Supradyn, 1 tablet/day 
            Fe. Omnibionta, 1 tablet/day 
○ Yes  ○ No 
In case your answer is yes, leave the product name and your daily use: 
....................................................... 
 
 
 
 
 
 
 
 
 
 
  
Lasagna, spaghetti, and pizza ○ Never or less 
than once per 
month 
○ 1-3 time per 
month 
○ 1 time per week 
○ 2-4 days per 
week 
○ 5-6 days per 
week 
○ Every day 
○ 200 g of less 
○ 200 -  400 g 
○ 400 -  600 g  
○ 600 g or more 
 
1 frozen pizza            =  400 g 
1 pre-packed lasagna = 400 g 
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Appendix E - Sample Size Estimation  
Sample size was calculated using a spreadsheet accessed from the Boston University and Boston 
Medical Centre Research Compliance website (“Sample-Size Calculations”, 2014). 
The sample size calculation for the studies presented in chapters 4 and 6 was based on pilot data 
(see chapter 3), whereby rIL-6 caused a significant increase in the nuclear concentrations of 
DNMT3B. 10 participants were recruited based on this, to account for drop out. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For the final study presented in chapter 7, sample size was estimated based on previous studies that 
had investigated ?̇?O2max changes following a training period. Zoladz, Pilc, Majerczak, Grandys, 
Zapart-Bukowska, & Duda (2008) reported that ?̇?O2max increased from 34.7 (± 0.9) to 35.9 (± 1) 
ml∙kg-1∙min-1 following 5 weeks of aerobic training on a cycle ergometer in recreationally active 
young men.   
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Dengel, Pratley, Hagberg, Rogus, & Goldberg (1996) demonstrated that 10 months of aerobic 
treadmill training increased ?̇?O2max from 2.58 (± 0.19) to 2.91 (± 0.18) l∙min-1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Finally, 12 months of moderate intensity aerobic training in a sample of overweight men elicited a 
significant elevation in ?̇?O2max from 33.4 (± 2.9) to 42.5 (± 5.1) ml∙kg-1∙min-1 (Thompson et al., 
1997). 10 men were recruited for each group (exercise and control) to allow for potential drop outs.  
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Appendix F – Physical Activity Readiness Questionnaire (PAR-Q) 
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Appendix G – Food Record Diary  
 
 
INSTRUCTIONS FOR USING THE FOOD DIARY 
 
 Everything that you eat and drink over the course of the day should be recorded. 
 
 Do not forget to record second helpings and snacks between meals. 
 
 Eating Out – most people eat foods away from home each day - please do not forget to 
record these. Take your diary with you wherever possible.  
 
 Names and descriptions of foods should be as detailed as possible, including the brand 
name and any other information available.  
 
e.g. Cheese  
  
Cheese, cheddar (Pilgrim’s Choice)  - 30g 
 
 Start a new page in your diary for each day, and record each item on a separate line. 
Record the time of day in the first column of each  line. 
 
e.g. 10:30 am  - McVities  Digestive Biscuits (x2) - 50g 
            
 The space provided at the foot of each page for general comments is for you to give any 
further information about your diet  
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DAY 1   
Date:        /              /  
 
Please use a separate line for each item eaten; write in weight of plate; leave a line between different ‘plate’ entries. 
A B C D E F 10 Office 
Use   
Time Food eaten Brand name of each 
item (except fresh 
food) 
Full description of each item 
including: 
-whether fresh, frozen, dried, 
canned 
-cooked: boiled, grilled, 
fried (incl. type of fat), 
roasted etc. 
 
Weight 
Served 
Weight 
of 
Leftovers 
Actual 
Weight 
am/pm home away  
(gms) 
 
(gms) 
 
(gms) 
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
GENERAL COMMENTS 
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Appendix H – Gel Electrophoresis Images  
The image below shows all potential primer pairs performed in triplicate. Gel electrophoresis was 
used to check for product specificity and dimerization. 
 
 
 
Optimal annealing temperatures were then tested (from 55 oC to 59 oC). 
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Appendix I – High Resolution Melting Primer Design  
IL6 
 
Selected assay mapped onto mock bisulfite converted gene sequence 
 
TTATAATTGGTTTTTTTGTTTTGTTAAGAAGAGATTTTTTTAAGATCGATAAAATAGTGATTTTTGTTGGGTA
TTTATTTAAGTTTTGTTTCGTGTATAATATTTTAGGATTCGTT(TGTTGGGGAAAGTGAGGTTATTTATTTTT
TATCGATTGTTTAAATAGAGACGGTGGTTTTTTGTCGCGGTGGGATTTTTTGGTGTGAAAATGAAAATGGGGG
AGGA)TGGTTGGATGGTTTTATTTTTAGTGTTTTTTTGTTTTAAGTAACGTAGATATTTTTGAATTAAGTTTT
TTTTTTTGTATGAAACGAAGTTATTGTTTTTAGTTTCGTAGTCGTGTATTGTGATTCGTTTATGTAATGTGAG
TTTGTTTTTATTTAATTATTTATTTTTTAGAAAATATAATTTAATAAATTTTAAGTATTTGAATTGAGTGATA
TAATATAATATATAGATTTATTTTTTTAATAAAAAGTGTTTTTTAAATAGGAAGTTCGTGTTTATGATAAAAT
GTTTAAATAGGATATTAGGGTATGTAGGGAAAAGTGTTTTTTTTTTTTTTTGGTTTTTTTTTTTAGAGGTAGT
ATTTAATTGTTTGTATTTTTAATTAAATTTTTTGTTATTTTAGTTTGGGAAAGGTTTTTTCGTTTTTTTAGTT
GTTTGATTTTGGTTGTTATATTAAGGATTTGTGTTTTTGTTTATTTATTTATAAAACGGGGGTAATAATAGTT
TTTTTTTTTTAGGGTTGTTGTGAAGATGGAACGTGATGTAGTGTAAAAAATTTTTGGCGTATAGTAATTTTAT
AATATATGTTAGTTTTTTGAATATTTTTTGGTTTAGAGTTTTTGTTTTGGAGAGTTTTTTTAGTTCGGTTATA
TCGGTTTATTTGGTGTTTTGTTTATGAAGGAATTATGAATGAATTAGGTTTTTGTGTTAGTAATGAGTTGGTT
TTTTAATTATTTTTTTTTAAAAGAAATGAGATTTTATGTTTTGTTGAAAATGTTTTTTTGTTGGGGATGTTAA
AGGAGGATTTTGTGGTATTTTGTAGAGTTTGTGTTTATCGTTTTTTTTTTTTGTAAGTTTTGATTTGAAATTA
AAAGAAGTTAGAAGGAAATTACGGACGTAGGTACGGTTTTAGGTTTTGAATTTGTTTTCGCGTCGGTATTTAA
GAATTTTTTATTGGGTTAAGTTGGTTTAGAAGTTTTTTTTTTTTAGGATGGTGTTTTTTGTAGGAGGATTTTT
GGTTTTATGTAAATGGGTTTTAGATTAGGTTGTTTTTTTAGTTTTTAGAGATTTAGATAGTTTTGAGATGGTT
TTAGGTTGAAATTAGATTTTTGTATAATATTAAAATATTTATTTATTAAATATGGTGTTATTT 
1st Exon 
(CpGi) 
Primers 
Product 
CG 
 
  
Primer 
No. 
Forward Sequence Reverse Sequence Position 
1 GGAGAGTATTAAAAATGAAATTATT
TAGTT 
ATAACCTCTATTAAACATTTACTCAA
ATTT 
Promoter 
2 GGAAAGAGAATTTGGTTTAGGAGT AAAATAAAATCATCCATTCTTCACC 1st exon 
3 GTTGGGGAAAGTGAGGTTATTTATT ACACTAAAAATAAAACCATCCAACC Promoter 
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NFκB2 
 
Selected assay mapped onto mock bisulfite converted gene sequence 
 
GAAGTTATTTTTGCGGTCGGTTTCGGGCGTTTTTTGGCGGTTTTTTTGGGTTCGCGAGTAGATTTTATTCGGT
TTCGGTTTTTTTTTCGTTTCGTTTTATTAGTTTTAAGGTTTCGGGAGAGATAGTTCGGATTTCGAATTTTTTT
AGAAGTGATAGGTTTTTAGCGGGTTAGGGTTTAGGAGTTTTGTTTAGGAGAAGGGAAATGAAGTGTTTATTTA
TTAAGGAGATTTGGAATATTAGAATTGAAAAAGGTATTTAGAGTTTAAATAGTTTAAATTTTTATCGATGTGG
GAAATCGTTTTTTTTTTTTAGTTTTAGGTTGGAATGTAGTGAGGGGATTTTGGTTTATTGTAATTTTTGTTTT
TCGGGTTTAAATTATTTTTTTGTTGTAGTTTATCGAGTAGTTGGGATTATAGGCGGTTATTATTACGTTCGTT
TAATTTATGTATTTTTAGTAGAGTTGGGGGTTTTATTACGTTGGTTAGGTTGGTTTCGAATTTTTGATTTTAG
GTGATTCGTTGGTTTTCGTTTTTTAAAATGTTGGAATTATAGTCGTGAGTTATTGCGTACGGTTTATTTATTT
ATTTATTTATTTATTTATGTTTTTGAGATAGTGTTTTGTTTTGTTATTTAGGTTGGAGTATAGTGGCGTGATT
ATGGTTTATTGTAATTTCGAATTTCGGGGTGCGTCGATTTTTTGATTTTTTTGAGTAGTTGGGGTTATAGGTG
TATATTATTATATTTGGTAAATTTTAAAATTTTTAGTGGAGATGGATTTTATTGCGTTGTTTAGGTTGGTTTT
AAATTTTTGGGTTTAAGTGATTTTTTTATTTTGGTTTTTTAAAATGTTTGGATTTTGGATTATAGACGTGAGT
TATTGTATGTTGTCGAATTGTTTTTTATAGATTTTTTAATTTTTATTTGAATATTTTTAGAGGTAGCGAGGTT
AGGATAGAAATTTATTAAGTACGGAGTATATGATTGGATTTTTTTTTGGTTGAGTGTCGTCGTTTGCGCGTTT
TTTTCGGTTGTGTGTAGTTGTTGTTTTTTAGTTTTAGGCGTTGTTCGTTAAAGGTTTTTTTTTTTTT(TTTTT
TTTGTTTCGGTTATTTAGGGGTTTGAATTTAGTTATTTATCGTGGCGGCGGTTTTGGTTGCGGTTTTTTTTCG
CGTTCGATTTATTTGGGATCGGTCGCGATATTTCGTTTGTTAGTAGGGTTTAGGGTCGGGAAAGTTTTTTTTC
GGTTTTTCGGAGGGGGGAATTTTTATGACGTTTTCGTGCGTTACGTTTCGCGTTTTTTTTTATTGGTTGAAAG
TTTAATTTTGGATTGGCGTAGTTAATTCGGAGCGATTCGGGCGCGTTTTTGAGAGGGGATAGGTTTATTTAGG
GCGGGGAGCGGGGTGATAGGATATTAGGCGCGAGTTCGGTCGGTTAGGGGATCGTCGAGAAGGTATTCGTTGA
TTTAGCGTTATTTCGGGTCGGGAGTTTTCGTTGTTTTTCGGTTTTGGTTGCGTTTAACGTTTGGTTTTTTTTG
AAGCGGGGGATTTTTAGGGGGAAGTCGACGGTTTTAGTTTTCGGGGTTTTTATTTTGAGCGGCGCGTTGTCGG
GAA)GTTAGCGGAAGAGGAAGGAAGTTATTTTTGCGGTCGGTTTCGGGCGTTTTTTGGCGG 
1st Exon 
(CpGi) 
Primers 
Product 
CG 
 
 
Primer No. Forward Sequence Reverse Sequence Position 
1 GGTTTTGAGTTTTGTTGGTAGG AAATCTAAATCCAACCACTCACC 1st exon 
2 TTAGGGGTTTGAATTTAGTTATTTAT ACCCTAAACCCTACTAACAAAC 1st exon 
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ASC 
 
Selected assay mapped onto mock bisulfite converted sequence 
 
AGAGTATTGTTTTTTATCGTGGTTTTTGTTTGTTTGTTTTTGTTTTTGTTTTGAGATGGAGTTTCGTTTTTGT
TGTTTAGGTTGAAGTGTAATGGTGTGATTTTAGTTTATTGTAATTTTTATTTTACGGGTTTAGGCGATTTTTT
TGTTTTAGTTTTTTTAGTAGTTGGGATTATAGGTATTTGTTATTACGTTCGGTTAATTTTTGTATTTTTAGTA
GAGATGGGGTTTTATTTTGTTGGTTAGGTTGGTTTTAAATTTTTGATTATTTATTTCGTTTTTTTAAAATGTT
GGGATTATAGGTATGAGTTATCGTGTTCGGTTTATTTTGGTTGTTTTGTTTGTTTTTGAGATAAGGTGTTTGT
TGTCGAGTGGTATAGAGTGTAGTGGTATAATTATAGTTTATTGTATTTTTAATTTTTTGGGTTTAAGTGATTT
TTCGGTTTTAGTTTTTTAAAGTATTGAGATGATATGCGTGATGAGTTATTGTATTTAGTTATGTTGGAAGTTT
TTGAATATAATATGTTGTAGGTATTATAGTTTTATTTATTTTTTTATTTAGTAAATTTTTATTTAGTATTTAA
TGTGTTTTAGATATATTTTTTTTTTTTAGATGGAATTTAGTTTTGTTATTTAGGTTGGAGTGTAGTGGTGTAA
TTTTGGTTTATTGTAGTTTTTGTTTTCGAGGTTTAAGCGATTTTTATGTTTTAGTCGTTTTAGTAGTTAGGAT
TATAGGTGTTTTTTATTATATATAGTTATTTTTAGGTATATTTTTGACGTTAGGAATTTAGTAAAGAATAAGA
TAGTTAAGGTTTTCGATGTTTATAGGTTTTATATTTTAGAGAGGGATGAATGTTTAATAAGTATATAAACGTA
TAATATGTTAGGGTCGTATGATTATAAGGAATAGTGATTGTTATAATTTAGATGAGAGGGAAAAATAAAGGAT
TTTAAATATTTTTTTTGGGAAGTAGAGTTAGGATTTAAATAAAGAATTGTATGGTTTTAAGTTTATGGTTTTT
AATTTTTTGGAGGTTGTTTTTTTTTTTTTTTTTTTTTTTTTAATTAGTGTTGGGATTAAATTTTGGTTTTTTT
AGGAAGTATTTGGTAAGGTTTCGGGAGTTATCGGGTTGGTTATGTTATGTTGGAATATTTATAAGTATCGGAG
GGTTATTTTTATGTCGTAGAAAATGAAATTGAAGTTTAGAGAGATTTGTATTTTTTGTTTTTTTGTATAATTT
ATTTTTTTTTAGTATGTGGAATTGAGGGAGTTTTACGTTTTTAG(TTGTTATGATTTTAAGATTTTACGATAT
GTGGGAGAGGATTTTAAGGTTCGGGGAATCGCGGAGGTTTCGGGGTTTTAGAAATTCGAGGTTTTAAGTTTAG
GTGTTT)TAATAAATTTAGTGAGAGTTAGTTTAGGTTTTCGGTTTGTATTCGTTGGTGTAAGTTTAGAGATAA
GTAGGTGTTATTTATGAGTTTTTTTGCGGTTTTTTTTCGGGTTTTATTTCGTAGGTTAGTTGGAGGGCGCGAT
TTTGGCGTTTTTCGACGGTTTGGGGTTTTAATTTAGAGGTTTGGGTGGGAGGGGATTAAGGGTGTAGTAAGGA
A(GTGTTTTTTGTTGGAGGGTAACGGATCGGGGCGGGGAGTCGGGAGATTAGAGTGGGAGGAAGGCGGGGAGT
TTAGGTTTCGTTTCGGAGTCGATTTTTTTTTGGTCGGTGGTTGTAGCGGGGTGAGCGGCGGTAGCGGTCGGGG
ATTTTGGAGTTATGGGGCGCGCGCGCGACGTTATTTTGGATGCGTTGGAGAATTTGATCGTCGAGGAGTTTAA
GAAGTTTAAGTTGAAGTTGTTGTCGGTGTCGTTGCGCGAGGGTTACGGGCGTATTTCGCGGGGCGCGTTGTTG
TTTATGGACGTTTTGGATTTTATCGATAAGTTGGTTAGTTTTTATTTGGAGATTTACGGCGTCGAGTTTATCG
TTAACGTGTTGCGCGATATGGGTTTGTAGGAGATGGTCGGGTAGTTGTAGGCGGTT)ACGTATTAGGGTGAGT
CGTTTTCGTTTTTTTTTATTTCGTTTTTTTTTTTTATTTATATTAGCGTTTATTTCGCGGGTTTTTTCGTTTT
TTGTTTTTTTTATTTTTAAATAAAGTTGTTTTATCGGAAAGGAGGTTTTTTACGTTTGGTTTATCGATTAACG
GGATTTCGGTTTTACGGCGGGAAGGGAAGGGAAGGGGATTATTTGGTTTATATTTTTTTAGGTTTTGGAGTCG
CGCTAGTTGGGATTTAGGTTTTTTTTTAGTCGGTAGTTAAGTTAG 
1st Exon 
(CpGi) 
Primers 
Product 
CG 
 
  
Primer 
No. 
Forward Sequence Reverse Sequence Position 
1 TAAGAAGTTTAAGTTGAAGTTGTTGT ACCATCTCCTACAAACCCATATC 1st exon 
2 TTTTAGTATGTGGAATTGAGGGAGT ATTAAACACCTAAACTTAAAACCTC 1st exon 
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Appendix J – Gene Expression Primer Design  
DNMT3A 
 
DNMT3B 
 
RPLP0 (‘Housekeeping gene’) 
 
*not NCBI recognised protein coding transcripts 
Green sequences were successfully amplified 
  
Transcript Forward Sequence Reverse Sequence Probe # 
All (common 
assay) 
TTGATGAGCGCACAAGAGAG CCACAGGAGATGCAGATGTC 29 
001 GAAGCCTCAAGAGCAGTGGA TGTTCTTTGCCCGCTTCT 46 
002 GCTGCACCTGGCCTTATG CGTCTTTCAGGCTACGATCC 1 
011 GAAGCCTCAAGAGCAGTGGA TGTTCTTTGCCCGCTTCT 46 
012 GCGCTTTCTCATACATTATCACAT GCACATATGCAAAACAACCTG 81 
013*    
Transcript Forward Sequence Reverse Sequence Probe # 
All (common 
assay) 
ATCTCACGGTTCCTGGAGTG GGTTGCCCCAGAAGTATCG 84 
001 TCGTGCAGGCAGTAGGAAAT TCGTGCAGGCAGTAGGAAAT 83 
002 ACAGCAGTCAGGGACAGACATA TTTGCAGTTTTCCCTGTCATC 60 
003 ACAGCAGTCAGGGACAGACATA TTTGCAGTTTTCCCTGTCATC 60 
004 GGCTAATTGCACAGAGCAGTC GCACCCAGGACAGAGTGG 23 
201*    
202*    
203/006*    
204/005 ACAGCAGTCAGGGACAGACATA TTTGCAGTTTTCCCTGTCATC 60 
Transcript Forward Sequence Reverse Sequence Probe # 
RPLP0 CACTGAGATCAGGGACATGTTG CTTCACATGGGGCAATGG 74 
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DNMT3A protein coding transcripts 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DNMT3B protein coding transcripts 
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Appendix K – Normalised and Temperature Shifted Melt Curves 
 
Normalised and temperature shifted curves for IL6 standards (top) and with all participant samples 
(bottom).
 
 
Normalised and temperature shifted curves for NFκB2 standards (top) and with all participant 
samples (bottom). 
 
  
204 
 
 
 
Normalised and temperature shifted curves for ASC standards (top) and with all participant samples 
(bottom). 
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